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 This dissertation deals with the interaction of the biologically important 
nitrogen oxides (nitric oxide and nitrite) with manganese and ruthenium centers in 
small inorganic porphyrin and nonporphyrin complexes as well as with manganese 
and cobalt centers in manganese and cobalt substituted myoglobin.  
 Chapter 1 introduces the fundamental background of the biological 
importance of nitric oxide, nitrite, manganese porphyrins and manganese-
reconstituted myoglobin.  
 Chapter 2 describes the preparation of the oxo-bridged dimer 
[Ru(bpb)(NO]2(µ-O) in 60% isolated yield from the reaction of the known 
Ru(bpb)(NO)Cl with silver nitrite.  The compound exhibits a υΝΟ of 1758 cm-1 (KBr 
pellet).   The crystal structure reveals a linear ON-Ru-O-Ru-NO fragment with the 
oxo atom serving as an inversion center in the molecule.  The redox behavior in DMF 
is characterized by a reversible reduction followed by a second but irreversible 
reduction in this solvent.  
 Chapter 3 describes the syntheses of a new set of six-coordinate manganese 
nitrosyl porphyrins of the general form (por)Mn(NO)(L) (por = TTP, TPP, T(p-
OCH3)PP; L = piperidine, methanol, 1-methylimidazole) in moderate to high yields.  
The (por)Mn(NO)(pip) complexes were prepared from the reductive nitrosylation of 
the (por)MnCl compounds with NO in the presence of piperidine.  The IR spectra of 
the (por)Mn(NO)(pip) compounds as KBr pellets show new strong bands at 1746 cm-
1 (for TTP) and 1748 cm-1 (for (T(p-OCH3)PP) due to the NO ligands.  Attempted 
crystallization of one of these compounds (por = TTP) from 
 xiii 
dichloromethane/methanol resulted in the generation of the methanol complex 
(TTP)Mn(NO)(CH3OH).  Reaction of the (por)Mn(NO)(pip) compounds with excess 
1-methylimidazole gave the (por)Mn(NO)(1-MeIm) derivatives in good yields.  The 
IR spectra of these compounds show υNO bands that are ~12 cm-1 lower than those of 
the (por)Mn(NO)(pip) precursors, indicative of greater Mn→NO π-backdonation in 
the 1-MeIm derivatives.  X-ray crystal structures of four of these compounds, namely 
(TTP)Mn(NO)(CH3OH), (TTP)Mn(NO)(1-MeIm), (TPP)Mn(NO)(1-MeIm), and 
(T(p-OCH3)PP)Mn(NO)(1-MeIm) were obtained, and reveal that the NO ligands in 
these complexes are linear. 
Also we report the room and the low temperature (–78 °C) cyclic 
voltammetric behavior of three six coordinate (por)Mn(NO)(1-MeIm) (por = 
tetraphenylporphyrin dianion (TPP), tetratolylporphyrin dianion (TTP) or tetra-p-
methoxyphenylporphyrin dianion (T(p-OCH3)PP)) complexes at a Pt disc electrode in 
two nonaqueous solvents (CH2Cl2 and THF).  In CH2Cl2 at room temperature, the 
compounds undergo four oxidations and two reductions within the solvent limit; in 
THF, the compounds undergo one oxidation and three reductions.  In both solvents, 
the first oxidation represents a chemically irreversible one-electron process involving 
the rapid loss of nitric oxide.  The oxidation occurs at the MnNO site as judged from 
bulk electrolysis, UV-vis spectroscopy at room temperature, and IR-
spectroelectrochemistry at room temperature and at –78 °C. The second oxidation, 
accessible in CH2Cl2, is also chemically irreversible and occurs at the porphyrin ring; 
the third and the fourth oxidations are, on the other hand, chemically reversible but 
also occur at the porphyrin ring.  The first reduction is chemically irreversible in 
 xiv 
CH2Cl2, occurs at the porphyrin ring, and is followed by loss of NO.  In THF, the first 
reduction is chemically reversible and is followed by reversible loss of NO.  
 Chapter 4 describes the 1.6–2.0 Å resolution crystal structures of the as-isolated 
Mn-substituted horse heart myoglobin (hh MnIIIMb), the reduced form hh MnIIMb, 
and complexes of hh MnMb with methanol, azide, nitric oxide, and nitrite.  The 
MnIIIMb compound contains distal pocket water in two positions, one coordinated and 
the other not coordinated.  The reduced form, MnIIMb, lacks a distal pocket water 
molecule, in contrast to that observed previously for the iron-containing deoxyMb.  
Interestingly, the structure of the NO adduct suggests a loosely bound NO in the 
distal pocket; the Mn–N–O moiety is surprisingly bent, and represents the first such 
distinctly bent metal-NO unit for a natural or synthetic manganese porphyrin 
complex. Both crystal structures of hh MnIIIMb(ONO) and hh CoIIIMb(ONO) 
determined in this work also reveal this unusual nitrito coordination mode.  In 
addition, this surprising result for the cobalt case, when compared with nitrite ligand 
orientations in related model compounds, demonstrates the importance of the Mb 
distal pocket in orienting the nitrite towards this O-binding mode. 
 In summary, this dissertation shows that nitric oxide binds to the manganese 
center in a linear axial fashion in manganese porphyrin model compounds and in a 
bent tilted fashion in manganese-substituted myoglobin. Nitrite displays the O-
binding coordination mode to both manganese model compounds and manganese-
substituted myoglobin.  Although nitrite exhibits the N-binding coordination mode in 
all known cobalt model compounds, it shows O-binding mode to cobalt-substituted 
myoglobin. The O-binding mode that nitrite exhibits to manganese- and cobalt-
 xv 
substituted myoglobin as well as that reported for ferric-myoglobin further 
demonstrates the crucial role of the distal amino acids in the heme pocket in changing 
the coordination preferences of ligands to metal center in myoglobin.
 1 
Chapter 1. Introduction 
  
 It is now widely recognized that nitric oxide (NO)1-8 and nitrite (NO2–)9-13 have 
a direct relationship to many physiological and pathological processes such as 
vasodilation, neurotransmission, immune system defense, thrombosis, and ischemia 
reperfusion. Indeed, the function of NO and NO2– ion in these physiological and 
pathological processes is tied in with their interactions with heme-containing 
biomolecules. The active site of these heme-containing biomolecules is either a heme-
imidazole active site such as that in hemeoglobin, myoglobin, and soluble guanylyl 
cyclase or a heme-thiolate active site such as that in cytochrome P450 and nitric oxide 
synthases. 
 Studies on the interactions of NO and NO2– ion with metalloporphyrin-
imidazole and metalloporphyrin-thiolate model compounds have contributed 
substantially in understanding the biological chemistry of NO/NO2–-heme protein 
interactions as well as in understanding their many roles in many disease processes 
affecting humans. Since iron is the biologically relevant metal, iron porphyrin model 
compounds have received the greatest attention.  However, these studies have been 
hampered with many difficulties such as the common instability of iron porphyrin 
nitrosyl complexes, the difficulties in obtaining them in a pure state, and the common 
mixed spin states of iron nitrosyl moieties in these compounds.  
 Manganese is only one electron less than iron, and manganese (II) porphyrin 
complexes are isoelectronic with their iron (III) porphyrin analogues. Also, 
manganese has been used to replace iron in many heme-containing biomolecules. 
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However, only few manganese porphyrin nitrosyl and manganese porphyrin nitrite 
compounds have been reported in the literature. In this dissertation, we focus on the 
interaction of nitric oxide (NO) and nitrite ion (NO2–) with manganese porphyrin 
model compounds and with manganese and cobalt substituted myoglobin model 
compounds. In this chapter, we give a brief background about the biology of NO, 
NO2– ion, manganese porphyrin and manganese substituted heme proteins.  
 
1.1 Nitric Oxide in Biology 
 The discovery of nitric oxide as a biological molecule was in the late1980s 
when the research groups of Ignarro and Moncada revealed that the endothelium-
derived relaxing factor (EDRF) proposed by Furchgott is NO.2,14-16 Like 
norepinephrine and epinephrine, nitric oxide (NO) is an important intercellular 
messenger in all vertebrates. It regulates blood flow rate, platelet aggregation, and 
neuronal activity. NO is produced in most mammalian cell types provided they are 
appropriately stimulated.7  It was shown by the Food and Drug Administration that 
inhaling a low dose of NO gas can be a powerful treatment of persistent pulmonary 
hypertension in the newborn.5,17  Two biologically pathways are known for NO 
biosynthesis; conventional and non-conventional pathways.  
 In the conventional pathway, nitric oxide is synthesized, in two enzymatic 
steps, from L-arginine by three heme-containing isozymes of nitric oxide synthases 









































 In neuronal cells, nitric oxide is produced by the neuronal nitric oxide 
synthase (nNOS or NOSI) isozyme. This isozyme was the first NOS that was cloned 
and purified.1,18  It has been proposed that NO, in the brain, provides an important 
signal-averaging mechanism to control synaptic plasticity.19 Indeed, the nNOS is 
particularly well suited to produce NO in a manner that facilitates synaptic plasticity.6
 Nitric oxide production in macrophages was established by Stuehr and 
Nathan.3  It is produced by the calcium independent inducible nitric oxide synthase 
(iNOS or NOSII) isozyme and serves as a defending agent against pathogens after 
conversion to peroxynitrite (ONOO–) from the reaction with the superoxide ion in a 
diffusion-limited non-enzymatic reaction.20 
 In endothelium cells, nitric oxide is produced by the endothelial nitric oxide 
synthase (eNOS or NOSIII) isozyme.21,22  It can then rapidly diffuse, through tissues, 
either into the smooth muscles or into red blood cells.23,24  In vascular smooth muscles 
NO activates another heme-containing enzyme, soluble guanylate cyclase (sGC), to 
produce cyclic guanosine monophospate (cGMP) from guanosine triphosphate 
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(GTP). Only 5-10 nM concentration of NO is required to activate the sGC enzyme. 
Increased levels of cGMP within vascular smooth muscles had been known to allow 
blood vessels to relax and thus increase blood flow.14  Indeed, cGMP activates cGMP-
dependent kinases in the target tissue that modulates intracellular calcium levels to 
modulate many diverse activities in the target tissues. In red blood cells most of NO is 
scavenged rapidly (k = 3.4 × 107 M−1 s−1)25  by another heme-containing protein 
(oxyhemoglobin) and converted to the inert metabolite nitrate ion (NO3–) (eq. 1.2). 
 
NO + oxyhemoglobin (Fe2+)    nitrate (NO3−) + methemoglobin (Fe3+)       (1.2) 
 
The oxyhemeoglobin limits the half-life time of NO in vivo to less than a second, and 
prevents the accumulated NO concentration from directly reacting with oxygen to 
form significant amounts of nitrogen dioxide (very reactive nitrogen species). A 
fraction of NO produced by eNOS in the vasculature (approximately 20%) escapes 
inactivation by hemoglobin and is oxidized to nitrite ion (NO2–), another biologically 
important nitrogen oxide species, in the plasma by a reaction with oxygen.28 The NO 
oxidation reaction to nitrite has recently been proposed to be catalyzed by the 
ceruloplasmin, a multicopper plasma protein.26 
 
1.2 Nitrite ion in Biology 
  Nitrite (NO2–) is an important inorganic ion for all living organisms. Its typical 
concentration levels are 0.1-1.0 µM in plasma, 0.5-2.0 µM in tissues and up to 20 µM 
in vascular tissues.27-32  Most of the nitrite in mammalian cells comes from exogenous 
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sources such as food.  A small portion comes from the reaction of NO with molecular 
oxygen as mentioned above.28 Nitrite can readily modify various biomolecules by, for 
example, protein and lipid nitration,33,34 and S-, N-,31 and Fe- nitrosation.35,36  
 In the meat industry, nitrite ion is used in color fixing and as a protecting 
agent against botulism. However, it has been reported that nitrite in the digestive 
system is a source of nitrosoamines that are commonly believed to promote cancer in 
humans.37,38  Also, high concentrations of nitrite in the blood stream have been known 
as a causative agent for methemoglobinemia (loosing the oxygen carrying capability 
of hemoglobin due to its oxidation to met-hemoglobin).39  
 Recently, evidence has accumulated that nitrite ion has beneficial effects 
under conditions of low oxygen in physiological processes such as ischemia 
reperfusion and hypoxic vasodilation and these effects are attributed to the reduction 
of nitrite back to NO.10,27,40  Non-enzymatic and enzymatic mechanisms have been 
proposed to explain this reduction. The non-enzymatic reduction is very slow41 except 
under high acidic conditions that might only be found in stomach,42,43 urine, 44 or 
ischemic tissue.45,46  In the enzymatic reduction, certain mammalian enzymes catalyze 
the reduction of nitrite to NO. Examples are glutathione-S-transferase,47 xanthine 
oxidoreductase,48-50 deoxyhemoglobin,  deoxymyoglobin,27,51-55 cytochrome P450,56 
and nitric oxide synthases.57,58 
 Modeling the interaction of nitrite with heme-containing biomolecules will 
contribute in our understanding of the nitrite reduction mechanism. In Chapter 4 of 
this dissertation, structural details of the interaction of nitrite with manganese- and 
cobalt-reconstituted myoglobin are discussed.  
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1.3 Manganese porphyrins and manganese proteins 
Manganese is a required trace element for all known living organisms.  It is 
essential for many biological processes such as bone and tissue formation, 
reproductive processes, and carbohydrate and lipid metabolism.59  It is a cofactor for a 
number of metalloenzymes such as arginase, catalase, ribonucleotide reductase, 
enolase, superoxide dismutase and the oxygen-evolving complex of photosystem II.60-
63  Humans have a mean manganese concentration of 9.03±2.25 mg/L in whole blood 
with a mean concentration of 1.82 ± 0.64 mg/L in the serum.64 
 Fifty years ago, Borg and Cotzias discovered that injection of radiolabeled 
54MnCl2 into patients in vivo resulted in the incorporation of Mn2+ into red cell 
fractions, and that the incorporated Mn2+ was non-exchangeable and non-dialyzable.65-
67 Based on their data, they suggested that the Mn2+ was most likely incorporated into 
heme, thus providing some circumstantial evidence for the production of a natural 
manganese heme in humans.68  Mahoney and Sargent confirmed this finding, and 
showed that between 0.5-9.0% of administered radiolabeled 54Mn was incorporated 
into red blood cells, and that 60-70% of the radioactivity was recovered in the 
resulting crystalline hemin preparation.69  Hancock and Fritze later showed that, 
indeed, injection of 54MnCl2 into rats resulted in the formation of a 54Mn-containing 
species that had identical gel chromatographic elution behavior as hemoglobin, bis-
pyridine hemochrome and hematin;70  this provided further evidence for the in vivo 
formation of a manganese porphyrin, confirming the earlier results of Borg and 
Cotzias.  These authors noted, however, that added Mn2+ was not able to displace iron 
from heme by a simple metal displacement reaction, suggesting the incorporation of 
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Mn2+ at the heme biosynthesis stage.  In a separate study, Wibowo et al. determined 
that increased levels of protoporphyrin in erythrocytes (induced by exposure to Pb) 
resulted in incorporation of in vivo manganese by the porphyrin.71 In metal ion 
accumulation studies using Norway lobsters, it was determined that exposure of the 
lobsters to Mn2+ resulted in accumulation of the metal ion in nerve tissue, and in the 
hemolymph where it was bound mainly to the respiratory protein hemocyanin (the 
authors noted that Mn2+ was not able to displace copper in the protein).72 
 Manganese-substituted derivatives of a number of heme proteins have been 
prepared and studied.  In many cases, these Mn-substituted derivatives were 
investigated in order to provide insight on the role of heme iron in the reactions of the 
native proteins.73  Manganese-substituted derivatives of heme proteins that have been 
reported to date include those of hemoglobin (Hb),74,75 myoglobin (Mb),76-78 
cytochrome P450,79 soluble guanylyl cyclase,80 cytochrome c,81 nitric oxide 
synthase,82 horse radish peroxidase,75,77,83 cytochrome b5,84 cytochrome c peroxidase 
(CcP),77,85,86 and prostaglandin H2 synthase-1.87  
 Unlike the native iron analogues, MnII-substituted hemoglobin (MnIIHb) and –
myoglobin (MnIIMb) do not bind dioxygen or carbon monoxide,77 although the MnIII-
derivatives bind azide.77,88-90  Mitra and coworkers have shown that MnIIIMb binds 
cyanide and thiocyanate at a location > 6Å from the metal center.91  
 Clearly, Mn porphyrins are becoming increasingly recognized for their 
potential biological applications.  The fact that MnII is incorporated into heme at the 
biosynthesis level (mentioned above) raises an intriguing possibility that Mn-hemes 
might be of some physiological importance, although their function (if any) remains 
 8 
unknown.  Despite numerous reports on the spectroscopy of Mn-substituted heme 
proteins, there are only a few reports of crystal structures of these complexes.  Moffat 
and coworkers reported the structure of MnHb using X-ray difference Fourier 
techniques92,93 and demonstrated the similarity of the structure of this complex to that 
of the native iron compound.  Arnone later reported the 3.0 Å resolution structure of 
the heterometallic complex Hb(α-FeIICO)(β-MnII).94  Very recently, Loll and 
coworkers reported the 2.0 Å resolution crystal structure of Mn-PGHS.87   
 This dissertation is organized as follows. Chapter 2 describes the synthesis, 
characterization, molecular structure, and electrochemical properties of an oxo-
bridged dimmer of a ruthenium nitrosyl compound containing the bpb ligand system. 
Chapter 3 describes the synthesis, characterization, molecular structures, and fiber-
optic IR-spectroelectrochemical properties of a series of six-coordinate manganese 
porphyrin nitrosyl complexes containing three different axial ligands, piperidine, 
methanol, and 1-methylimidazole and three different porphyrin ligands, TPP, TTP, 
and T(p-OCH3)PP. Chapter 4 describes the ligand conformations in derivatives of 
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Chapter 2. Synthesis, Molecular Structure, and Redox Behavior of 
                   an oxo-bridged dimer of a Ruthenium-bpb Nitrosyl*  
 
2.1 Introduction 
 Nitrosyl complexes of the group 8 metals have been studied for many 
decades.1,2  This is due in large part to the fact that the interaction of nitric oxide (NO) 
with iron is biologically relevant both for heme and non-heme proteins.3  The use of 
synthetic models in the study of the heme-NO interactions has provided a wealth of 
information concerning the electronic structure and the predicted geometries of the 
FeNO moiety in these systems. However, a common byproduct of iron porphyrin 
chemistry in aerobic environments is the µ-oxo dimer [(porphyrinato)Fe]2(µ-O).  
Several of these iron porphyrin oxo-bridged dimers have been characterized by X-ray  
crystallography. 4-7  
 In 1998, our group described an unexpected product formed during work with 
organoosmium nitrosyl porphyrins.4  This product, namely [(OEP)Os(NO)]2(µ-O) 
(OEP = octaethylporphyrinato dianion) was characterized by spectroscopy and by X-
ray crystallography, and displayed a linear oxo-bridged ON-Os-O-Os-NO linkage.  
This product was found to be rather unreactive towards acid, and this lack of 
reactivity of the oxo-bridge was attributed to the removal of electron-density in this 
bridge by the two trans NO ligands.  We have not, to date, been successful at 
obtaining the corresponding ruthenium analogue [(porphyrinato)Ru(NO)]2(µ-O). 
-------------------------------------------------------------------------------------------------------
∗ Taken in part from “Synthesis, molecular structure, and redox behavior of an oxobridged dimer of a 
ruthenium-bpb nitrosyl” Zahran, Z. N.; Powell, D. R.; Richter-Addo, G. B. Inorg. Chim. Acta 2006, 
359, 3084–3088, with permission from Elsevier. 
 
 14 
 1,2-Bis(pyridine-2-carboximido)benzene (H2bpb) and its various derivatives 
have been extensively employed as tetradentate diamide ligands for various transition 
metal ions. Mascharak and coworkers have utilized the H2bpb ligand for the design 




mild photochemical conditions.8  Importantly, they have investigated possible 
similarities between the H2bpb ligand and porphyrin ligands.9  Ford,10,11 and  
Mascharak,8,12-15 have published extensively on the phototochemical release of NO 
from group 8 metal-NO compounds with related polydentate ligands.   
  Based on the work of Mascharak, we explored the possibility of designing 
(bpb)Ru(NO)-containing compounds that will complement our work on ruthenium 
nitrosyl porphyrins.  In this chapter, we describe (i) the preparation and spectroscopic 
properties of an oxo-bridged dimer of a ruthenium nitrosyl compound containing the 
bpb ligand system, (ii) its crystal structure, and (iii) its electrochemical properties.  
 
2.2 Experimental Section 
 2.2.1 General. All reactions were performed under an atmosphere of 
prepurified nitrogen using standard Schlenk glassware and/or in an Innovative 
 15 
Technology Labmaster 100 Dry Box.  Solutions for spectral studies were also 
prepared under a nitrogen atmosphere.  Solvents were distilled from appropriate 
drying agents under nitrogen just prior to use. 
 2.2.2  Chemicals. 1,2-Bis(pyridine-2-carboxamido)benzene (H2bpb)16 and 
Ru(bpb)(NO)Cl8 were prepared by the literature methods.  Silver nitrite, tetra-n-
butylammonium hexafluorophosphate (NBu4PF6), and anhydrous DMF were 
purchased from Aldrich Chemical Company and used as received.  Chloroform-d 
(99.8%) was obtained from Cambridge Isotope Laboratories.  Diethyl ether, CH2Cl2 
and THF were distilled from calcium hydride under a nitrogen atmosphere just prior 
to use.  Nitrogen of ultra high purity was purchased from Trigas (Houston, TX). 
 2.2.3 Instrumentation. Infrared spectra were recorded on a Bio-Rad FT-155 
FTIR spectrometer.  Proton NMR spectra were obtained on Varian Mercury VX 300 
MHz spectrometer and the signals referenced to the residual signal of the solvent 
employed (CHCl3 at δ 7.24 ppm).  ESI mass spectra were obtained on a Micromass 
Q-TOF mass spectrometer.  UV-vis spectra were recorded on a Hewlett-Packard 
model 8453 diode array instrument.  Electrochemical measurements were performed 
with a BAS CV-50W instrument.  A three-electrode cell was used (Pt working and 
auxiliary electrodes, Ag/AgCl reference electrode).  The solutions used were 1.0 mM 
in analyte in 10 ml of 0.1 M NBu4PF6.  Nitrogen gas was bubbled through the 
solution for about 8 min before each set of measurements and was passed 
continuously over the surface of the solution during the measurements.   
 2.2.4  Synthesis of [(bpb)Ru(NO)]2(µ-O).  A solution of AgNO2 (0.06 g, 0.4 
mmol) in DMF (10 mL) was added slowly, via cannula, to a solution of 
 16 
Ru(bpb)(NO)Cl (0.20 g, 0.4 mmol) in DMF (5 mL).  The mixture was stirred under 
nitrogen gas overnight at room temperature.  Dichloromethane (30 ml) was added, 
whereby a white precipitate formed.  The solution was filtered, and filtrate was heated 
at ~100 °C under vacuum to remove the solvent.  The IR spectrum of the residue 
showed two bands in the υNO region at 1758 cm-1 (major) and 1840 cm-1 (minor).  
The residue was washed several times with CH2Cl2 to remove an as-yet 
uncharacterized byproduct.  The remaining orange residue, after the wash with 
CH2Cl2, was dried under vacuum for several hours to give the orange-red compound 
[(bpb)Ru(NO)]2(µ-O) (0.11 g, 60% yield based on Ru).  IR (KBr, cm-1): υNO = 1758 
vs, υRu-O-Ru = 816s; also 3057vw, 2984 vw, 1631vs, 1595vs, 1563s, 1470s, 1447w, 
1372s, 1359w, 11268vw, 1112vw, 1092vw, 1028w, 970w, 745w, 725w, 693vw, 
682w, 653vw, 571w, 512w, 452vw.  1H NMR (CDCl3; δ, ppm ): 8.28 (m, 4H), 8.07 
(m, 2H), 8.05 (m, 2H), 7.93–7.84 (overlapping m, 8H), 7.30 (m, 4H), 6.93 (m, 4H);  
also, 5.29 (s, trace CH2Cl2) and 1.57 (s, trace H2O).  ESI mass spectrum: m/z 913.0 
[(Ru(bpb)NO)2O + H]+ (100%). 
The complex is soluble only in DMF and insoluble or only sparingly soluble 
in most organic solvents. 
 2.2.5  X-ray crystallography. Suitable crystals for X-ray crystallography were 
grown by vapor diffusion of CH2Cl2 (25 ml) into a DMF solution of the compound at 
room temperature under inert atmosphere.  A red prism-shaped crystal of dimensions 
0.16 x 0.10 x 0.10 mm was selected for structural analysis.  Intensity data for this 
compound were collected at 90(2) K using an instrument with a Bruker APEX CCD 
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area detector17,18 using graphite-monochromated Mo Kα radiation (λ = 0.71073 Å).  
Cell parameters were determined from a non-linear least squares fit of 5577 peaks in 
the range 2.27 < θ < 28.18°.  A total of 15194 data were measured in the range 2.09 < 
θ < 26.00° using ω oscillation frames.  The data were corrected for absorption by the 
semi-empirical method19 giving minimum and maximum transmission factors of 
0.840 and 0.897.  The data were merged to form a set of 3859 independent data with 
R(int) = 0.0234 and a coverage of 100.0 %. The monoclinic space group P21/n was 
determined by systematic absences and statistical tests, and verified by subsequent 
refinement.  The structure was solved by direct methods and refined by full-matrix 
least-squares methods on F2.20  Hydrogen atom positions were initially determined by 
geometry and refined by a riding model.  Non-hydrogen atoms were refined with 
anisotropic displacement parameters.  Hydrogen atom displacement parameters were 
set to 1.2 times the displacement parameters of the bonded atoms.  A total of 305 
parameters were refined against 7 restraints and 3859 data to give wR(F2) = 0.0541 
and S = 1.001 for weights of w = 1/[σ2 (F2) + (0.0280 P)2 + 1.5000 P], where P = 
[Fo2 + 2Fc2] / 3.  The final R(F) was 0.0211 for the 3587 observed, [F > 4σ(F)], data.  
The largest shift/s.u. was  0.002 in the final refinement cycle.  The final difference 
map had maxima and minima of 0.341 and -0.344 e/Å3, respectively.  Details of the 
crystal data and structure refinement are given in Table 2.1.  Thermal ellipsoids are 






Table 2.1.  Crystal Data and Structure Refinement of [(bpb)Ru(NO)]2O. CH2Cl2 
Formula (C36 H24 N10 O7 Ru2)⋅ (CH2Cl2)2C38 
H28Cl4N10O7Ru2 
Fw 1080.64 
T (K) 90(2) 
Crystal system Monoclinic 
Space group P21/n 
a (Å), α (°) 10.1710(14), 90 
b (Å), β (°) 12.7547(18), 97.919(5) 
C (Å), γ (°) 15.256(2), 90 
V,  Z, Z- 1960.3(5) Å3, 2, 0.5 
D(calcd), mg/m3 1.831  
Abs coeff, mm-1 1.109 mm 
F(000) 1076 
Crystal size (mm) 0.16 x 0.10 x 0.10 
θ range for data collection, deg 2.09 -26.00 
Reflections collected 15194 
Independent reflns 3859 [R(int) = 0.0234] 
Max and min trans. 0.897 and 0.840 
Data / restraints / parameters 3859 / 7 / 305 
Goodness-of-fit on F2 1.001 
Largest and mean shift / s.u. 0.002and 0.000 
R indices (all data) R1 = 0.0211, wR2 = 0.0541 
Largest diff. peak and hole, eÅ-3 0.341 and -0.344 
Observed data [I > 2σ(I)] 3587 
 wR2 = { S [w(Fo2 - Fc2)2] / S [w(Fo 2)2] }1/2  
R1 = S ||Fo| - |Fc|| / S |Fo| 
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2.3  Results and Discussion 
 2.3.1  Synthesis and spectroscopy of [(bpb)Ru(NO)]2(µ-O).  Several years 
ago, Bohle and coworkers21 reported the preparation of (TTP)Ru(NO)(ONO) in 60% 
yield from the metathesis reaction of the precursor (TTP)Ru(NO)Cl with silver nitrite.  
In our attempt to generate an analogous Ru(bpb)(NO)(ONO) complex, we reacted 
Ru(bpb)(NO)Cl with silver nitrite in DMF.  The product obtained after workup, in 
60% yield, was the oxo-bridged dimer [Ru(bpb)(NO)]2(µ-O).  The production of this 
oxo-bridged dimer from the use of a nitrite reagent is not unusual.  For example, 
Ankers and Fanning22 have reported that ferric salen complexes (salen = N,N’-
ethylenebis(salicylideneiminato) dianion) react with nitrite reagents to generate the 
[Fe(salen)]2(µ-O) species, and that no evidence for the target nitrite adducts was 
obtained.    
 The IR spectrum of [Ru(bpb)(NO)]2(µ-O) as a KBr pellet shows a strong band 
at 1758 cm-1 attributed to υΝΟ.   This υΝΟ band is lower than that of the monometallic 
precursor Ru(bpb)(NO)Cl (υΝΟ = 1867 cm-1), and is reflective of the replacement of 
the chloride ligand by the oxo-bridge in the product.   A similar lowering of υΝΟ  is 
observed in the related Ru(salen)(NO)Cl (1844 cm-1) and [Ru(salen)(NO)]2(µ-O) 
(1762 cm-1) derivatives in CH2Cl2.10  A strong band at 816 cm-1 is also evident in the 
IR spectrum, and is assigned to the IR-active asymmetric Ru-O-Ru stretch.  Related 
stretches have been reported for [Fe(salen)]2(µ-O).py (805 cm-1),23 [Fe(sal-O-
phen)]2(µ-O).py (820 cm-1),23 and [Ru(salen)]2(µ-O) (805 cm-1).10 
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 2.3.2  X-ray crystallography of [(bpb)Ru(NO)]2(µ-O). There are only a 
handful of oxo-bridged compounds of ruthenium containing the (Ox)N-Ru-O-Ru-
N(Ox) fragment that have been structurally characterized in the solid state by X-ray 
crystallography (Table 2.2). Slow diffusion of CH2Cl2 vapor into a DMF solution of 
[Ru(bpb)(NO)]2(µ-O) at room temperature over several days produced single crystals 
suitable for X-ray diffraction.  The molecular structure of this oxo-bridged dimer is 
shown in Figure 2.1, and selected structural data are presented in Table 2.3. Details of 
the bond lengths and angles are presented in Tables 2.4 and 2.5 in the appendix at the 
end of this dissertation.  
 
 
Figure 2.1.  Molecular structure of [Ru(bpb)(NO)]2(µ-O). Thermal ellipsoids are 
                     shown at 50%. Hydrogen atoms and the methylene chloride solvent 





Table 2.2.  Selected Vibrational Frequencies (cm-1) and Geometric Parameters (Å, °) for oxo-bridged Ruthenium  Compounds.a 
 
 
a  Abbreviations:  dmpH = 3,5-dimethylpyrazole; bpy = bipyridine, tw = this work.
Compound υNO υRuORu Ru-O Ru-N(O) Ru-O-Ru Ru-N-O O-Ru-N(O) Ref 












































{[Ru(bpy)2(NO2)]2(µ-O)}2+   1.876(6) 
1.890(7) 
 157.2(3)   [25] 
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Table 2.3.  Selected Bond Lengths and Angles for [Ru(bpb)(NO)]2(µ-O) 
____________________________________________________________________ 
Bond Lengths (Å) 
 
N(25)-O(26) 1.174(2) Ru(1)-N(16) 1.9935(15) 
Ru(1)-N(25) 1.7486(17) Ru(1)-N(24) 2.1507(16) 
Ru(1)-N(1) 2.1277(15) Ru(1)-O(27) 1.8829(3) 
Ru(1)-N(9) 1.9890(16)   
 
Bond Angles (°)  
 
O(26)-N(25)-Ru(1) 175.85(15) N(16)-Ru(1)-O(27) 89.49(5) 
N(25)-Ru(1)-O(27) 174.14(5) N(24)-Ru(1)-O(27) 86.41(4) 
N(25)-Ru(1)-N(1) 91.61(7) N(1)-Ru(1)-N(9) 80.14(6) 
N(25)-Ru(1)-N(9) 95.07(7) N(1)-Ru(1)-N(16) 162.84(6) 
N(25)-Ru(1)-N(16) 95.54(7) N(1)-Ru(1)-N(24) 115.53(6) 
N(25)-Ru(1)-N(24) 91.52(7) N(9)-Ru(1)-N(24) 162.86(6) 
N(1)-Ru(1)-O(27) 84.36(4) N(9)-Ru(1)-N(16) 83.69(6) 
N(9)-Ru(1)-O(27) 88.44(5)   
 
 Each ruthenium center is octahedrally coordinated, and the oxo group is at an 
inversion center.  The Ru-N-O moiety is near-linear with a bond angle of 
175.85(15)°, and a Ru-N(O) bond length of 1.7486(17) Å.  The Ru-N(pyridyl) bonds 
are longer than the Ru-N(amide) bonds (Figure 2.1 and Table 2.3) with an average 
Ru-N(bpb) value of 2.06 Å.  The ON-Ru-O-Ru-NO linkage is linear and imposed by 
symmetry, with a Ru-O bond length of 1.8829(3) Å; this Ru-O bond length is similar 
to those determined for related Ru oxo-bridged dimers (Table 2.2).24,25  
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 2.3.3 Redox behavior of Ru(bpb)(NO)Cl and [Ru(bpb)(NO)]2(µ-O). The 
redox behavior of the known compound Ru(bpb)(NO)Cl and the newly-synthesized 
oxo-bridged compound [Ru(bpb)(NO)]2(µ-O) in DMF have been investigated using 
cyclic voltammetry.   These compounds are insoluble or only sparingly soluble in 
other organic solvents, hence we were limited with our choice of solvent for 
electrochemistry.   The electrochemistry of Ru(bpb)(NO)Cl is characterized by two 
reversible one-electron reductions at E°/1 = –0.17 V and E°/2 = –0.64 V vs Ag/AgCl 
(Figure 2.2), and these are represented by equations (2.1) and (2.2), respectively. 
 
 
Fig. 2.2. Cyclic voltammogram of 0.1 mM Ru(bpb)(NO)Cl in DMF containing 0.1 M 








_     [Ru(bpb)(NO)Cl]1-              (2.1) 
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_     [Ru(bpb)(NO)Cl]2-              (2.2) 
 
No oxidation behavior for Ru(bpb)(NO)Cl was apparent in this solvent.  
The oxo-bridged compound [Ru(bpb)(NO)]2(µ-O) displays a quasi-reversible 
and diffusion-controlled reduction in DMF, and the cyclic voltammogram showing 
this reduction (E°/ = –0.99 V vs Ag/AgCl) is shown in Figure 2.3.   
 
-1.30-1.00-0.70
E (V vs. Ag/AgCl)
 
Fig. 2.3. Cyclic voltammogram of 0.1 mM [Ru(bpb)NO]2O in DMF containing 0.1 
M NBu4PF6. Scan rate = 0.2 V/s. 
 
 
The peak separation (ΔE = Epa-Epc) is 132 mV.  We thus represent this first reduction 
by equation (2.3). 
 




_     {[Ru(bpb)(NO)]2(µ-O)}1-       (2.3) 
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The compound also undergoes a second, but irreversible, reduction at Ep2= –
1.63 V (not shown).  Analysis of the peak geometry indicates that the overall process 
consists of a reversible electron transfer followed by a fast chemical (decomposition) 
reaction, i.e., equations (2.4) and (2.5). 
 




_     {[Ru(bpb)(NO)]2(µ-O)}2-      (2.4) 
 
{[Ru(bpb)(NO)]2(µ-O)}2-        decomposition          (2.5)  
 
 Interestingly, a similar pattern of reductions has been reported for the oxo-
bridged ruthenium complexes {[RuX(bpy)2]2(µ-O)}2+ (X = Cl or NO2) in acetonitrile 
vs. SCE (E°/ = –0.32 V and –0.15 V, respectively; Ep2 = –1.0 V and –0.75 V, 
respectively).26  As seen in Figures 2.2 and 2.3, the large negative shifts of the 
reductions of [Ru(bpb)(NO)]2(µ-O) (υNO = 1758 cm-1) compared with those of the 
precursor compound Ru(bpb)(NO)Cl (υNO = 1867 cm-1), by ~0.8-1.0 V,  
 are consistent with the greater electron density in the oxo-bridged compound. 
 
2.4 Conclusion 
 In this chapter we reported the preparation of the oxo-bridged dimer 
[Ru(bpb)(NO]2(µ-O) in 60% isolated yield from the reaction of the known 
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Ru(bpb)(NO)Cl with silver nitrite.  The compound exhibits a υNO of 1758 cm-1 (KBr 
pellet).   The crystal structure reveals a linear ON-Ru-O-Ru-NO fragment with the 
oxo atom serving as an inversion center in the molecule.  The redox behavior in DMF 
is characterized by a reversible reduction followed by a second but irreversible 
reduction in this solvent.  
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Chapter 3. Synthesis, Molecular Structures, and Fiber-optic Infrared 
                   Spectroelectrochemical Studies of Six-Coordinate  
                   Manganese Nitrosyl Porphyrins∗ 
 
3.1 Introduction 
 As mentioned in Chapter 1, the biological role of nitric oxide (NO) is tied in 
with its interactions with iron center in heme-containing biomolecules.1  For example, 
the receptor for NO in smooth muscles is the heme-containing enzyme soluble 
guanylyl cyclase (sGC), and this enzyme contains histidine as an axial ligand to iron.  
NO binds to the ferrous heme site in sGC to give a six-coordinate (por)Fe(NO)(His) 
complex that converts rapidly to a five-coordinate (por)Fe(NO) species.2-5  The 
binding of NO to the heme iron in sGC has been correlated with activation of this 
enzyme, resulting in the formation of cyclic guanosine monophosphate (cGMP) from 
guanosine triphosphate (GTP).  The accumulation of cGMP is associated with 
vasodilation.  Other histidine-liganded hemes also form adducts with NO, and these 
include hemoglobin (Hb), myoglobin (Mb), cytochrome oxidase, nitrophorins, FixL, 
and nitrite reductase.1  In many cases, the binding of NO has been shown to be 
biologically relevant.   
 ------------------------------------------------------------------------------------------------------ 
∗ Taken in part from;  
i-“Synthesis, Characterization, and Molecular Structures of Six-Coordinate Manganese Nitrosyl 
Porphyrins” Zahran Z. N.; Lee J.; Alguindigue S. S.; Khan M. A.; Richter-Addo G. B. Dalton Trans. 
2004, 44–50, with permission from Elsevier. 
ii- “Fiber-optic Infrared Spectroelectrochemical Studies of Six-coordinate Manganese Nitrosyl 
Porphyrins in Nonaqueous Media” Zahran Z. N.; Shaw M.; Khan M. A.; Richter-Addo G. B. Inorg. 
Chem. 2006, 45, 2661-2668, with permission from The American Chemical Society. 
iii-“Specific detection of gaseous NO and 15NO in headspace from liquid-phase reactions involving 
NO-generating organic, inorganic, and biochemical samples using a mid-infrared laser” Yi J.; Namjou 






 NO binds to both ferric and ferrous hemes, although NO binding to ferric 
hemes is weaker than that for ferrous hemes.6  The biological relevance of NO 
binding to ferric heme is best exemplified by ferric nitrophorins from the kissing bug 
Rhodnius prolixus.7  The nitrophorins are ferric heme proteins contained in the saliva 
of the insect, and the hemes bind NO.  When the insect bites the host, NO is released 
from the ferric nitrosyl nitrophorins, resulting in local vasodilation which ensures that 
the insect obtains a sufficient blood meal.   
Efforts to study well-characterized six-coordinate ferric nitrosyl porphyrins 
have been hampered by the fact that they are difficult to obtain pure, and only a few 
have been obtained in sufficient quantities for detailed spectroscopic and 
crystallographic studies.8  Such ferric nitrosyl porphyrins belong to the {MNO}6 class 
as defined by Enemark and Feltham.9-11  
 We are interested in the study of manganese nitrosyl porphyrins belonging to 
the {MnNO}6 classification.  These are isoelectronic with their ferric nitrosyl and d6 
ferrous carbonyl FeCO counterparts. NO binding to manganese-substituted heme 
provides a possible scenario in which the strong Mn-NO bond formed between NO 
and MnII will effectively mimic the labile Fe-NO bond formed between NO and ferric 
FeIII ion (which is isoelectronic with MnII).  Manganese-substituted hemoproteins 
containing NO continue to provide very valuable information to complement that 
obtained from their isoelectronic and biologically relevant FeCO analogues.  
Examples of such Mn-substituted nitrosyl complexes include those of Hb, Mb, sGC, 
neuronal nitric oxide synthase (nNOS), cytochrome c, and peroxidases.4,12-15 
MnHbNO and MnMbNO have been prepared as spectroscopic models for their EPR-
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silent Fe-CO analogues.16-18  The MnHbNO derivative was shown to behave similarly 
to native HbCO in terms of ligand rebinding kinetics and cooperativity.19  In the case 
of Mn-substituted sGC, binding of NO generated a six-coordinate 
(porphyrinato)Mn(NO)(His) species that did not activate the enzyme.4  Other 
manganese hemes have been prepared for NO-sensing20-22 and for peroxynitrite 
decomposition.23,24 
 Prior to our work in this area, there were only two X-ray crystal structures of 
manganese nitrosyl porphyrins, namely those of (TTP)Mn(NO) and (TPP)Mn(NO)(4-
Mepip).25  In order to better understand the nature of binding of NO to manganese 
porphyrins and to determine the nature of the trans effect of the bound NO ligand in 
these complexes, we prepared a new set of synthetic manganese nitrosyl porphyrin 
complexes containing methanol, and N-donor ligands.  In this chapter, we report their 
syntheses and structural characterization by spectroscopy and high resolution X-ray 
crystallography.  
We were also interested in examining the redox properties of the six-
coordinate (por)Mn(NO)(1-MeIm) compounds containing the axial imidazole group.  
To the best of our knowledge, only one other electrochemical study of MnNO 
porphyrins was reported prior to our work, that of the five-coordinate 
(TPP)Mn(NO).26 The electrochemistry of non-NO-containing manganese porphyrins 
is well developed.27-29  In this chapter, we also report the redox behavior of three 
(por)Mn(NO)(1-MeIm) (por = TPP, TTP, T(p-OCH3)PP)) compounds in CH2Cl2 and 
THF as determined by cyclic voltammetry, infrared spectroelectrochemistry, and bulk 
electrolysis.  
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Figure 3.1. Structural representation of the new (por)Mn(NO)(L) complexes 
                    X = H, L =  1-Methylimidazole or piperidine     
                    X = CH3, L= 1-Methylimidazole, piperidine, or MeOH 
                    X = OCH3, L = 1-Methylimidazole or piperidine 
 
3.2 Experimental Section 
 All reactions were performed under an atmosphere of prepurified nitrogen 
using standard Schlenk glassware and/or in an Innovative Technology Labmaster 100 
Dry Box.  Solutions for spectral studies were also prepared under a nitrogen 
atmosphere.  The toluene, CH2Cl2, and THF solvents were distilled from calcium 
hydride under nitrogen gas just prior to use. 
3.2.1 Chemicals.  H2TPP (TPP = 5,10,15,20-tetraphenylporphyrinato 
dianion), H2TTP (TTP = 5,10,15,20-tetra-p-tolylporphyrinato dianion), H2(T(p-
OCH3)PP (T(p-OCH3)PP =  5,10,15,20-tetra-p-methoxyphenylporphyrinato dianion), 
(TPP)MnCl, (TTP)MnCl, (T(p-OCH3)PP)MnCl, and (TPP)Mn(1-MeIm) were 
prepared by literature methods.30,31  Pyrrole (98%), benzaldehyde (99%), p-
tolylaldehyde (97%), p-anisaldehyde (98%), piperidine (99.5+%), 1-methylimidazole 
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(1-MeIm, 99+%), anhydrous CH3OH (99.8%) and tetra-n-butylammonium 
hexafluorophosphate (NBu4PF6) were purchased from Aldrich Chemical Company 
and used as received.  Chloroform-d (99.8%) was obtained from Cambridge Isotope 
Laboratories.  Nitric oxide (98%, Matheson Gas) for the synthesis work was passed 
through KOH pellets and two cold traps (dry ice/acetone, -78 °C) to remove higher 
nitrogen oxides. Nitrogen of ultrahigh-purity grade was purchased from Trigas 
(Houston, TX). 
3.2.2 Instrumentation.  Infrared spectra were recorded on a Bio-Rad FT-155 
FTIR spectrometer.  Proton NMR spectra were obtained on Varian VXR-S 500 MHz 
or Varian Mercury VX 300 MHz spectrometers for low temperature and room 
temperature measurements, respectively, and the signals referenced to the residual 
signal of the solvent employed (CHCl3 at 7.24 ppm).  All coupling constants are in 
Hz.  ESI mass spectra were obtained on a Micromass Q-TOF mass spectrometer.  
Elemental analyses were performed by Atlantic Microlab, Norcross, Georgia.  
Electrochemical measurements were performed with a BAS CV-50W 
instrument.  IR spectra were recorded with a Bruker Vector 22 FTIR spectrometer 
equipped with a mid-IR fiber-optic dip probe system and a liquid-nitrogen cooled 
MCT detector (RemSpec corporation, Sturbride, MA, USA).  The stainless steel 
mirror of the fiber-optic dip probe system was replaced by a Pt disc (3 mm diameter) 
working electrode (Bioanalytical Systems).  The spectrometer was set to 4 cm-1 
resolution. Typically 16 scans from 2200−1000 cm-1 were recorded.   
The IR spectroelectrochemical measurements were performed in a three-
electrode cell as described previously (Pt working and auxiliary electrodes, Ag wire 
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quasi-reference electrode).32  The room temperature was 23±1 °C.  We jacketed the 
cell to allow for a dry ice-acetone bath (–78°C) for the low temperature 
measurements.   Potentials are reported versus the ferrocene-ferrocenium couple (~ 
+0.46 V vs. SCE).33  Corrections for iR drop between the working and reference 
electrodes were applied.  The solutions used were 0.5–1.0 mM in analyte in 10 mL of 
0.1 M NBu4PF6.  Nitrogen gas was bubbled through the solution for about 8 min 
before each set of measurements and was passed continuously over the surface of the 
solution during the measurements.  Each measurement was performed in triplicate or 
greater.  
 Nitric oxide detection was based on high-resolution tunable diode laser 
absorption spectroscopy (TDLAS). The experimental setup is shown in Fig. 3.2. The 
system consists of a cold head, optics and control electronics. The cold head, inside 
the cryostat housing, contains an infrared photovoltaic detector, a foil heater, a 
temperature sensor, and a mid- infrared tunable diode laser source emitting in the 
wavelength region around 5.2 µm. The optics consist of a gas cell and a series of 
plane and focusing mirrors for steering and collimating the infrared beam. Associated 
electronics include a laser current controller, a laser temperature controller, a lock-in 
amplifier, two waveform generators, and a computer. The present system employs a 
closed-cycle refrigerator system that cools the diode laser and detector to cryogenic 
temperatures with no need for liquid nitrogen refills. An auto-tuning temperature 
controller (LakeShore, OH), working in conjunction with cryo-cooler (IGC Polycold, 
CA), is used to maintain laser temperatures at set points between 85 and 110 K. The 
spectrometer takes advantage of a second harmonic detection scheme, and a 100-m 
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long optical multi-pass Herriott cell (Aerodyne, MA). 
 
 
Figure 3.2. Schematic diagram of the TDLAS instrument. Major components include 
a cryostat, Herriott multipass cell, electronics, and an integrated gas sampling 
interface. 
 
3.2.3 Preparation of (por)Mn(NO)(pip) compounds (por = TPP, TTP, T(p-
OCH3)PP).  A Schlenk flask was charged with (TTP)MnCl (0.035 g, 0.046 mmol), 
CH2Cl2 (8 mL), and piperidine (0.7 mL).  The mixture was stirred to generate a green 
solution, and NO gas was bubbled through the solution for 20 min.  [Note:  during 
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this time, an uncharacterized white gas was generated from solution]  The color of the 
reaction mixture turned bright red.  Nitrogen was bubbled through the solution for 5 
min to remove any unreacted NO and other gaseous products.  Anhydrous methanol 
(15 mL) was added to the solution, and the volume of the solution was reduced in 
vacuo until a solid precipitated.  The supernatant solution was discarded, and the red-
purple solid was dried in vacuo to give (TTP)Mn(NO)(pip).0.65CH2Cl2 (0.026 g, 
0.029 mmol, 63% isolated yield).  Anal. Calcd for C53H47N6O1Mn1.0.65CH2Cl2: C, 
72.07; H, 5.44; N, 9.40; Cl, 5.15.  Found: C, 71.78; H, 5.66; N, 9.53; Cl, 4.99.  IR 
(KBr, cm-1):  υNO = 1746 s; also 3022 w, 2935 w, 2920 w, 2859 w, 1533 m, 1503 m, 
1450 m, 1404 vw, 1346 m, 1305 w, 1268 vw, 1209 w, 1181 m, 1108 w, 1070 m, 1027 
vw, 1015 w, 1001 s, 871 w, 847 vw, 796 s, 718 m, 631 w, 552 vw, 522 m.  1H NMR 
(CDCl3; δ, ppm, –50 °C): 8.74 (s, 8H, pyrrole-H of TTP), 8.03 (d, J = 7, 4H, o-H of 
TTP), 7.99 (d, J = 7, 4H, o'-H of TTP), 7.52 (app t (overlapping d's), 8H, m/m'-H of 
TTP), 5.29 (s, CH2Cl2), 2.67 (s, 12H, CH3 of TTP), 0.15 (br d, 1H of pip), –0.40 (br d, 
2H of pip), –0.78 (br d, 1H of pip), –1.34 (br d, 2H of pip), –3.42 (app q, J = 13, 2H 
of pip), –3.76 (br d, 2H of pip), –5.48 (app t, J = 13, 1H of pip).  The peaks of 
piperidine ligand were not observed in the 1H NMR spectrum of the complex at room 
temperature.  ESI mass spectrum: m/z 723 [(TTP)Mn]+ (100%). 
   Attempts to obtain suitable crystals of this sample for a single-crystal X-ray 
structural determination have not been successful.  Unexpectedly, however, crystals 
grown by slow solvent evaporation of a CH2Cl2/CH3OH (2:1) solution mixture of 
(TTP)Mn(NO)(pip) under inert atmosphere were identified as 
(TTP)Mn(NO)(CH3OH) by X-ray crystallography.  The IR spectrum of 
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(TTP)Mn(NO)(CH3OH) (as a KBr pellet) showed a strong band at 1743 cm-1 assigned 
to υNO. 
The (TPP)Mn(NO)(pip) and (T(p-OCH3)PP)Mn(NO)(pip) compounds were 
prepared similarly from the reaction of (TPP)MnCl and (T(p-OCH3)PP)MnCl, 
respectively, with NO gas in the presence of piperidine.  The red (TPP)Mn(NO)(pip) 
product was obtained in 85 % isolated yield. IR (KBr, cm-1): υNO = 1744 s; also 3447 
w, 2938 w, 1598 m, 1534 vw, 1490 vw, 1441 m, 1347 m, 1303 vw, 1273 w, 1205 w, 
1175 vw, 1071 m, 1003 vs,  870 vw, 797 m, 752 s, 702 s, 667 w. 1H NMR (CDCl3; δ, 
ppm ): 8.71 (s, 8H, pyrrole-H of TPP), 8.16 (d, J = 7 Hz, 4H, o-H of TPP), 8.06 (d, J 
= 8 Hz, 4H, o’-H of TPP), 7.69–7.64 (overlapping m,  m-H and p-H of TPP).  The 
peaks of piperidine ligand were not observed in the 1H NMR spectrum of the complex 
at room temperature.  ESI mass spectrum: m/z 667.1 [(TPP)Mn]+ (100%). 
The red-purple (T(p-OCH3)PP)Mn(NO)(pip) product was obtained in 81% 
isolated yield.  IR (KBr, cm-1): υNO = 1748 s; also 3032 vw, 2997 vw, 2935 w, 2834 
w, 1608 m, 1574 vw, 1533 m, 1512 s, 1502 s, 1464 m, 1439 m, 1410 vw, 1347 m, 
1303 w, 1287 m, 1248 s, 1206 w, 1175 s, 1107 w, 1071 w, 1039 w, 1026 m, 1002 s, 
872 vw, 848 w, 803 s, 719 m, 637 vw, 632 vw, 607 m, 575 vw, 555 w, 538 m. 1H 
NMR (CDCl3; δ, ppm, –50 °C): 8.73 (s, 8H, pyrrole-H of T(p-OCH3)PP), 8.04 (d, J = 
8, 4H, o-H of T(p-OCH3)PP), 8.01 (d, J = 8, 4H, o'-H of T(p-OCH3)PP), 7.22 (br 
(overlapping with CHCl3 peak), 8H, m/m'-H of T(p-OCH3)PP), 5.29 (s, CH2Cl2), 4.07 
(s, 12H, OCH3 of T(p-OCH3)PP), 0.12 (br d, 1H of pip), –0.43 (br d, 2H of pip), –
0.80 (br d, 1H of pip), –1.36 (br d, 2H of pip), –3.46 (app q, J = 13, 2H of pip), –3.79 
(br d, 2H of pip), –5.50 (app t, J = 13, 1H of pip).  The peaks of piperidine ligand 
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were not observed in the 1H NMR spectrum of the complex at room temperature.  ESI 
mass spectrum: m/z 787 [(T(p-OCH3)PP)Mn]+ (100%). 
3.2.4 Preparation of (por)Mn(NO)(1-MeIm) compounds (por =  TPP, TTP, 
T(p- CH3)PP).  To a stirred CH2Cl2 solution  (8 mL) of 
(TTP)Mn(NO)(pip).0.65CH2Cl2 (0.020 g, 0.022 mmol) was added 1-MeIm (0.01 mL).  
The mixture was stirred for 5 h.  The solvent was removed in vacuo, and the residue 
was redissolved in a CH2Cl2/CH3OH (1:1, 10 mL) mixture.  To this solution was 
added 1-MeIm (0.1 mL).  Slow evaporation of this solution at room temperature 
under inert atmosphere gave spectroscopically pure (TTP)Mn(NO)(1-MeIm) (0.012 
g, 0.014 mmol, 64% isolated yield) as purple crystals.  IR (KBr, cm-1): υNO = 1738 s, 
1732 s; also 3128 vw, 3019 vw, 2952 vw, 2918 vw, 2866 vw, 1532 w, 1506 m, 1457 
vw, 1347 m, 1304 vw, 1284 vw, 1233 w, 1209 w, 1181 m, 1108 m, 1081 w, 1071 m, 
1001 s, 943 vw, 908 vw, 846 vw, 796 s, 731 w, 719 m, 670 vw, 660 vw, 628 vw, 615 
vw, 523 m.  1H NMR (CDCl3; δ, ppm): 8.69 (s, 8H, pyrrole-H of TTP), 8.07 (d, J = 7, 
4H, o-H of TTP), 7.90 (d, J = 7, 4H, o'-H of TTP), 7.50 (d, J = 7, 4H, m-H of TTP), 
7.44 (d, J = 7, 4H, m'-H of TTP), 2.67 (s, 12H, CH3 of TTP).  The peaks of the 1-
MeIm ligand were not observed at room temperature.  1H NMR (CDCl3; δ, ppm, -40 
°C): 8.69 (s, 8H, pyrrole-H of TTP), 8.04 (d, J = 7, 4H, o-H of TTP), 7.91 (d, J = 7, 
4H, o'-H of TTP), 7.50 (d, J = 7, 4H, m-H of TTP), 7.45 (d, J = 7, 4H, m'-H of TTP), 
4.60 (s, 1H of 1-MeIm), 2.66 (s, 12H, CH3 of TTP), 2.06 (s, 3H, CH3 of 1-MeIm), 
1.17 (s, 1H of 1-MeIm), 0.73 (s, 1H of 1-MeIm).  ESI mass spectrum: m/z  805 
[(TTP)Mn(1-MeIm)]+ (57%), 723 [(TTP)Mn]+ (100%). 
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The red (TPP)Mn(NO)(1-MeIm) compound was prepared in 80% isolated 
yield by similar procedures.  IR (KBr, cm-1): υNO = 1737s; also 3122vw, 3030vw, 
2994vw, 2952vw, 2930vw, 2900vw, 2865vw, 1686vw, 1655vw, 1637vw, 1596w, 
1533w, 1489vw, 1440w, 1420vw, 1365vw, 1348s, 1284vw, 1231w, 1204w, 1176w, 
1070s, 1003s, 796s, 752s, 703s, 663w, 614vw, 526vw, 453vw.  1H NMR (CDCl3; δ, 
ppm ): 8.67 (s, 8H, pyrrole-H of TPP), 8.20 (d, J = 7 Hz, 4H, o-H of TPP), 8.01 (d, J 
= 8 Hz, 4H, o’-H of TPP), 7.68–7.64 (overlapping m,  m-H and p-H of TPP).  The 
peaks of the 1-MeIm ligand were not observed in the spectrum at room temperature.  
ESI mass spectrum: m/z 667.2 [(TPP)Mn]+ (68.8%), 749.2 [(TPP)Mn(1-MeIm)]+ 
(100%).  The (por)Mn(NO)(1-MeIm) complexes are stable in the solid state in air for 
at least 1 week (as judged by IR and 1H NMR spectroscopy). Suitable crystals for X-
ray crystallography were grown by slow evaporation of a CH2Cl2/toluene (2:1) 
solution of the compound containing 1-MeIm at room temperature under inert 
atmosphere. 
The purple (T(p-OCH3)PP)Mn(NO)(1-MeIm) compound was obtained in 77% 
isolated yield after recrystallization from CH2Cl2/CH3OH (2:1) in the presence of 
excess 1-MeIm at room temperature under inert atmosphere.  IR (KBr, cm-1): υNO = 
1736 s; also 3128 vw, 3033 vw, 2998 vw, 2958 vw, 2934 vw, 2906 vw, 2833 vw, 
1606 m, 1533 w, 1501 s, 1466 w, 1460 w, 1439 w, 1346 m, 1303 vw, 1285 m, 1247 s, 
1205 vw, 1177 s, 1108 w, 1089 vw, 1073 vw, 1037 vw, 1024 w, 1001 s, 849 vw, 808 
m, 799 m, 735 w, 719 w, 670 vw, 662 vw, 607 w, 582 vw, 540 w. 1H NMR (CDCl3; 
δ, ppm): 8.69 (s, 8H, pyrrole-H of T(p-OCH3)PP), 8.08 (dd, J = 8.4/2.1, 4H, o-H of 
T(p-OCH3)PP), 7.91 (dd, J = 8.4/2.1, 4H, o'-H of T(p-OCH3)PP), 7.22 (dd 
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(overlapping with CHCl3 peak), 4H, m-H of T(p-OCH3)PP), 7.17 (dd, J = 8.4/2.1, 4H, 
m'-H of T(p-OCH3)PP), 4.06 (s, 12H, OCH3 of T(p-OCH3)PP). The peaks of the 1-
MeIm ligand were not observed at room temperature. 1H NMR (CDCl3; δ, ppm, -40 
°C): 8.70 (s, 8H, pyrrole-H of T(p-OCH3)PP), 8.07 (dd, J = 8/2, 4H, o-H of T(p-
OCH3)PP), 7.93 (dd, J = 8/2, 4H, o'-H of T(p-OCH3)PP), 7.22 (dd (overlapping with 
CHCl3 peak), 4H, m-H of T(p-OCH3)PP), 7.18 (dd, J = 8/2, 4H, m'-H of T(p-
OCH3)PP), 4.60 (s, 1H of 1-MeIm), 4.06 (s, 12H, OCH3 of T(p-OCH3)PP), 2.07 (s, 
3H, CH3 of 1-MeIm), 1.15 (s, 1H of 1-MeIm), 0.72 (s, 1H of 1-MeIm). ESI mass 
spectrum: m/z 787 [(T(p-OCH3)PP)Mn]+ (100%).  
 3.2.5 Structural determinations by X–ray crystallography.  X-ray data were 
collected on a Bruker Apex diffractometer using MoKα (λ = 0.71073 Å) radiation.  
The structures were solved by the direct method using the SHELXTL system 
(Version 6.12; 1997) and refined by full-matrix least squares on F2 using all 
reflections.  All the non-hydrogen atoms were refined anisotropically.  All the 
hydrogen atoms were included with idealized parameters.  
(i) (TTP)Mn(NO)(CH3OH). Crystals for X-ray crystallography were grown 
during an attempt at crystallizing (TTP)Mn(NO)(pip) using CH2Cl2/CH3OH.  X-ray 
diffraction intensity data, which approximately covered the full sphere of the 
reciprocal space, were measured as a series of ω oscillation frames each 0.3º for 21 
sec/frame.  The detector was operated in 512 x 512 mode and was positioned 6.00 cm 
from the crystal.  Coverage of unique data was 99.0% complete to 54º(2θ).  Cell 
parameters were determined from a non-linear least squares fit of 7582 reflections in 
the range of 2.8< θ < 25.9º.  A total of 37158 reflections were measured.  The data 
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were corrected for absorption by multi-scan method from equivalent reflections 
giving minimum and maximum transmissions of 0.9193 and 0.9403.  The asymmetric 
unit contains one and half units of the C49H40N5O2Mn complex (with the Mn(2) atom 
situated very near the inversion center) and fractional amounts of dichloromethane 
(0.2) and methanol (1.15) solvent molecules.   SHELXTL restraints of DFIX and 
ISOR were applied to the atoms belonging to the disordered axial group and the 
solvent molecules to achieve convergence during least squares refinement.  The final 
R1 = 0.067 is based on 12836 “observed reflections” [I > 2σ(I)], and wR2  = 0.178 is 
based on all reflections (13303 reflections). 
(ii) (TTP)Mn(NO)(1-MeIm).0.28CH2Cl2. Suitable crystals for X-ray 
crystallography were grown by slow evaporation of CH2Cl2/CH3OH (1:1) solution of 
the compound containing 1-MeIm at room temperature under inert atmosphere.  
Coverage of unique data was 99.1% complete to 53º(2θ).  Cell parameters were 
determined from a non-linear least squares fit of 8729 reflections in the range of 3.6 < 
θ < 26.2º.  A total of 13983 reflections were measured.  The data were corrected for 
absorption by multi-scan method from equivalent reflections giving minimum and 
maximum transmissions of 0.8602 and 0.9036.  The asymmetric unit contains one 
and half units of the C52H42N7OMn complex (with the Mn(2) atom situated very near 
the inversion center) and fractional dichloromethane solvent molecules.  The unit of 
the C52H42N7OMn complex that lies at the inversion center is disordered at the axial 
sites.  The N(10) atom from the NO group lies very close to the N(11) atom of the 1-
methylimidazole ligand.  As a result, the refinement of the positional and thermal 
parameters is compromised.  The Mn-N-O angles and N-O bond distances in the two 
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molecules are significantly different.  However, in view of the axial disorder in the 
disordered molecule, it is not possible to ascertain whether these differences in bond 
angles and bond lengths are real or an artifact of the poor refinement due to the 
disorder.  SHELXTL restraints of DFIX, ISOR and EADP were applied to achieve 
convergence during least squares refinement (the disordered NO group in the 
molecule #2 was allowed to refine without any restraints).  The final R1 = 0.078 is 
based on 13129 “observed reflections” [I > 2σ(I)], and wR2  = 0.222 is based on all 
reflections (13983 reflections).  
(iii) (TPP)Mn(NO)(1-MeIm).2.5toluene.  Suitable crystals for X-ray 
crystallography were grown by slow evaporation of a CH2Cl2/toluene (2:1) solution of 
the compound containing 1-MeIm at room temperature under inert atmosphere.  X-
ray data were collected at 120(2) K.  Intensity data, which approximately covered the 
full sphere of the reciprocal space, were measured as a series of ω oscillation frames 
each 0.3° for 21 sec/frame.  The detector was operated in 512 x 512 mode and was 
positioned 6.12 cm from the crystal.  Coverage of unique data was 94.5 % complete 
to 53.0°(2θ).  Cell parameters were determined from a non-linear least squares fit of 
6715 reflections in the range of 2.5 < θ < 28.2°.  A total of 30030 reflections were 
measured. All the non-hydrogen atoms were refined anisotropically.  All the 
hydrogen atoms were included with idealized parameters.  The asymmetric unit 
contains one C48H34MnN7O molecule and 2.5 toluene solvent molecules which sit on 
the crystallographic two-fold axis.  The final R1 = 0.0448 is based on 10214 
“observed reflections” [I > 2σ(I)].  
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(iv) (T(p-OCH3)PP)Mn(NO)(1-MeIm).CH2Cl2.  Suitable crystals for X-ray 
crystallography were grown by slow evaporation of CH2Cl2/CH3OH (2:1) solution of 
the compound containing 1-MeIm at room temperature under inert atmosphere.  
Coverage of unique data was 98.4% complete to 50º(2θ).  Cell parameters were 
determined from a non-linear least squares fit of 7823 reflections in the range of 3.2 < 
θ < 24.4º.  A total of 23420 reflections were measured.  The data were corrected for 
absorption by multi-scan method from equivalent reflections giving minimum and 
maximum transmissions of 0.9223 and 0.9820.  An initial data set was collected at 
100(2) K and yielded poor refinement.  Better data were obtained at 178(2) K, 
showing much sharper spots on the frames.  There is a highly disordered CH2Cl2 
solvent molecule and some minor disorder involving the nitrosyl O(1) atom, the 
imidazole N(7) atom, and the C(27), C(34), C(41) and C(48) atoms of the porphyrin 
periphery.  The non-solvent atoms were refined without resolving into their 
disordered components due to the very close proximity of these components.  The 
overall geometry of the molecule of interest is sound.  SHELXTL restraints of DFIX, 
ISOR and SADI were applied to the atoms belonging to the disordered solvent 
molecule to achieve convergence during least squares refinement.  The final R1 = 
0.075 is based on 4461 “observed reflections” [I > 2σ(I)], and wR2  = 0.1896 is based 
on all reflections (8054 unique reflections). The data fit well for a triclinic cell (Rint = 
0.07); the Laue symmetry is 1-bar.  
Displacement ellipsoids in Figures 3.3-3.6 are drawn at the 35% probability 
level.  Details of the crystal data and refinement are given in Table 3.1. Some selected 
bond lengths and angles are given in Table 3.2. Details of bond lengths and angles for  
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Table 3.1 Crystal Data and Structure Refinement of (TTP)Mn(NO)(CH3OH) (1), 
(TTP)Mn(NO)(1-MeIm).0.28CH2Cl2 (2), (TPP)Mn(NO)(1-MeIm).2.5toluene (3), and 
(T(p-OCH3)PP)Mn(NO)(1-MeIm).CH2Cl2 (4). 
  
a R1 = ∑||Fo| - |Fc||/∑|Fo|.   b wR2 = {∑[w(Fo2 - Fc2)2]/∑[wFo4]}1/2 
 
Compound 1 2 3 4 
Formula  C49.90H43.33Cl0.27N5O2.77 
Mn  
C52.28H42.56Cl0.56NO 





Mn   
Fw 821.69 859.65 1009.59 984.79 
T (K) 96(2) 120(2) 120(2) 178(2) 




























V,  Z 3074.9(3) Å3, 3 3407.4(3) Å3, 3 2593.6(3) Å3, 2 2325.3(5) 
Å3, 2 
D(calcd), g/cm3  1.331 1.257 1.293 1.407 
Abs coeff, mm-1  0.389 0.370 0.307 0.457 
F(000) 1288 1343 1057 1020 
Crystal size (mm) 0.22 x0.18 x 0.16 0.42 x0.38 x 0.28 0.28 x0.12 x 0.04 0.18 x 0.04x 
0.04 
θ range for data 
collection (°) 
1.68–27.00 1.84–26.50 1.66–28.26° 1.62–25.00 
Index ranges –14 ≤ h ≤ 14, –15 ≤ k ≤ 
15, –29 ≤ l ≤ 29  
–18 ≤ h ≤ 18, –18 ≤ k 
≤ 18, –19 ≤ l ≤ 19  
–13 ≤ h ≤12, –17 ≤ 
k ≤17, –28 ≤ l ≤ 27 
–14 ≤ h ≤ 14, 
–14 ≤ k ≤ 15,  
–17 ≤ l ≤ 17  
Reflns. collected 37158 36783 30030 23420 
Independent reflns 13303 [Rint = 0.0162] 13983 [Rint = 
0.0198] 
12135 [Rint = 
0.0195] 
8054 [Rint = 
0.0715] 












13303 / 124 / 916 13983 / 69 / 948 12135 / 0 / 680 8054 / 63 / 
672 
Good-of-fit on F2 1.127 1.193 1.053 1.004 
Final R indices 
[I>2σ(I)]a,b 
R1 = 0.0670, wR2 = 
0.1769 
R1 = 0.0780, wR2 = 
0.2205 
R1 = 0.0448, wR2 = 
0.1202 
R1 = 0.0750, 
wR2 = 
0.1721 
R indices (all 
data)a,b 
R1 = 0.0685, wR2 = 
0.1778 
R1 = 0.0811, wR2 = 
0.2220 
R1 = 0.0550, wR2 = 
0.1303 
R1 = 0.1437, 
wR2 = 
0.1896 
Largest diff. peak 
and hole, eÅ-3 




the four compounds are presented in Tables 3.6-3.13 in the appendix at the end of this 
dissertation. 
 
3.3 Results and Discussion  
 3.3.1 Synthesis and spectroscopic characterization.  The synthesis and 
chemistry of manganese- and other metalloporphyrin nitrosyl complexes has been 
reviewed.1  Scheidt and coworkers showed, over thirty years ago, that reductive 
nitrosylation of manganese (III) porphyrins took place in the presence of aliphatic 
amines to generate manganese nitrosyl porphyrins.34,35  We have used similar 
methodology for the preparation of (TTP)Mn(NO)(pip),  (TPP)Mn(NO)(pip), and 
(T(p-OCH3)PP)Mn(NO)(pip) in 65%, 85%, and 81% isolated yields, respectively (eq. 
3.1). 
 
(por)MnCl  +  xs NO  + pip  →   (por)Mn(NO)(pip)       (3.1) 
(por = TTP, TPP, or T(p-OCH3)PP; pip = piperidine) 
 
These red-purple complexes are soluble in CH2Cl2, CHCl3, and acetone, but 
are only slightly soluble in hexane and methanol.  The complexes are moderately 
stable in air in the solid state, showing no noticeable signs of decomposition over a 
one month period as judged by IR and 1H NMR spectroscopy.  Their solutions, 
however, are air-sensitive.  
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 The IR spectra of the (por)Mn(NO)(pip) complexes (as KBr pellets) show 
new strong bands at 1746 cm-1 (for TTP), 1744 cm-1 (for TPP), and 1748 cm-1 (for 
(T(p-OCH3)PP), respectively, which are attributed to the terminal NO ligands.  These 
bands are similar to that reported for the crystallographically characterized 
(TPP)Mn(NO)(4-Mepip) compound (υNO 1740 cm-1) that exhibits a linear NO 
geometry.34,35  Although the (por)Mn(NO)(pip) compounds are isoelectronic with 
their ferric-NO counterparts, the υNOs of the manganese compounds are significantly 
lower than those of the isolable ferric [(por)Fe(NO)(N-base)]+ complexes (υNO 1894-
1921 cm-1) reported by Scheidt and Ellison.36  Parthasarathi and Spiro have suggested, 
based on resonance Raman studies, that there is reduced metal→NO backbonding in 
FeIII-NO compared with MnII-NO due to the higher effective charge on iron in FeIII-
NO.16  Clearly, such an effect is responsible for the differences in the observed NO 
stretching frequencies between the Mn and Fe compounds.  We have not been able to 
observe the parent ions of the (por)Mn(NO)(pip) compounds in their ESI mass 
spectra; the spectra show ion fragments due to loss of both axial ligands.  Attempts to 
grow crystals of the (TTP)Mn(NO)(pip) complex from dichloromethane/methanol 
resulted in the replacement of the piperidine ligand with methanol solvent to give 
(TTP)Mn(NO)(CH3OH) (υNO 1743 cm-1), as determined from the X-ray crystal 
structure of the crystallization product (see later). 
 The (TTP)Mn(NO)(1-MeIm), (TPP)Mn(NO)(1-MeIm) and (T(p-
OCH3)PP)Mn(NO)(1-MeIm) derivatives were prepared in 62%, 80%, and 77% 
isolated yields, respectively, from the reaction of their piperidine precursors with an 
excess of 1-MeIm in CH2Cl2 (eq. 3.2).  
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(por)Mn(NO)(pip)  +  1-MeIm   →   (por)Mn(NO)(1-MeIm) +  pip     (3.2) 
 
Prior to this work, the (por)Mn(NO)(imidazole) compounds reported in the literature 
were prepared in situ from exposure of NO to solutions of MnII-porphyrins containing 
an excess of the imidazole ligand, and the success of this synthetic procedure was 
very limited.16,37  We find that the preparative route described by eq. 3.2 provides a 
convenient method by which pure samples of the nitrosyl products can be obtained in 
sizeable quantities. 
These products of eq. 3.2 are purple and have similar solubilities and 
stabilities as those of their piperidine precursors.  The IR spectra of the 
(por)Mn(NO)(1-MeIm) complexes (as KBr pellets) reveal bands at 1738/1732 cm-1 
(split band),  1737, and 1736 cm-1 for the TTP, TPP, and T(p-OCH3)PP derivatives, 
respectively, assignable to υNO.  The split υNO band of (TTP)Mn(NO)(1-MeIm) is 
likely due to the presence of two orientations of the 1-MeIm ligand in the bulk solid.  
In any event, the υNOs  in (por)Mn(NO)(1-MeIm) are ~ 12 cm-1 lower in energy than 
the υNOs of the precursor (por)Mn(NO)(pip) complexes.  This feature is consistent 
with the replacement of piperidine ligand with the π -interacting 1-MeIm ligand, 
which makes more electron density available for MnII→NO backdonation, resulting 
in the lowering of υNO.   
The low temperature 1H NMR spectra of the (por)Mn(NO(1-MeIm) 
complexes show, in addition to the peaks due to the porphyrin rings, the peaks of the 
bound 1-MeIm ligands.  The ESI mass spectrum of (TTP)Mn(NO)(1-MeIm) and 
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(TPP)Mn(NO)(1-MeIm) show ion fragments assigned to loss of the NO ligand or loss 
of both axial ligands, whereas that of (T(p-OCH3)PP)Mn(NO)(1-MeIm) shows ions 
fragments from loss of both axial ligands. 
3.3.2 X-ray Crystallographic Characterization.  We were successful in 
obtaining suitable crystals of (TTP)Mn(NO)(CH3OH), (TTP)Mn(NO)(1-MeIm), 
(TPP)Mn(NO)(1-MeIm), and (T(p-OCH3)PP)Mn(NO)(1-MeIm) for single-crystal X-
ray crystallography.  The molecular structures of the four compounds are shown in 
Figures 3.3-3.6.  Selected structural parameters for all four compounds are reported in 
Table 3.2. As stated in the Experimental Section, the asymmetric units in the crystals 
of (TTP)Mn(NO)(CH3OH) and (TTP)Mn(NO)(1-MeIm) contain one 
crystallographically ordered molecule and a second disordered molecule.  Only the 
more accurate data from the ordered components are discussed here. 
 The Mn-N-O moieties in all four complexes are linear, and this observed 
linearity is consistent with the classification of these (por)Mn(NO)(L) compounds as 
{MnNO}6 species.9-11  The axial Mn-N(O) bond length in (TTP)Mn(NO)(CH3OH) is 
1.680(2) Å, and the N-O bond length is 1.165(2) Å.  The Mn-N(por) distances fall in 
the 2.008(2)-2.032(2) Å range, and the Mn atom is displaced by 0.12 Å from the 24-
atom mean porphyrin plane toward the π-acid NO ligand.  The methanol ligand in 
(TTP)Mn(NO)(CH3OH) is oriented essentially between two porphyrin N-atoms (Fig. 
3.3b).  The Mn-O bond length is 2.086(2) Å and the Mn-O2-C49 angle is 124°.  The 
Mn-O bond length is shorter than those observed in other structurally characterized 
MnII and MnIII porphyrins containing alcohol ligands: [(TPP)Mn(CH3OH)2]ClO4 
(2.252(2) and 2.270 (2) Å),38 [(TPP)Mn(CH3OH)2]SbCl6 (2.283(5) Å),39 
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(TPP)Mn(N3)(CH3OH) (2.329(7) Å),40 (P*)Mn(CH3OH)(OH) (2.251(7) Å; P* = D4 
symmetrical chiral porphyrin),41 (TCPP)Mn(CH3OH)(H2O) (2.246 Å; TCPP = 
tetracarboxyphenylporphyrin),42 and [(OEP)Mn(EtOH)]ClO4 (2.145(2) Å).43 
The axial Mn-N(O) bond lengths in the three (por)Mn(NO)(1-MeIm) 
complexes are 1.650(2)-1.645(3) Å and are similar to that observed previously in 
(TPP)Mn(NO)(4-Mepip) (1.644(5) Å)25,34 but are shorter than that determined for 
(TTP)Mn(NO)(CH3OH) (1.680(2) Å).  This feature is suggestive of greater Mn→NO 
π-backdonation in these (por)Mn(NO)(N-base) compounds.  The lower  υNO of the 1-
methylimidazole complexes compared with that of the methanol complex supports 
this view of a greater Mn→NO π-backdonation in (por)Mn(NO)(1-MeIm).  
Importantly, the axial trans Mn-N(imidazole) bond lengths of 2.096(2), 2.0882(13),  
and 2.097(3) Å for the (TTP)Mn(NO)(1-MeIm), (TPP)Mn(NO)(1-MeIm), and (T(p-
OCH3)Mn(NO)(1-MeIm) compounds, respectively, are shorter than that reported for 
the five-coordinate high-spin (TPP)Mn(1-MeIm) complex (2.192(2) Å)44 reflecting 
the influence of the strong field π-acid NO ligand on these trans Mn-N(imidazole) 
bond lengths.  A comparison of the structural data of the (por)Mn(NO)(1-MeIm) 
compounds with those of the previously reported and isoelectronic  [(OEP)Fe(NO)(1-
MeIm)]+ shows that in both classes of compounds, the metal-NO groups are linear.  
Furthermore, the Mn-N(O) bond lengths (1.645(3)-1.650(2) Å) are similar to that in 
[(OEP)Fe(NO)(1-MeIm)]+ (1.6465(17) Å) 36 although the N-O bond lengths in 
(por)Mn(NO)(1-MeIm) (1.174(3)-1.176(4) Å) are slightly longer than that observed 

















Table 3.2  Selected Bond Lengths in (Å) and Angles in (°) of 
(TTP)Mn(NO)(CH3OH) (1), (TTP)Mn(NO)(1-MeIm) (2), (TPP)Mn(NO)(1-MeIm) 
(3), and (T(p-OCH3)PP)Mn(NO)(1-MeIm (4). 
 
Compound 1 2 3 4 
Mn-N(NO) (Å) 1.680(2) 1.650(2) 1.6411(13) 1.645(3) 









N-O (Å) 1.165(2) 1.174(3) 1.1718(17) 1.176(4) 
Mn-N-O (°) 175.66(18) 176.6(2) 178.42(12) 178.3(3) 
X-Mn-N(NO) (°) 177.36(7) 176.76(11) 178.30(5) 179.31(13) 












Figure 3.3.  (a) Molecular structure of (TTP)Mn(NO)(CH3OH).  Only the 
crystallographically ordered molecule is shown.  (b) View of the 
orientation of the methanol ligand relative to the porphyrin skeleton.  








Figure 3.4. (a) Molecular structure of (TTP)Mn(NO)(1-MeIm).  Hydrogen atoms 
have been omitted for clarity.  Only the crystallographically ordered 
molecule is shown.  (b) View of the orientation of the 1-MeIm ligand 
relative to the porphyrin skeleton.  The porphyrin tolyl substituents 








Figure 3.5.  (a) Molecular structure of (TPP)Mn(NO)(1-MeIm).  Hydrogen atoms 
have been omitted for clarity. (b) View of the orientation of the 1-
MeIm ligand relative to the porphyrin skeleton.  The porphyrin p-





Figure 3.6. (a) Molecular structure of (T(p-OCH3)PP)Mn(NO)(1-MeIm). 
Hydrogen atoms have been omitted for clarity.  (b) View of the 
orientation of the 1-MeIm ligand relative to the porphyrin skeleton.  
The porphyrin p-methoxyphenyl substituents have been omitted for 




 3.3.3 Fiber-optic Infrared Spectroelectrochemical Studies of 
(por)Mn(NO)(1-MeIm) (por = TPP, TTP, and T(p-OCH3)PP) in Nonaqueous 
Media.  We have examined the electrochemical properties of the three compounds, 
(TPP)Mn(NO)(1-MeIm) , (TTP)Mn(NO)(1-MeIm), and (T(p-OMe)PP)Mn(NO)(1-
MeIm) at a platinum disc electrode in a typically non-coordinating solvent (CH2Cl2) 
and in a coordinating solvent (THF).  The electrochemical properties for the three 
compounds are similar within a given set of conditions of solvent and temperature.  
The data for (T(p-OCH3)PP)Mn(NO)(1-MeIm) will be described as a representative 
example. The data for the other two compounds are presented in Tables 3.3 and 3.4. 
We will consider oxidation processes first, followed by the reduction processes. 
(a) Oxidations.  The cyclic voltammogram of (T(p-OCH3)PP)Mn(NO)(1-
MeIm) at 100 mV s-1 in CH2Cl2/0.1M NBu4PF6 is shown in Figure 3.7.  The 
compound exhibits a chemically irreversible oxidation at Epa(1) = –0.15 V (peak 1 in 
Figure 3.7) vs the ferrocene-ferrocenium couple as an internal standard, and this 
oxidation has associated with it a small return reduction peak at –0.85 V (peak 1//) 
coupled with an anodic peak in a chemically reversible manner (not shown).  The 
analysis of the data for the second oxidation (Epa(2) = 0.66 V; peak 2) suggests that 
this process consists of a slow one-electron transfer followed by a rapid irreversible 
chemical reaction (see later). The third and fourth oxidations, represented by couples 
3/3/ (E°/(3) = 0.78 V) and 4/4/ (E°/(4) = 1.05 V) respectively, were chemically 
reversible.  In all cyclic voltammograms shown, the primed numbers (e.g., 3/) refer to 
the associated return peaks in reversible processes, whereas the double-primed 
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Figure 3.7. Cyclic voltammogram of (T(p-OCH3)PP)Mn(NO)(1-MeIm) in CH2Cl2 
at 23 ºC.  Conditions: 1 mM analyte, 100 mV/s, 0.1M NBu4PF6. 
 
 The first oxidation process is chemically irreversible even at higher scan rates 
up to 1.6 V/s; an analysis of the cyclic voltammograms as a function of scan rate and 
the geometry of the peak (|Epa(1)-Epa/2(1)| = 60 ± 10 mV) suggests an 
electrochemically reversible one-electron transfer followed by a fast irreversible 
chemical reaction (ErCi; see later).  To investigate the first oxidation process further, 
fiber-optic IR-potential step experiments were performed at room temperature where 
the electrode was held at the potential corresponding to the first oxidation peak for 70 
s while FTIR spectra were collected, and a cyclic voltammogram was recorded 
immediately after this period.  The difference IR spectrum, where the unoxidized 
(T(p-OCH3)PP)Mn(NO)(1-MeIm) was used as the background/reference is shown in 
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Figure 3.8a.  The data reveal a consumption of starting (T(p-OCH3)PP)Mn(NO)(1-
MeIm) near the electrode surface after the first oxidation, indicated by the loss of the 
NO stretching frequency at 1732 cm-1 (i.e., the negative peak in Figure 3.8a) without 
formation of a new nitrosyl-containing species.  
 Bulk electrolysis at the first oxidation potential was performed on (T(p-
OCH3)PP)Mn(NO)(1-MeIm), and IR and UV-vis spectra were collected during the 
electrolysis experiment (Figures 3.9a and 3.9b, respectively). Coulombic integration 
of one Faraday equivalent was obtained from the experiment for the first oxidation 
process.  The IR spectra in Figure 3.9a show the loss of NO from the compound 
(similar to that observed in Figure 3.8a), and the UV-vis spectra show the conversion 
to a MnIII species 28,45; the initial Soret band at λ 429 nm is converted into two split 
broad bands at 384 and 411 nm, and the Q band at 481 nm remains at the same 
position but becomes more intense.  This implies that the first oxidation results in a 
net formal oxidation at the metal center at the timescale of the bulk electrolysis with 
concomitant loss of NO, similar to that observed for (TPP)Mn(NO).  
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Figure 3.8. Difference IR spectra of (T(p-OCH3)PP)Mn(NO)(1-MeIm) and its 
products in CH2Cl2: (a) showing the consumption of starting (T(p-
OCH3)PP)Mn(NO)(1-MeIm) after the first oxidation without the 
formation of a new nitrosyl-containing species at 23 ºC, (b) showing 
the consumption of starting (T(p-OCH3)PP)Mn(NO)(1-MeIm) after 
the first oxidation with the concomitant formation of a new nitrosyl-
containing species at –78 ºC, and (c) showing the consumption of 
starting (T(p-OCH3)PP)Mn(NO)(1-MeIm) and the formation of  a new 
nitrosyl-containing species when the electrode potential is held at half 






Figure 3.9. Infrared (a) and UV-visible (b) spectra recorded during the bulk 
electrolysis (first oxidation) of (T(p-OCH3)PP)Mn(NO)(1-MeIm) in 
CH2Cl2.  Conditions: 1 mM analyte, 0.29 V, 0.1M NBu4PF6.  The 




The low temperature (–78 °C) cyclic voltammogram of (T(p-
OCH3)PP)Mn(NO)(1-MeIm) in CH2Cl2 is shown in Figure 3.10, and it shows that the 
first oxidation process becomes chemically reversible (E°/(1) = –0.19 V) at low 
temperature.  The difference IR spectra obtained after the first oxidation is shown in 
Figure 3.8b (see Discussion).  The other chemically reversible oxidation peaks, at 
E°/(2) = 0.57 V (couple 7/7/) and E°/(3) = 0.91 V (couple 8/8/), are attributed to 
further oxidation of this cationic species at low temperature.  
 
 
Figure 3.10.  Cyclic voltammogram of (T(p-OCH3)PP)Mn(NO)(1-MeIm) in CH2Cl2 
at –78 ºC.  Conditions: 1 mM analyte, 100 mV/s, 0.1M NBu4PF6. 
 
The cyclic voltammogram of (T(p-OCH3)PP)Mn(NO)(1-MeIm) in the 
coordinating solvent THF  is shown in Figure 3.11.  The compound exhibits an 
irreversible oxidation (peak 1; Epa(1) = –0.05 V) in this solvent, similar to that seen in 
CH2Cl2.  Monitoring the first oxidation in THF by IR spectroelectrochemistry reveals 
the loss of the NO band at 1739 cm-1 due to (T(p-OCH3)PP)Mn(NO)(1-MeIm) 
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without build-up of a new NO-containing species (similar to that observed in Figure 
3.8a).  There is no significant difference in the electrochemistry of (T(p-
OCH3)PP)Mn(NO)(1-MeIm) in THF at –78 °C and at 23 °C.  
Tables 3.3-3.5 summarize the electrochemical data for the three 






Figure 3.11.  Cyclic voltammogram of (T(p-OCH3)PP)Mn(NO)(1-MeIm) in THF at 













Table 3.3.   Infrared (cm-1) and Electrochemical Data for the (por)Mn(NO)(1-MeIm) 
Compounds in CH2Cl2 at 23 °C.a   
 
  Oxidations 
 
Reductions 
Por υNO Epa(1) Epa(2) E°
/(3) E°/(4)  Epc(5) E°/(6) 
TPP 1735 –0.12 0.70 0.89 1.10  –1.93 –2.11 
TTP 1731 –0.15 0.69 0.83 1.05  –1.95 –2.05 
T(p-OCH3)PP 1732 –0.15 0.66 0.78 1.05  –1.94 –2.02 
a  Potentials are in volts, and are referenced to the ferrocene-ferrocenium couple set at 
0.00 V.  Conditions:  1 mM analyte, 100 mV/s, 0.1 M NBu4PF6. 
 
 
Table 3.4.   Electrochemical Data for the (por)Mn(NO)(1-MeIm) Compounds in 





Por E°/(1) E°/(7) E°/(8)  Epc(5) E°/(6) 
TPP –0.15 0.94 1.22  –2.24 –2.32 
TTP –0.16 0.74 1.10  –2.20 –2.26 
T(p-OCH3)PP –0.19 0.57 0.91  –2.15 –2.20 
a  Potentials are in volts, and are referenced to the ferrocene-ferrocenium couple set at 
0.00 V.  Conditions:  1 mM analyte, 100 mV/s, 0.1 M NBu4PF6. 
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Table 3.5.   Infrared (cm-1) and Electrochemical Data for the (por)Mn(NO)(1-MeIm) 
Compounds in THF at 23 °C.a   
 
  Oxidation 
 
Reductions 
Por υNO Epa(1)  E°
/(9) E°/(10) E°/(11) 
TPP 1741 –0.01  –1.74 –2.11 –2.59 
TTP 1740 –0.03  –1.73 –2.10 –2.59 
T(p-OCH3)PP 1739 –0.05  –1.74 –2.12 –2.60 
a  Potentials are in volts, and are referenced to the ferrocene-ferrocenium couple set at 
0.00 V.  Conditions:  1 mM analyte, 100 mV/s, 0.1 M NBu4PF6. 
 
(b) Reductions.  The reduction behavior of the (por)Mn(NO)(1-MeIm) 
compounds at low temperature were not different from those observed at room 
temperature.  The cyclic voltammogram of (T(p-OCH3)PP)Mn(NO)(1-MeIm) in 
CH2Cl2 displays a chemically irreversible peak at –1.94 V (peak 5 in Figure 3.7) that 
has with it an associated small return peak at –1.25 V (labeled 5// in the Figure).  The 
ratio iPc(5)/υ1/2 increased linearly with increase in scan rate.  In addition, the peak 
geometry |Epc(5)–Epc1/2(5)| remained essentially constant at 62 mV over the potential 
scan range 50–1000 mV/s.  
The product of the first reduction of (T(p-OCH3)PP)Mn(NO)(1-MeIm) was 
examined by IR spectroelectrochemistry.  Figure 3.8c shows the difference IR 
spectrum when the electrode was held at the mid-point potential Epc/2(5).  The 
spectrum shows the presence of a new band that is shifted to a lower wavenumber by 
19 cm-1, assigned to the υNO of the monoanion [(T(p-OCH3)PP)Mn(NO)(1-MeIm)]- 
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(there is a slow loss of NO at this potential, however).  The other two 
(por)Mn(NO)(1-MeIm) compounds display similar υNO shifts (ΔυNO = 22 cm-1 for 
TPP, and 21 cm-1 for TTP).  
In THF, the compound shows a chemically reversible reduction with slow 
electron-transfer kinetics (Figure 3.11, peak 9; with an associated peak 9/), and two 
chemically reversible reductions (couples 10/10/ and 11/11/) on the cyclic 
voltammetry timescale.   
 (c) Discussion. As mentioned earlier, the electrochemical properties of the 
three (por)Mn(NO)(1-MeIm) complexes are similar.  Hence, the more general “por” 
macrocycle will be used in the equations described below.  The cyclic voltammogram 
of (T(p-OCH3)PP)Mn(NO)(1-MeIm) in CH2Cl2/[Bu4N]PF6 is shown in Figure 3.7, 
and the cyclic voltammograms of the (por)Mn(NO)(1-MeIm) compounds reveal an 
interesting comparison with that of (TPP)Mn(NO) in CH2Cl2/[Bu4N]ClO4 reported 
earlier by Kadish and coworkers.26  
(i) Oxidations.  The first oxidation of (T(p-OCH3)PP)Mn(NO)(1-MeIm) is 
irreversible, and the peak geometry indicates an ErCi mechanism for the first 
oxidation.  This peak geometry is similar to that determined for (TPP)Mn(NO)26 in 
which NO dissociation has been shown to occur after the first oxidation process.  The 
first oxidation of the related (TPP)Mn(NO)(1-MeIm) compound (–0.12 V; Table 3.3) 
occurs at a more negative potential than that required for the first oxidation of the 
five-coordinate (TPP)Mn(NO) (–0.01 vs Fc), and this is due to the destabilization of 
the Mn(II) formal oxidation state relative to the Mn(III) state in the six-coordinate 
(por)Mn(NO)(1-MeIm) compounds.  
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 Our IR spectroelectrochemical studies (Figure 3.8a) are consistent with the 
loss of the NO ligand after the first oxidation of (T(p-OCH3)PP)Mn(NO)(1-MeIm) 
without formation of a new NO-containing species. Further evidence of the loss of 
NO upon oxidation comes from the detection of NO gas in the headspace of  a 
CH2Cl2 solution of (TTP)Mn(NO)(1-MeIm) (1.7 mM) upon chemical oxidation using 






















Figure 3.12.  NO release from  (TTP)Mn(NO)(1-MeIm) (1.7 mM in CH2Cl2) after  
                      addition of AgBF4 (10 mM) at time t = ∼ 20 sec.  
 
Thus, we assign the first oxidation to the ErCi  process described by eqs 3.3 and 3.4. 
 
(por)Mn(NO)(1-MeIm)  -  e-      [(por)Mn(NO)(1-MeIm)]+      (3.3) 
[(por)Mn(NO)(1-MeIm)]+    [(por)MnIII(1-MeIm)]+ +  NO         (3.4) 
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Indeed, adding a sample of the known compound (TPP)Mn(1-MeIm)44,47 to 
the solution of (TPP)Mn(NO)(1-MeIm) during the cyclic voltammetry experiments 
resulted in an increase in the intensity of the redox couple at E°/ = –0.77 V associated 
with the 1//  peak in Figure 3.7 (i.e., eq  3.5), 
 
[(por)MnIII(1-MeIm)]+  +  e-       (por)MnII(1-MeIm)    (3.5) 
 
as expected if [(por)Mn(1-MeIm)]+ was indeed produced from eq 3.4.  The intensities 
of the peaks in Figure 3.7 associated with the second (peak 2), third (couple 3/3/), and 
fourth (couple 4/4/) oxidations also increased as well, suggesting that these further 
oxidations are due to electrogenerated [(por)Mn(1-MeIm)]+ or its products.  This 
Mn(III)/Mn(II) couple (eq 3.5) is similar to the Mn(III)/Mn(II) couple determined for 
(TPP)MnCl in CH2Cl2/[Bu4N]BF4 (–0.81 V) 48 and in CH2Cl2/[Bu4N]ClO4 (–
0.78V).26     
The irreversibility of peak 2 in Figure 3.7 suggests a loss of the axial 1-MeIm 
ligand after this second oxidation (eqs 3.6 and 3.7).  
 
[(por)MnIII(1-MeIm)]+   -   e-    [(por)MnIII(1-MeIm)]2+     (3.6) 
[(por)MnIII(1-MeIm)]2+       [(por)MnIII]2+     +  1-MeIm      (3.7) 
 
We note that the previously reported second (reversible) oxidation of the five-
coordinate (TPP)Mn(NO) compound (presumably the reversible oxidation of 
electrogenerated [(TPP)Mn]+)  is at E1/2 = 0.69 V (vs Fc),26 whereas the second 
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(irreversible) oxidation of (TPP)Mn(NO)(1-MeIm) is at Epa(2) =  0.70 V.  This 
difference is not unexpected, since the products of the first oxidation of 
(TPP)Mn(NO) and (TPP)Mn(NO)(1-MeIm) are different.  Indeed, this result is 
consistent with the presence of 1-MeIm in the latter compound making it easier to 
oxidize.                                                                                                         
The large difference between Epa(1) and Epa(2) is not inconsistent with a 
change from a metal-centered oxidation (Epa(1)) to a ring-centered oxidation (Epa(2)).  
The relatively smaller difference between the second and third oxidations (|E°/(3)-
Epa(2)| = 0.12 V), and the third and fourth oxidations (|E°/(4)-E°/(3)| = 0.27 V) 
suggests ring-centered redox processes.29 
 Rogers and Goff49 have examined the products of chemical and 
electrochemical oxidation of tetraarylporphyrin manganese complexes in CH2Cl2, 
and have proposed the formation of isoporphyrins from some highly oxidized 
(por)MnX compounds (por = TPP, TMP; X = Cl, OAc).  For example, a peak at +0.6 
V vs SCE in the room temperature cyclic voltammogram of (TPP)MnX was 
tentatively assigned to an isoporphyin derivative.  In the presence of 4-Mepy, 
however, the peak assigned to the isoporphyrin was not observed.49  We do not 
observe such a 0.6 V peak (0.14 V vs Fc) in our experiments involving the 
(por)Mn(NO)(1-MeIm) compounds on the cyclic voltammetry timescale, although we 
cannot rule out the formation of such species on longer experimental timescales.    
We focused on the identities of the products of the first oxidation processes 
for the (por)Mn(NO)(1-MeIm) compounds, and we were interested in stabilizing the 
first oxidation products at low temperature.  Our group have previously reported a 
 67 
simple infrared reflectance spectroelectrochemical set-up for the study of short-lived 
species generated at the electrode surface.32  We have modified the glassware slightly 
to allow for jacketing of the cell compartment with a dry ice bath, and we have found 
this practical for low temperature infrared spectroelectrochemistry. 
The cyclic voltammogram of (T(p-OCH3)PP)Mn(NO) in CH2Cl2 at –78 °C is 
shown in Figure 3.10, reveals that the product of the first oxidation (eq 3.3) is indeed 
stabilized at low temperature.   
  
(por)Mn(NO)(1-MeIm)  -  e-      [(por)Mn(NO)(1-MeIm)]+    (3.3) 
 
Further evidence for a stable [(por)Mn(NO)(1-MeIm)]+ oxidation product 
from eq 3.3 comes from IR spectroelectrochemistry at –78 °C.  The difference IR 
spectrum upon oxidation of (T(p-OCH3)PP)Mn(NO)(1-MeIm) at –78 °C is shown in 
Figure 3.8b, and it reveals a new IR υNO band that is 100 cm-1 higher in energy than 
that of the parent compound.  Such a large shift in υNO is indicative of metal-NO-
centered oxidations in nitrosyl metalloporphyrins, although larger υNO shifts of 166-
187 cm-1 have been observed upon similar electrooxidations of some iron nitrosyl 
porphyrins;50 however, these latter cases likely involve a change in geometry of the 
FeNO linkages from bent to linear.   The other two (por)Mn(NO)(1-MeIm) 
compounds have similar υNO shifts (ΔυNO = 111 cm-1 for TPP, and 108 cm-1 for TTP; 
spectra not shown) upon low-temperature oxidations in CH2Cl2.   
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Follow-up reversible redox processes are observed in the cyclic 
voltammogram of (T(p-OCH3)PP)Mn(NO)(1-MeIm), as observed in Figure 3.10, and 
we assign these tentatively to the processes described by eqs 3.8 and 3.9.    
 
[(por)Mn(NO)(1-MeIm)]+  -  e-       [(por)Mn(NO)(1-MeIm)]2+  (3.8) 
[(por)Mn(NO)(1-MeIm)]2+ -  e-       [(por)Mn(NO)(1-MeIm)]3+ (3.9) 
 
The product of eq 3.9 is not very stable, generating a secondary species with an 
associated peak at 8// in Figure 3.10.  The large 1/1/ peak separation (ΔE = 315 mV) in 
Figure 3.10 suggests slow electron transfer kinetics for this metal-centered process, 
relative to the fast electron processes associated with the ring-centered 7/7/ and 8/8/ 
redox couples.  In general, the voltammograms shown in Figures 3.7 and 3.10 are 
representative of the voltammograms obtained for all three (por)Mn(NO)(1-MeIm) 
compounds in CH2Cl2. 
 We also examined the redox behavior of the compounds in the coordinating 
solvent THF.  The first oxidation is irreversible, and we suggest an electrochemical 
oxidation (eq. 3.3) followed by loss of NO involving coordination of the solvent (eq. 
3.10). 
 
(por)Mn(NO)(1-MeIm)  -  e-      [(por)Mn(NO)(1-MeIm)]+     (3.3) 
[(por)Mn(NO)(1-MeIm)]+  +  THF     [(por)MnIII(1-MeIm)(THF)]+  +  NO   (3.10) 
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The peak at 1// can then be represented by the reduction of the product of eq. 
3.10 (i.e., eq. 3.11). 
 
   [(por)MnIII(1-MeIm)(THF)]+  +  e-      (por)MnII(1-MeIm)(THF)     (3.11) 
 
 The cyclic voltammogram is not altered when the data are recorded at –78 °C, 
indicating that THF coordination (eq 3.10) results in a significant denitrosylation of 
the first oxidation product. 
 (ii) Reductions.  The data for the reduction of (T(p-OCH3)PP)Mn(NO)(1-
MeIm) in CH2Cl2 (peak 5 in Figure 3.7) are consistent with an ErCi mechanism (eqs 
3.12 and 3.13).  
 
[(por)Mn(NO)(1-MeIm)]  +  e-       [(por)Mn(NO)(1-MeIm)]-   (3.12) 
[(por)Mn(NO)(1-MeIm)]-             [(por)Mn(1-MeIm)]-     +     NO        (3.13) 
 
Evidence for the existence of the short-lived [(por)Mn(NO)(1-MeIm)]-  monoanion is 
provided by IR spectroelectrochemistry as shown in Figure 3.8c.  The relatively small 
shift in υNO (ΔυNO 19 cm-1) upon reduction suggests that the reduction is centered on 
the porphyrin ring rather than on the MnNO fragment.  The new υNO band disappears 
completely at Epc(5) or at lower potentials, indicative of a fast rate of NO loss at 
Epc(5).  The first reduction peak is coupled to a return peak at –1.25 V labeled 5// in 
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Figure 3.7.  We thus assign peak 5// to the oxidation of electrogenerated [(T(p-
OCH3)PP)Mn(1-MeIm)]- as shown in eq. 3.14.   
 
[(por)Mn(1-MeIm)]-  -  e-       [(por)MnII(1-MeIm)]       (3.14) 
 
 In the case of the previously reported five-coordinate compound 
(TPP)Mn(NO), the first reduction process occurs at –1.41 V26 and is reversible. The 
reduction of (TPP)Mn(NO)(1-MeIm) thus occurs at a more negative potential (at –
1.93 V; Table 3.3), a shift of –0.52 V due to the presence of the axial 1-MeIm ligand.  
We note that the reduction of (TPP)Mn(NO)(py) also occurs at a potential that is 
more negative (by –0.40 V) than that needed for (TPP)Mn(NO)26 and it also exhibits 
irreversible reduction behavior.  In contrast to the first reduction of (TPP)Mn(NO)(1-
MeIm) in CH2Cl2/[Bu4N]PF6, however, the irreversible reduction of 
(TPP)Mn(NO)(py) in CH2Cl2/[Bu4N]ClO4 results in the loss of the axial py ligand 
rather than NO on the cyclic voltammetry timescale.   
A second chemically reversible reduction in CH2Cl2 (represented by the 6/6/ 
couple in Figure 3.7) is thus attributed to the reduction of the electrogenerated 
[(por)Mn(1-MeIm)]- species. 
 We attribute the first reduction of (T(p-OCH3)Mn(NO)(1-MeIm) in THF 
(peak 9 in Figure 3.11) to the process described by eq 3.12.  However, the slow loss 
of NO upon reduction in THF suggests an additional process (eq 3.15) which may be 
intimately coupled with eq 3.12. 
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[(por)Mn(NO)(1-MeIm)]  +  e-       [(por)Mn(NO)(1-MeIm)]-  (3.12) 
[(por)Mn(NO)(1-MeIm)]-       [(por)Mn(1-MeIm)(THF)]-   +   NO   (3.15) 
 
This positive shift in the first reduction potential in THF (–1.74 V) compared to that 
in CH2Cl2 (–1.94 V) is indicative of solvent coordination in the product.  Consistent 
with this is the observation that holding the potential at Epc(9) or at values more 
negative to this value results in complete loss of NO.   
Interesting comparisons can thus be made between the electroreductions of the 
(por)Mn(NO)(1-MeIm) complexes and the electroreductions of the five-coordinate 
(TPP)Mn(NO) compound in the presence of Lewis bases.  Reduction of 
(TPP)Mn(NO) in the mixed solvent systems CH2Cl2/DMF, CH2Cl2/Me2SO, and 
CH2Cl2/py, results in the formation of the [(TPP)Mn(NO)(S)]- anion (S = donor 
solvent); NO remains coordinated in the shorter timescale of cyclic voltammetry, but 
is dissociated at longer experimental timescales.26  For example, in neat pyridine, the 
electrochemical reduction of (TPP)Mn(NO)(py) is neat and reversible, and produces 
[(TPP)Mn(NO)(py)]-. 
The other two redox processes (couples 10/10/ and 11/11/) are thus due to the 
reductions of non-nitrosyl containing species and are reversible. 
 (d) Summary. The redox behavior of the (por)Mn(NO)(1-MeIm) compounds 
in CH2Cl2 at room temperature and at –78 °C may be summarized as shown in 
Scheme 3.1.  As mentioned before, only one other electrochemical study of 
manganese nitrosyl porphyrins was reported prior to this study, namely that of the 
five-coordinate compound (TPP)Mn(NO).26  
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The first oxidation of (por)Mn(NO)(1-MeIm) at room temperature is 
essentially irreversible and follows an ErCi mechanism resulting in the net loss of NO 
(eqs 3.3 and 3.4).  This is similar to that reported for (TPP)Mn(NO) (i.e., 
denitrosylation upon oxidation), except that in the present study the product of the 
first oxidation is a five-coordinate [(por)Mn(1-MeIm)]+ species which undergoes an 
irreversible oxidation (eqs 3.6 and 3.7) to lose the axial ligand.  We have stabilized 
the product of the first oxidation (eq 3.3) by recording the redox behavior at –78 °C.  
At this temperature, the initial oxidized product [(por)Mn(NO)(1-MeIm)]+ undergoes 
two further reversible oxidations (eqs 3.8 and 3.9). The reduction behavior of 
(por)Mn(NO)(1-MeIm) is different from that of the five-coordinate (TPP)Mn(NO).  
In the case of (TPP)Mn(NO),26 this compound undergoes two successive reductions 
without loss of NO.  For the six-coordinate (por)Mn(NO)(1-MeIm), however, 
denitrosylation occurs after the first reduction (eqs 3.12 and 3.13).  Importantly, our 
infrared spectroelectrochemistry set-up32 which we have now adapted for low-
temperature work, has allowed us to identify several of the nitrosyl-containing species 






































 Our study complemented previous structural studies by Scheidt and 
coworkers25,34 on the five- coordinate (TTP)Mn(NO) and the six- coordinate 
(TPP)Mn(NO)(4-Mepip) (TPP = tetraphenylporphyrinato dianion) compounds.  In 
summary, we have prepared several isolable six-coordinate manganese nitrosyl 
porphyrins and have characterized them by spectroscopy.  Our successful 
crystallization of four of these derivatives, which were characterized by single-crystal 
X-ray crystallography, significantly increases the number of available structures of 
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manganese nitrosyl porphyrins.  In particular, the trans influence of the linear NO 
group observed in these structures provides a convenient entry into further studies of 
this structural effect.  Comparisons between these manganese(II)  nitrosyl derivatives 
and the ferric nitrosyl derivatives suggest that there are structural similarities between 
these formally isoelectronic MnII-NO and FeIII-NO species.  However, care must be 
taken in the interpretation of these results, since subtle π-backbonding differences 
exist between them.  
 We also studied the room and low temperature (–78 °C) cyclic voltammetric 
behavior of the six coordinate (por)Mn(NO)(1-MeIm) (por = TPP, TTP, or T(p-
OCH3)PP) complexes at a Pt disc electrode in two nonaqueous solvents (CH2Cl2 and 
THF). This study significantly increased the number of the manganese nitrosyl 
porphyrin complexes that have been electrochemically characterized in the literature 
and represent the only spectroelectrochemically characterized manganese nitrosyl 
porphyrin complexes in the literature.  
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Chapter 4. Ligand Conformations in Derivatives of Manganese- and  
                   Cobalt-Substituted Horse Heart Myoglobin As  
                   Determined by X-ray Crystallography 
 
4.1 Introduction  
 Heme-containing enzymes serve a wide range of biological functions ranging 
from oxygen storage and transport, oxoanion reduction, hydrocarbon oxidation and 
electron transport to multi-electron catalysis.1-3 The heme prosthetic groups in these 
enzymes have been replaced by other synthetic metal-hemes mainly to examine their 
effects on structure and function or to probe the active site via the altered electronic 
and steric requirements of using different metal ions. Among these metal-hemes, 
cobalt-4 and manganese-protoporphyrin IX5-7 have the greatest attention.  
 Manganese protoporphyrin IX-reconstituted heme proteins are well known for 
hemoglobin (Hb),8,9 myoglobin (Mb),10-12 cytochrome P450,13 soluble guanylyl 
cyclase,14 cytochrome c,15 nitric oxide synthase,16 horse radish peroxidase,9,11,17 
cytochrome b5,18 cytochrome c peroxidase (CcP),11,19,20  and prostaglandin H2 
synthase-1.21  These manganese protoporphyrin IX- reconstituted enzymes were fully 
characterized by the traditional spectroscopic techniques such as UV-vis,11,19 
resonance Raman,22,23 EPR,9 and NMR spectroscopy.  However, no X-ray structure of 
any of these manganese protoporphyrin IX- reconstituted proteins or enzymes was 
reported except that of the unrefined X-ray difference Fourier crystallographic studies  
∗ Taken in part from;  
i-“Crystal Structures of Manganese- and Cobalt-substituted Myoglobin in Complex with NO and 
Nitrite Reveal Unusual Ligand Conformations” Zahran Z. N.; Chooback L.; Copeland D. M.; West A. 
H.; Richter-Addo G. B. J. Inorg. Biochem. 2007, in press, with permission from Elsevier. 
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on the metmanganohemoglobin24,25 and that recently reported for prostaglandin H2 
synthase-1.21 
 The preparation and functional properties of manganese protoporphyrin IX-
reconstituted Mb and its reaction with, oxygen,11  hydrogen peroxide,11 carbon 
monoxide,11 cyanide, nitrite, azide,11,26 and nitric oxide27,28 have been extensively 
investigated and compared with that of the native iron Mb. Although the protein fold 
of the native Mb and the manganese protoporphyrin IX-reconstituted Mb are 
expected to be similar, their ligation properties are quite different. Thus, for example, 
oxygen, carbon monoxide, cyanide, nitrite, azide, and nitric oxide bind to Mb at the 
iron-heme moiety, whereas the oxidized or the reduced manganese protoporphyrin 
IX-reconstituted Mb did not form complexes with oxygen and carbon monoxide.11  
Azide11,26 binds to the oxidized form, and nitric oxide23,28 binds to the reduced form of 
the Mn-heme moiety while cyanide binds to the oxidized MnIIIMb away from the Mn-
heme moiety.29 
 Interestingly, Mn-substituted hemoglobin (MnHb) exhibits allosteric effects in 
its binding of NO.5,7,30,31  The resulting adduct, written simply as MnIIHbNO, has been 
prepared and characterized.15,31,32  The NO adduct of Mn-substituted Mb is also 
known,31,32 as are the NO adducts of Mn-substituted sGC,14 cytochrome c,15 CcP,32 
cytochrome P450,13 and that of a monomeric MnHb from the insect Chironomus 
thummi thummi.33  Lan and coworkers have examined the ability of sol-gel 
encapsulated MnIIMb to act as an NO sensor under physiological conditions (since it 
binds NO but not O2).34  We, and others, have prepared and characterized several 
synthetic manganese porphyrins ((por)Mn) that bind NO.35-40  In some cases, synthetic 
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(por)Mn compounds have been shown to electrocatalyze the reduction of NO to 
hydroxylamine and ammonia.41  
 We are interested in the structures of the heme pockets in Mb derivatives of 
nitrogen oxides, and in particular how the distal amino acid residues might affect the 
binding preferences of nitrogen oxide ligands.  In this chapter, we describe, for the 
first time, the crystal structures of Mn-substituted Mb; namely the as-isolated 
MnIIIMb and the reduced MnIIMb derivative.  The crystal structures obtained for these 
compounds may help explain some of the contradictory results on the spectroscopy 
previously reported in the literature.  Azide is a known inhibitor of heme enzymes.42  
The physiological role of nitrite is only now being fully recognized43,44 and its 
interaction with Hb and Mb has been shown to result, under conditions of hypoxia, in 
enzymatic NO production.43  To this end, we also report the crystal structures of the 
MnMb adducts with methanol, azide, and nitric oxide (NO).  Further, we report the 
structures of the nitrite adducts of MnMb and CoMb.  
 
4.2 Materials and Methods 
Manganese(III) protoporphyrin IX chloride ((PPIX)MnIIICl), sodium 
dithionite (85%), and 2-butanone were purchased from Aldrich Chemical Company.  
Tris(hydroxymethyl)aminomethane hydrochloride (Tris-HCl, molecular biology 
grade), and ammonium sulfate (99.5%) were obtained from Fluka.  Sodium nitrite 
(98.0%) was obtained from Baker and Adamson.  Cobalt(III) protoporphyrin IX 
chloride ((PPIX)CoIIICl) was purchased from Frontier Scientific Company.  Nitric 
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oxide (98%, Matheson Gas) was passed through KOH pellets and two cold traps (dry 
ice/acetone, –78 °C) to remove higher nitrogen oxides.   
Horse heart met-myoglobin (hh metMb) was purchased from Sigma.  The 
heme group was removed from metMb (30 mg/ml) using the method of Yonetani19 
and Teale.45  MnIIIPPIX was reconstituted into apoMb following the method of 
Yonetani11 and the product characterized by UV-vis spectroscopy (λmax 378 and 471 
nm).11,12  The CoIIIMb complex was similarly prepared and characterized (λmax 425 
nm).4  The purity of the metal-reconstituted myoglobins were established by SDS 
PAGE.  
 
4.3 Crystallization and Complex Formation 
 All eight Mn- and Co-substituted myoglobin crystalline complexes were 
prepared and structurally characterized in (at least) duplicate. 
 4.3.1 MnIIIMb and CoIIIMb.  Crystals of MnIIIMb and CoIIIMb were grown 
using identical procedures.  The crystals were grown at room temperature (~23 °C) 
using the hanging-drop vapor diffusion method.  A hanging drop (10 μL) containing 
0.45 mM protein (8 mg/mL) and 0.8 M (NH4)2SO4 in 10 mM Tris-HCl buffer at pH 
7.4, was suspended over a well containing 500 μL of 3.4 M (NH4)2SO4 in 10 mM 
Tris-HCl buffer at pH 7.4.  The crystals grew in clusters of plates and reached a 
suitable size in 3-5 days.  A suitable crystal was harvested with a cryoloop, 
transferred to 10 μL of artificial mother liquor containing 10% glycerol as a 
cryoprotectant, and flash frozen in liquid nitrogen. 
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4.3.2 MnIIIMb(MeOH).  The MnIIIMb(MeOH) complex was prepared by 
adding 20 μL MeOH to a MnIIIMb solution (180 μL, 0.9 mM) in 10 mM Tris-HCl 
buffer at pH 7.4.  The mixture was kept at 4°C for 10 min before setting up for 
crystallization using the hanging drop vapor diffusion method employing the same 
conditions as described above for MnIIIMb.  A suitable crystal was harvested and 
soaked for 10 min in a droplet of 10 mM Tris-HCl buffer (pH 7.4) containing 
(NH4)2SO4 (3.4 M), 10% glycerol as cryoprotectant, and MeOH (2% v/v).  The 
crystal was then flash frozen in liquid nitrogen.  
4.3.3 MnIIMb.  The reduced MnIIMb crystal was obtained by soaking a crystal 
of MnIIIMb anaerobically in a 20 μL droplet of the buffer (10 mM Tris-HCl, pH 7.4) 
containing (NH4)2SO4 (3.4 M), 10% glycerol as cryoprotectant, and sodium dithionite 
(114 mM) for at least 20 min.  The crystal and the droplet were submerged in mineral 
oil under an atmosphere of nitrogen.  During the soaking of the crystal, it cracked into 
several pieces and its color changed from purple-red to orange-red indicative of the 
formation of the reduced MnIIMb.11,46  A suitable crystal was harvested with a 
cryoloop and flash frozen in liquid nitrogen. 
4.3.4 MbIIIMb(N3
–).  The azide complex was prepared as reported 
previously22,26 by adding 20 μL of a sodium azide solution (200 mM) directly into a 
solution of MnIIIMb (180 μL, 0.9 mM) in 10 mM Tris-HCl buffer at pH 7.4.  The 
mixture was left at 4 °C for 10 min, and the resulting azide complex crystallized 
using the hanging-drop vapor diffusion method employing the same conditions as 
described above for MnIIIMb.  Crystals grew in 3-5 days.  A suitable crystal was 
harvested and soaked in a 10 μL droplet of 10 mM Tris-HCl buffer (pH 7.4) 
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containing (NH4)2SO4 (3.4 M), 10% glycerol as cryoprotectant, and NaN3 (200 mM) 
for 10 min, and flash frozen in liquid nitrogen.  The excess NaN3 added to the 
cryoprotectant was to maximize the occupancy of the azide ligand in the complex.  
4.3.5 MnIIMbNO.  This complex was obtained by transferring a crystal of 
MnIIMb into a 10 μL droplet of the buffer (10 mM Tris-HCl, pH 7.4) under anaerobic 
conditions and submerged in mineral oil.  The droplet contained (NH4)2SO4 (3.4 M), 
10% glycerol as cryoprotectant, and NO (~2 mM).  The crystal was soaked in this 
solution for ~2 min, and the color changed from orange-red to pink suggesting 
formation of the nitrosyl adduct MnIIMbNO.  The crystal was harvested with a 
cryoloop and flash frozen in liquid nitrogen. 
4.3.6 MnIIIMb(ONO–).  The nitrito-liganded complex, MnIIIMb(ONO–), was 
obtained by soaking crystals of MnIIIMb in a 10 μL droplet of the buffer (10 mM Tris-
HCl, pH 7.4) under anaerobic conditions by submerging the droplet in mineral oil.  
The droplet contained (NH4)2SO4 (3.4 M), 7.5% glycerol as cryoprotectant, sodium 
dithionite (187 mM).  Sodium nitrite (to give 100 mM) was then added to the droplet, 
and the crystal soaked for 2 min in this mixture.  The crystals were then harvested 
with cryoloops and flash frozen in liquid nitrogen.  We note that in our hands, the 
MnIIIMb(ONO–) complex could not be obtained either by soaking the MnIIIMb 
crystals in a droplet free of sodium dithionite (but containing the other components), 
or from co-crystallization of MnIIIMb in presence of excess NaNO2.   
 4.3.7 CoIIIMb(ONO–).  The CoIIIMb(ONO–) complex was prepared by mixing 
a solution of CoIIIMb (10 mg/mL) with a solution of NaNO2 (0.5 M) solutions in a 1:1 
v/v ratio and keeping the mixture at 4 °C for 30 min.  The product was then 
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crystallized using the vapor diffusion method using the same conditions as used for 
CoIIIMb(H2O), and suitable size crystals grew in 3-5 days.  Suitable crystals were 
harvested with cryoloops and flash frozen in liquid nitrogen.  The complex was also 
obtained by soaking CoIIIMb crystals in a droplet of Tris-HCl buffer (10 mM, pH 7.4) 
containing (NH4)2SO4 (3.4 M), 10% glycerol as cryoprotectant, and NaNO2 (500 mM) 
for 30 min.  However, this latter method resulted in a product containing nitrite at 
only ~60 % occupancy as determined by crystallography. 
 
4.4 X-ray Diffraction Data Collection and Processing 
Diffraction data sets were collected at 100 K by using CuKα radiation (λ = 
1.5418 Å) produced from a RigakuMSC RU-H3R X-ray generator operated at 50 
kV/100 mA.  Diffracted X-rays were detected using an R-AXIS IV++ dual image plate 
detector system.  The crystal-to-detector distance was set at 100 mm, and 220 frames 
of data were collected for each crystal, with 1° oscillations and a 5 min exposure time 
per frame.  X-ray intensity data were indexed and processed with the stand-alone 
d*TREK program (Macintosh v.2D)47 available from Molecular Structure 
Corporation. 
 
4.5 Structure Solution and Refinement 
The CCP4 Suite of programs48 was used for structure solution and the 
subsequent refinement of all structures reported here.  Phase information was 
obtained using molecular replacement as implemented in CCP4 (MOLREP).49  The 
search model was the 1.3 Å resolution structure of MbIINO (PDB access code 2FRJ)50 
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with all the solvent molecules, sulfate anions and the NO ligand removed from the 
structure.  After molecular replacement, the iron atom was replaced by manganese or 
cobalt.  In all the structures, no electron density was observed for the C-terminal 
residue Gly153, thus it was not included in the models.  In all cases, ARP/wARP was 
used to add water molecules to the structure during refinement.  Lys47 was refined in 
two positions at 50% occupancy each.  Also, two sulfate groups (three in case of 
reduced MnIIMb) were added to the models based on the initial Fo-Fc map.  After 
completion of the refinement of the individual structures, the interactive 
macromolecular structure validation tool MolPROBITY (available online from the 
Richardson Lab at Duke University at http://kinemage.biochem.duke.edu/ 
molprobity/)51,52 was utilized to assign the final rotamer orientations of Asn, Gln, and 
His side chains, and to test for any unusual side chain contacts.   
In general, the structure solution and refinement procedures were similar for 
all eight structures reported here.  The statistics of the data collection and refinement 
are summarized in Table 4.1.  The Fo-Fc difference electron density maps shown in 
Figures 4.1 and 4.2 were generated using CNS53 and Fcs were calculated using the 
final model but by omitting the ligand from the structure.  All figures were drawn 
using PyMOL (Delano Scientific, 2002; http//www.pymol.org), and labels added 
using Adobe® Photoshop. 
4.5.1 MnIIIMb(H2O).  After molecular replacement, the R-factor was 30.98%.  
After 10 cycles of restrained refinement, the R-factor was 24.86% and initial electron 
density maps were generated.  At this stage, the initial Fo-Fc difference electron 
density map revealed the presence of cone-shaped electron density in the distal Mn-
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heme pocket.  We initially tried to model this as a methanol molecule (see Results 
Section).  This cone-shaped electron density was finally refined as a single water 
molecule in two disordered positions with 70% and 30% occupancies.  Two 
conformations of the distal His64 residue were modeled into the electron density, and 
the occupancies refined to 70% and 30%.  Solvent water molecules were added, 
followed by an additional 15 cycles of refinement with B-factors refined 
anisotropically, and the R-factor dropped to 17.9%.   
4.5.2 MnIIMb.  After molecular replacement the R-factor was 33.09%.  After 
10 cycles of restrained refinement the R-factor dropped to 22.09% and the initial Fo-
Fc difference electron density map showed the absence of electron density for any 
ligand in the Mn-heme distal pocket.  After the addition of the water molecules and 
further cycles of refinement, the R-factor dropped to 19.4%.   
4.5.3 MnIIIMb(MeOH).  At the start of refinement the R-factor was 28.79%.  
After 10 cycles of restrained refinement the R-factor dropped to 22.74% and initial 
electron density maps were generated.  The Fo-Fc difference electron density map 
showed clear electron density for the methanol ligand in the Mn-heme distal pocket, 
and methanol was modeled into this density.  After the addition of solvent molecules 
and further cycles of refinement, the R-factor dropped to 17.4%.  The methanol ligand 
refined to full occupancy with thermal factors of 14.25 and 11.69 Å2 for its O and C 
atoms, respectively.  
4.5.4 MnIIIMb(N3–).  After molecular replacement, the R-factor was 31.52%.  
Ten cycles of restrained refinement resulted in the lowering of the R-factor to 
24.93%.  The Fo-Fc difference electron density map showed clear density for the 
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azide ligand in the Mn-heme distal pocket, and azide was modeled into the density.  
Solvent molecules were added, and further cycles of refinement dropped the R-factor 
to 18.4%.  The azide ligand refined to near-full (94%) occupancy, with thermal 
factors of 17.95, 20.28 and 22.17 Å2 for its N1, N2, and N3 atoms, respectively.   
4.5.5 MnIIMb(NO).  At the start of refinement, the R-factor was 30.77%.  
After 10 cycles of restrained refinement, the R-factor dropped to 22.23%.  The Fo-Fc 
difference electron density map showed clear density for the nitrosyl ligand in the 
Mn-heme distal pocket, and NO was modeled into the density.  After the addition of 
solvent molecules and further cycles of refinement, the final R-factor dropped to 
17.7%.  The NO ligand refined to 70% occupancy.  Two conformations of the distal 
His64 were modeled into the electron density associated with this residue, and were 
refined with 70% and 30% occupancies.   
4.5.6 MnIIIMb(ONO–).  At the start of refinement, the R-factor was 32.11%.  
After 15 cycles of restrained refinement, the R-factor dropped to 24.36%.  The Fo-Fc 
difference electron density map showed clear density for the nitrite ligand in the Mn-
heme distal pocket, and nitrite was modeled into the density.  After the addition of 
solvent molecules and further cycles of refinement, the R-factor dropped to 18.6%.   
4.5.7 CoIIIMb(H2O).  After molecular replacement, the R-factor was 33.50%.  
After 10 cycles of restrained refinement, the R-factor dropped to 24.38%.  The Fo-Fc 
difference electron density map showed the presence of electron density consistent 
with the presence of a bound water molecule (bound to the heme cobalt atom).  After 
the addition of solvent molecules and further cycles of refinement, the R-factor 
dropped to 19.3%.  
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4.5.8 CoIIIMb(ONO–).  After molecular replacement, R-factor was 30.52%.  
After 10 cycles of restrained refinement, the R-factor dropped to 24.49%.  The Fo-Fc 
difference electron density map showed clear density for the nitrite ligand in the Co-
heme distal pocket, and nitrite was modeled into the density.  After the addition of 
solvent molecules and further cycles of refinement, the final R-factor dropped to 
17.4%.   
 
4.6 Protein Data Bank accession numbers 
 Atomic coordinates and structure factor amplitudes have been deposited with 
the RCSB Protein Data Bank.  The accession codes are listed in Table 4.1. 
 
4.7 Results 
 The crystal structures of the Mn- and Co-substituted myoglobin derivatives 
reported here display the normal protein fold expected for the native horse heart 
myoglobin.  The differences lie with the nature of the heme axial ligand and the 
resulting distal pocket structure.  Hence, we focus on the heme environment in these 
complexes.  Selected structural data for all eight complexes whose structures are 
reported here are shown in Table 4.2. 
4.7.1 MnIIIMb(H2O).  The MnIII-reconstituted myoglobin (MnIIIMb) was 
prepared from the reaction of MnIII-protoporphyrin IX chloride and apo-Mb in 
solution, and its formation confirmed by UV-vis spectroscopy.   The compound in 
solution displays a characteristic split Soret absorption at 378 and 471 nm as reported 
by Yonetani et al.19  We determined the crystal structure of this complex to 1.65 Å 
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resolution.  The MnIII-heme environment is shown in Figure 4.1a.  We also show the 
final Fo-Fc difference electron density map, contoured at 3σ, that reveals the presence 
of the axial water ligand.  This axial water is best refined as a disordered molecule in 
two distinct positions, with 70% (coordinated) and 30% (uncoordinated) occupancies.   
We located two positions for the distal His64 residue, and the occupancies correlate 
with the two water molecule positions.  The 2Fo-Fc map showing the electron density 
associated with the two His64 conformations is shown in Figure 4.2.  The distance 
between the Nε atoms of the two His64 conformations is 0.74 Å, with the minor 
conformation closer to the interior of the protein and closer to the uncoordinated 
water molecule. 
 The major disordered position of the water ligand is close to the MnIII center, 
with a Mn–O distance of 2.52 Å.  This MnIII–O(H2O) distance is longer than those 
determined for the six-coordinate model compound [(TPP)MnIII(H2O)2]ClO4 
(2.271(2) Å)54 and the five-coordinate compounds [(TPP)MnIII(H2O)]SbF6 (2.145(5) 
Å),54 [(TPP)MnIII(H2O)]OTf (2.105(4) Å),55 and [(OEP)MnIII(H2O)]ClO4 (2.149(3) 
Å).56  The O-atom of the water ligand in MnIIIMb(H2O) is 2.62 Å from the Nε atom of 
the major conformation of the distal His64 residue, indicative of hydrogen-bonding 
between these moieties.  In addition, the O-atom of the coordinated water ligand is 
tilted 15° from the normal to the heme four-nitrogen (4N) plane towards to the 
interior of the protein.   
The minor (30%) disordered position of the distal water molecule is 3.96 Å 
from the MnIII center, and is 2.84 Å from the Nε atom of the corresponding minor 





Table 4.1.  Statistics of X-Ray Data Collection and Refinement. 
 MnIIIMb(H2O) MnIIMb MnIIIMb(MeOH) MnIIIMb(N3) MnIIMb(NO) MnIIIMb(ONO) CoIIIMb(H2O) CoIIIMb(ON
O) 
PDB code 2O58 2O5B 2O5L 2O5M 2O5Q 2O5O 2O5T 2O5S 
Data collectiona            
  Space group P21 P21 P21 P21 P21 P21 P21 P21 
  Cell Dimen.             
     a (Å)   35.41 35.21 35.41 35.48 35.47 35.43 35.31 35.17 
     b (Å) 28.65 28.74 28.59 28.75 28.64 28.67 28.75 28.68 
     c (Å) 62.94 64.20 63.20 62.91 63.19 62.99 63.03 63.36 
     β (°) 106.0 105.45 105.74 105.9 105.7 105.5 106.5 106.1 
  Resolution (Å)  1.65 2.00 1.70 1.65 1.90 1.60 1.60 1.60 
  Mean I/σ(I)  15.2 (4.4) 9 (2.7) 12.5 (3.9) 17.0 (4.6)  9.0 (2.5) 14.5 (4.0) 10.1 (2.9) 20.4 (4.7) 
  No. Reflections              
     Observed  63842  25281 58562   64306 35.301 68845 64903 65732  
     Unique 14874  8510 13275  14301 9669 16177 15721 15758 
  Comp. (%)  99.6 (98.2)  98.7 (96.0) 96.8 (93.7)  95.3 (91.0)  97.8 (99.9) 98.5 (95.9) 96.2 (87.2) 96.5 (86.6) 
  Rmerge (%)b  5.6 (26.4)  7.6 (31.8) 6.8 (36.4)  5.1 (27.2)  9.5 (23.6) 5.3 (31.6) 7.7 (34.8) 4.4 (16.8) 
Refinement             
  Res. Range  (Å)  19.47-1.65  20.63-2.00 21.91 – 1.70  26.75- 1.65  26.57-1.90 25.92-1.60 26.61-1.60 26.58-1.60 
  R-factor (%)  17.9 19.4 17.4  18.4  17.7 18.6 19.3 17.4 
  Rfree (%)c 22.3 23.9 23.3 22.1  21.8 22.4 24.8 22.5 
  rmsd bond  dist. 0.015 0.023 0.014  0.015  0.021 0.013 0.017 0.012 
  rmsd angles (˚)  1.57 2.05 1.53 2.29  2.49 2.26 2.47 2.28 
  B factor (Å2)              
     Mean  17.6  32.12 18.17  16.2  22.02 16.88 21.59 15.36 
     rmsd main 0.82 1.15 0.86  0.81 1.05 0.81 0.85 0.77 
     rmsd side 2.40 3.06 2.48 2.34 2.80 2.27 2.49 2.37 
a Values in parentheses correspond to the highest resolution shells for MnIIIMb(H2O) (1.71–1.65 Å), MnIIMb (2.07-2.00), MnIIIMb(MeOH) (1.76–1.70 Å), 
MnIIIMb(N3-) (1.71–1.65 Å), MnIIMb(NO) (1.97–1.90 Å), MnIIIMb(ONO) (1.66–1.60 Å), CoIIIMb(H2O) (1.66–1.60 Å), and CoIIIMb(ONO) (1.66–1.60 Å). b R-
merge = Σ|I - <I>|/Σ(I) where I is the individual intensity observation and <I> is the mean of all measurements of I. c Rfree is calculated using randomly selected 




Table 4.2.  Selected Geometrical Data for the Mn- and Co-substituted Myoglobin Complexes. 
 
Compound M–N(por) (Å) M–X(axial)a (Å) M-X-Y (°) α (°)b M–N(His93) (M)X…N(His64)c 
(Å) 
ΔMd (Å) 
MnIIIMb(H2O) 2.04-2.08 2.52e − 15.3e 2.22 2.62e −0.18 
MnIIIMb(MeOH) 2.02-2.07 2.48 119 8.2 2.29 2.56 −0.07 
MnIIMb 2.03-2.10 − − − 2.27 − −0.34 
MnIIMb(N3–) 2.04-2.06 2.37 121 8.9 2.50 2.64 −0.08 
MnIIMb(NO)f 2.06-2.11 2.53f 130 12.5 2.20f 2.60 −0.20f 
MnIIIMb(ONO–) 2.07-2.10 2.33 112 9.7 2.34 2.57 −0.07 
CoIIIMb(H2O) 2.02-2.09 2.46 − 11.7 2.15 2.54 −0.04 
CoIIIMb(ONO–) 2.06-2.07 2.14 105 8.8 2.02 2.71 −0.04 
 
a Distance between the metal and the coordinating atom of the ligand in the distal pocket. b Tilt of the coordinating atom X (of the distal ligand) from the 
normal to the heme 4N plane. c  Distance between the coordinating atom X (of the distal ligand) and the nearest N-atom of the distal His64 residue. d  
Apical displacement of the central metal atom from the heme 4N plane towards the distal ligand. e  These data are for the component with coordinated  
H2O (70% occupancy).  f  The NO ligand refined to 70% occupancy.  Hence, these data likely represent an average of the MnIIMb (30%) and MnIIMb(NO) 






Figure 4.1.  Final models and final Fo-Fc difference electron density maps showing 
side views of hh MnMb derivatives.  Carbon, oxygen, nitrogen, and Mn atoms are 
colored grey, red, blue, and magenta, respectively.  The bonds to Mn are not shown 
for clarity.  (a) MnIIIMb(H2O):  The difference electron density map contoured at 3σ 
shows a single water molecule in two different positions. (b) MnIIIMb(MeOH): The 
difference electron density map is contoured at 3σ.  (c) The reduced MnIIMb showing 
the absence of electron density for a coordinated water molecule in the active site. (d) 






Figure 4.2. Final model of the Mn-heme environment in MnIIIMb(H2O), and the 2Fo-
Fc  electron density map, contoured at 1σ, associated with the two conformations of 
the distal His64 residue. 
 
distal His64 residue is consistent with hydrogen-bond stabilization of this non-
coordinated water in the distal pocket.   The Leu29 and Val68 residues are the closest 
distal pocket moieties to this water molecule; the distance between the water O-atom 
and the nearest C-atoms of Leu29 and Val68 are 3.14 and 3.32 Å, respectively.  
Thedistance between the O-atom positions of the coordinated and uncoordinated 
water molecules is 1.70 Å.  
 We attempted to refine the Mn atom at two positions to correlate with the 
presence of coordinated and uncoordinated water, but we were not successful.  Thus, 
it is likely that the Mn atom position represents an average between two close-by 
positions.  In the final refined structure, the Mn atom is apically displaced by 0.18 Å 
from the heme 4N plane towards the proximal His93 residue, with a MnIII–N(His93) 
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distance of 2.22 Å.  The displacement of the Mn atom towards the proximal His93 
residue is common feature for all the structures reported here (see Table 4.2), 
although variations in the extent of apical displacement are observed depending on 
the compound being examined. 
4.7.2 MnIIIMb(MeOH).  As part of a control experiment (see Discussion), we 
prepared the methanol adduct of MnIIIMb to determine the binding geometry of this 
ligand.  The structure of the MnIII-heme environment is shown in Figure 4.1b.  The 
Mn–O(MeOH) bond length is 2.48 Å, which is longer than the analogous Mn–O 
distance in the d4 high-spin model non-protein complexes (TPP)MnIII(N3)(MeOH) 
(2.329(7) Å),57 [(TPP)MnIII(MeOH)2]ClO4 (2.252(2), 2.270(2) Å),58 and for the five-
coordinate [(OEP)Mn(EtOH)]ClO4 (2.145(2) Å).59 
The major differences between the structure of MnIIIMb(MeOH) and 
MnIIIMb(H2O) are (i) only one position of MeOH was found, at full occupancy, (ii) 
only one His64 conformation was found in MnIIIMb(MeOH), and (iii) the MnIII atom 
was displaced only 0.07 Å from the heme 4N plane towards the proximal His93 
residue.  The methyl group of the MeOH ligand is oriented towards the interior of the 
protein in the direction of the Leu29 and Ile107 amino acid residues; the distance 
between the C-atom of the MeOH ligand and the nearest carbon atom of the closest 
residue Val68 is 3.51 Å.  The MnIII–O–C(Me) angle is 119°, and the distance between 
the O-atom of the MeOH ligand and the Nε atom of the distal His64 is 2.56 Å, 
indicative of a hydrogen-bonding interaction.   This MnIII–O–C(Me) angle is more 
acute than that observed in the model compound [(TPP)MnIII(MeOH)2]ClO4 
(124.6(3), 124.0(3)°),58 perhaps due to the presence of the hydrogen-bonding 
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interaction present in MnIIIMb(MeOH) which might also be responsible for the 
slightly longer Mn-O bond in the protein.  
4.7.3 The reduced MnIIMb.   Crystals of the reduced MnIIMb complex were 
prepared by soaking crystals of MnIIIMb in buffer containing dithionite.  The structure 
of the Mn-heme environment in the resulting MnIIMb is shown in Figure 4.1c.  The 
absence of electron density in the Fo-Fc map was consistent with the absence of an 
axial water ligand in the distal pocket.  Notable features of this structure include (i) a 
0.34 Å apical displacement of the Mn atom from the heme 4N plane towards the 
proximal His93 residue in this five-coordinate compound, with a MnII–N(His93) 
distance of 2.27 Å.  This is a larger apical displacement of the Mn atom than that 
observed for the six-coordinate MnIIIMb(H2O) compound (0.18 Å).  The MnII–
N(His93) distance is, however, similar to that in the oxidized MnIIIMb(H2O) analogue 
(i.e., only a 0.05 Å difference).   
The structure of the heme environment of MnIIMb reported here has some 
similarities with the structure of the model five-coordinate compound (TPP)MnII(1-
MeIm).60  Both MnIIMb and (TPP)MnII(1-MeIm) have a vacant sixth coordination 
site, with the MnII centers displaced from the porphyrin 4N planes towards the 
imidazole groups.  In the model compound (TPP)MnII(1-MeIm), the axial Mn–
N(MeIm) bond length is 2.192(2) Å, with the Mn atom apically displaced by 0.51 Å 
from the four-nitrogen plane of the porphyrin towards the imidazole ligand.60 Thus, 
the Mn-N(imidazole) bond length is ~0.08 Å longer in MnIIMb compared with the 
related distance in the model complex, but the apical displacements of the Mn atom 
towards the proximal imidazole (His93) ligands are similar.   
 
 95 
4.7.4 MnIIIMb(N3–).  Figure 4.1d shows the MnIII-heme environment of the 
1.65 Å resolution structure of MnIIIMb(N3–).  The azide ligand is coordinated to the 
MnIII center with a Mn–N(azide) distance of 2.33 Å.  This distance is longer than that 
observed in the model complexes (TPP)MnIII(N3–)(MeOH) (2.176(9) Å),57 
(TPP)MnIII(N3–) (2.045 Å),61 and (Schiff base)MnIII(N3–)  (2.221(4) Å).62   
The azide ligand in MnIIIMb(N3–) is oriented towards the interior of the 
protein, with a Mn–N–N(azide) angle of 121° and a tilt of 8.9° of the coordinating N-
atom from the normal to the Mn-heme 4N plane.  The coordinating atom of the azide 
ligand is 2.64 Å away from the Nε atom of the distal His64 residue, indicative of a 
hydrogen-bonding stabilization of the azide ligand in the distal pocket.  The next 
closest nonbonding distance between the azide ligand and distal pocket residues is 
that between the terminal N3 atom of the azide with the side-chain of Leu29, with an 
(azide)N-to-Leu(C-atom) distance of 3.46 Å.   Related distances between the azide 
terminal N-atom and distal pocket residues are with Ile107 (3.70 Å) and Val68 (3.74 
Å).  The Mn atom is apically displaced by 0.08 Å from the Mn-heme 4N plane 
towards the proximal His93 residue, with a Mn–N(His93) distance of 2.37 Å. 
4.7.5 MnIIMb(NO).  The interaction of NO with reduced MnIIMb in solution 
results in a blue shift of the Soret absorption band of MnIIMb at 442 nm to 429 nm 
(with β and α bands at 544 and 583 nm, respectively) indicative of the formation of 
MnIIMb(NO).32  Related absorption bands at (i) 424, 538 and 580 nm34 and (ii) 433, 
538 and 580 nm23,32 have been reported for MnIIMb(NO).  For convenience, we will 
use this oxidation state formalism to describe the adduct between NO and MnIIMb 
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(i.e., to distinguish it from the adduct between NO and MnIIIMb).  We discuss the 
oxidation state formalism later in the Discussion. 
We were not able to obtain, from solution, crystals of the preformed 
MnIIMb(NO) complex.  Fortunately, soaking crystals of MnIIMb (obtained by reacting 
crystals of MnIIIMb with dithionite) with NO also produced the desired nitrosyl 
product.  We determined the 1.9 Å resolution structure of this product, with the NO 
ligand refining to 70% occupancy.  We also located two conformations of the distal 
His64 residue that refined to 70% and 30% occupancies, with the major conformation 
assigned to MnIIMb(NO), and the minor conformation assigned to MnIIMb.  Figure 
4.3a shows the Mn-heme environment of the crystalline MnIIMb(NO) product.  
The Mn-NO moiety is distinctly bent with a Mn–N–O angle of 130°.  The 
nitrosyl N-atom is tilted by 12° from the normal to the Mn-heme 4N plane, and the 
NO group is oriented away from the distal His64 residue in the direction of Leu29.  
The nitrosyl N and O atoms are, respectively, 2.60 and 3.28 Å from the Nε atom of 
the major conformation of the distal His64 residue, consistent with hydrogen-bonding 
stabilization of the NO group in the distal pocket.  The next closest distance between 
the NO group and the distal pocket residues is with a carbon atom of Val68 (3.37 Å 
from the nitrosyl O-atom). 
In the structure of this MnIIMb(NO) complex, the NO ligand refined to 70% 
occupancy.  The apical displacement of Mn by 0.20 Å from the Mn-heme 4N plane 
towards the proximal His93 residue suggests that the structure shown in Figure 4.3a is 
likely a mixture of MnIIMb(NO) and MnIIMb (note that ΔMn for MnIIMb is 0.34 Å).  




Figure 4.3.  Final models and final Fo-Fc difference electron density maps showing 
side views of hh MnMb and CoMb derivatives.  Carbon, oxygen, nitrogen, Mn, and 
Co atoms are colored grey, red, blue, magenta, and green, respectively.  The bonds to 
Mn and Co are not shown for clarity.  (a) MnIIMb(NO):  The difference electron 
density map contoured at 3σ shows an NO molecule that refined to 70% occupancy. 
(b) MnIIIMb(ONO): The difference electron density map is contoured at 2.5σ.  (c) 
CoIIIMb(H2O): The difference electron density map is contoured at 2.5σ.  (d) 
CoIIIMb(ONO): The difference electron density map is contoured at 2.5σ. 
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Mn– N(O)  distance of 2.53 Å may thus not correctly represent this bond length.  For 
comparison, the Mn–N(O) bond length in the model compound (TPP)Mn(NO)(1-
MeIm) is 1.641(1) Å.39 
4.7.6 MnIIIMb(ONO–).  We were not able to crystallize this complex from the 
addition of nitrite to MnIIIMb(H2O); either by co-crystallization or by soaking of the 
MnIIIMb(H2O) crystals with nitrite.  Further, we did not observe any spectral change 
in the Soret region of the UV-vis spectrum upon addition of nitrite to a solution of 
MnIIIMb(H2O), consistent with the results from a previous study by Lan et al. 34  
However, addition of nitrite to reduced MnIIMb results in a spectral shift in the UV-
vis spectrum from 442 nm to a new “split” Soret peak at 471 and 378 nm indicative 
of the formation of a new MnIIIMb species.  Indeed, we were successful in obtaining 
crystals of MnIIIMb(ONO–) by this method, by adding nitrite to crystals of reduced 
MnIIMb. 
As demonstrated in Figure 4.3b, the nitrito (i.e., O-bonded) mode of 
coordination of the nitrite ligand is present in the MnIIIMb(ONO) complex.  The 
conformation of the Mn–O–N–O moiety is trans.  The Mn–O(nitrite) bond length is 
2.33 Å, and the coordinating O-atom of the nitrite ligand is tilted 10° from the normal 
to the Mn-heme 4N plane.  The Mn–O–N and O–N–O angles are 112° and 119°, 
respectively.   The coordinating atom of the nitrite ligand is 2.57 Å from the Nε atom 
of the distal His64 residue, indicative of a strong hydrogen-bonding interaction.  
Further, the nitrite N-atom is 3.3 Å from the His64 Nε atom and the Val68 (nearest C-
atom) residues.  The terminal O-atom of the nitrite is 3.26 Å from the His64 Nε atom, 
but is only 3.07 Å from the Leu29 (nearest C-atom) residue.  The bond length 
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between the Mn atom and the proximal His93 residue is 2.37 Å, and the Mn atom is 
displaced by 0.07 Å from the Mn-heme 4N plane towards His93.  
4.7.7 CoIIIMb(H2O).  The Co-heme environment in the crystal structure of 
CoIIIMb(H2O) is shown in Figure 4.3c.  In this six-coordinate complex, the Co–
O(water) distance is 2.46 Å, and the distance between the O-atom (of the coordinated 
water) and the Nε atom of His64 is 2.54 Å.  The O-atom of the water ligand is tilted 
12° from the normal to the Co-heme 4N plane towards the interior of the protein.  The 
Co atom is displaced 0.04 Å from the heme plane towards the proximal His93 
residue, with a Co–N(His93) distance of 2.15 Å.  We note that the 1.65 Å resolution 
structure for sperm whale CoIIIMb(H2O), (Co–O = 2.19 Å; Co–N(His93) = 2.06 Å; 
(Co)O…N(His64) = 2.87 Å) has been reported previously.63  The superposition of the 
heme environments of horse heart (this work) and sperm whale CoIIIMb(H2O) is 
shown in Figure 4.4. 
 
Figure 4.4. A superposition of the heme environments in the crystal structures of hh 
CoIIIMb(H2O) (this work, shown in light grey) and sw CoIIIMb(H2O) (pdb code 
1YOH,63 shown in dark grey) using a global Cα structural alignment. 
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4.7.8 CoIIIMb(ONO–).  Addition of excess nitrite to a solution of 
CoIIIMb(H2O) results in a 6 nm shift of λmax from 425 nm to 431 nm.  This shift is not 
immediately noticeable (e.g, even after 1 min), but is clearly evident several minutes 
after mixing of the nitrite and CoIIIMb(H2O) solutions.  This 6 nm red-shift is larger 
than the 3 nm red-shift observed in the reaction of nitrite ion with native aquometMb 
(λmax 409 nm) to form Mb(ONO) (λmax 412 nm).50,64   
Co-crystallization of CoIIIMb(H2O) in the presence of excess sodium nitrite 
gives crystals of the desired complex with full occupancy of the nitrite ion ligand as 
determined by crystallography.  Soaking crystals of CoIIIMb(H2O) in a solution 
containing a high concentration of nitrite for at least 30 min gives the same 
CoIIIMb(ONO) product, but with only ~60% occupancy of the nitrite ligand.  
The Co-heme environment of the CoIIIMb(ONO) complex obtained from the 
co-crystallization experiment (with full occupancy of the nitrite ligand) is shown in 
Figure 4.3d.  As with the MnIIIMb(ONO) complex described earlier (Figure 4.3b), the 
nitrite ligand displays the nitrito (O-bound) coordination mode with respect to the 
metal center, and the Co–O–N–O moiety is in a trans conformation.   The axial Co–
O(nitrite) distance is 2.14 Å, and the Co–O–N(nitrite) and O–N–O angles are 105° 
and 117°, respectively.  The coordinating atom of the nitrite ligand is within 
hydrogen-bonding distance to the Nε atom of the distal His64 residue (at a distance of 
2.71 Å), and is tilted by 9° from the normal to the Co-heme 4N plane.  The terminal 
O-atom of the nitrite ligand is situated 3.32 Å from the Nε atom of the distal His64 




The nitrite (Co)O1–N and N–O2 bond lengths are 1.29 and 1.30 Å, 
respectively; these are identical within the limitation of this 1.60 Å resolution 
structure.  The Co atom is 0.04 Å out of the heme plane towards the proximal 
histidine with a Co–N(His 93) of 2.02 Å, and the axial (His93)N–Co–O1 bond angle 
is 172°.  
  
4.8 Discussion  
 The preparation and ligand binding properties of Mn-substituted Mb have 
been studied in detail by spectroscopic methods.  Both MnIIIMb and MnIIMb are high-
spin species.6,9,46,65  In this chapter, we report the high-resolution crystal structures of 
the as-isolated MnIIIMb, its reduced product, and the methanol, azide, nitrosyl, and 
nitrite derivatives.  In addition, we report the crystal structures of Co-substituted hh 
Mb and its nitrite adduct.  
The overall structure of Mn-substituted horse heart Mb is very similar to that 
of the iron-containing analogue, and the protein retains the typical Mb fold.  Maurus 
et al. compared the crystal structures of natural and recombinant wild-type horse 
heart myoglobin, and showed that small differences existed in the structures.66  When 
the final MnIIIMb model is superimposed on the 1.7 Å resolution crystal structure of 
recombinant horse heart Mb reported by Maurus et al. (pdb access code 1WLA),66 the 
root-mean square deviations in the backbone and side-chain atomic positions are 0.32 
Å and 1.01 Å, respectively.  When compared with the structure of natural Mb (pdb 
access code 1YMB),67 these values are 0.32 and 1.12 Å, respectively.  We find that 
the structures of the heme environments in our Mn-substituted horse heart myglobins 
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more closely match those of the recombinant iron analogues, particularly with the 
Leu29 and Val68 side-chain orientations.  The superposition of the heme environment 
structures of MnIIIMb(H2O) and the two aquometMb structures are shown in Figure 
4.5.  It is interesting to note that Atassi reported earlier that MnIIIMb and wild-type 
Mb exhibit identical immunological properties.10  In this chapter, we focus on the Mn-
heme active sites and their immediate environments.  
4.8.1 The Nature of the Heme Site in MnIII-Substituted Myoglobin.  
Manganese-substituted myoglobin (MnMb) has been prepared and studied in solution 
for decades.  However, the coordination environment around the metal center in 
MnMb derivatives has been a subject of considerable debate.  MnIIIMb displays a 
characteristic “split” Soret band pattern at λmax 378 and 471 nm, whereas MnIIMb 
displays a single Soret peak at λmax 438 nm.6,19,46  Mitra and coworkers used 
multinuclear NMR and optical spectroscopy to determine that the sixth axial position 
in MnIIIMb was unlikely to be occupied by a water molecule.29  In the latter study, 
they did not observe a change in the optical spectrum of MbIIIMb in the pH 4–11 
range, suggesting the absence of an aquo↔hydroxo equilibrium for a hypothetical 
axial water ligand.  This result differed somewhat from that reported by Spiro and 
coworkers who studied the resonance Raman spectra of MnIIIMb and found evidence 
for a weakly interacting axial water ligand in the sixth position.23  As stated in the 








Figure 4.5.   A superposition of the heme environments in the crystal structures of hh 
MnIIIMb(H2O) (this work, shown in light grey) and (a) natural hh FeIIIMb(H2O) (pdb 
code 1YMB,67 shown in dark grey), and (b) recombinant hh FeIIIMb(H2O) (pdb code 
1WLA,66 shown in dark grey), using a global Cα structural alignment.  The major 
conformation of His64 in hh MnIIIMb(H2O) is similar to the conformation in 
FeIIIMb(H2O).  The Leu29 and Val68 conformations of the Mn- and Fe-proteins 
overlay better in the structures shown in Figure 4.5b. 
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heme proteins in the literature.  Using X-ray difference Fourier techniques, Moffat 
and coworkers determined that for MnIIIHb, the α hemes contained six-coordinate 
MnIII centers (with axial water) whereas the β hemes were five-coordinate (i.e., no 
axial water).24 
 Farmer and coworkers investigated the electrochemical properties of MnIIIMb 
in dimethyldidodecylammonium bromide surfactant films.68  They discovered a 
dynamic exchange between two MnIII/MnII redox couples (E1 = –0.25 V vs SCE; E2 = 
–0.41 V vs SCE), and they attributed this to the presence of two forms of MnIIIMb 
that probably differed in heme site geometry.   Interestingly, Hoffman and Gibson 
reported that MnIIIMb reacted with azide in two kinetically separable steps, and that 
this was likely due to the presence of two forms of the Mn-porphyrin that differed in 
the extent of metal displacement from the porphyrin plane.26  
 The crystal structure of MnIIIMb(H2O) reported here sheds new light on this 
debate regarding the axial coordination geometry of the metal site in this protein.  
Three independent preparations, crystallizations, and structure solutions at 1.65 Å 
resolution yielded identical MnIIIMb(H2O) crystal structures.  In the structure, there is 
a mixture of a six-coordinate species (with axial water; 70% occupancy) and a five-
coordinate species (without axial water; a non-bonded water refined to 30% in the 
distal pocket).  We also found two conformations for the distal His64 residue, and 
these conformations refined to the corresponding 70% and 30% occupancies (Figures 
4.1a and 4.2).  
During the initial stages of refinement of the structure, we were unsure if the 
electron density (attributed to an axial ligand) observed in the Fo-Fc difference map 
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was due to an adventitious solvent molecule such as methanol.  To test this, we 
performed the following additional experiments.  (i) We effected reduction of the 
purple-red MnIIIMb crystal with dithionite, and obtained the structure of the resulting 
orange-red five-coordinate reduced compound MnIIMb (see later).  We then 
reoxidized this MnIIMb crystal with ferricyanide and determined its 1.9 Å resolution 
structure; it was identical to that obtained for MnIIIMb(H2O) as shown in Figure 4.1a.  
This result reaffirmed to us that the electron density in the distal pocket was not due 
to an adventitious exogenous ligand such as methanol.  (ii) In addition, we prepared 
the previously unknown methanol adduct by cocrystallizing MnIIIMb in the presence 
of methanol, and determining the structure of the resulting MnIIIMb(MeOH) product.  
The positive electron density in the Fo-Fc difference map is consistent with the 
presence of a methanol ligand that refined to full occupancy.  Importantly, the 
geometry of the bound MeOH ligand in the structure of MnIIIMb(MeOH) (Figure 
4.1b) is clearly different from that shown for MnIIIMb(H2O) (Figure 4.1a).   
 The presence of distal-pocket uncoordinated water in the structure of 
MnIIIMb(H2O) is, while initially unexpected, not without precedent in crystal 
structures of native and mutant iron myoglobins.  For example, a similar distal-pocket 
(uncoordinated) water has been located in the 1.15 Å resolution crystal structures of 
wild-type ferrous deoxyMb (horse heart and sperm whale), and this water is stabilized 
by hydrogen-bonding with the distal His64 residue (HOH…N(His) distance of 2.8 
Å).69,70  In the case of hh deoxyMb, this distal pocket water was located 3.53(5) Å 
from the Fe center (c.f. 2.13 Å for liganded water in aquometMb).69  Further, distal 
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pocket water has been observed in other reported structures of wild-type71-73 and 
mutant (V68A,72 V68F,72 V68N (molecule B)74) deoxyMb’s. 
 The crystal structure of the Val68Thr mutant of pig deoxyMb provides an 
interesting comparison with the structure of hh MnIIIMb(H2O) reported here.  In 
molecule A of the Val68Thr deoxyMb, a single water molecule is distributed between 
two positions; one position is within direct bonding distance to Fe (Fe–O = 1.9 Å; 
30% occupancy of H2O), and the other is positioned 3.5 Å from the Fe (70% 
occupancy of H2O) yet within hydrogen-bonding distance of the distal His64 residue 
(HOH… Nε(His) = 2.6 Å).75  In molecule B, a single position of the distal water 
located 3Å from Fe is observed, and this is also within hydrogen-bonding distance to 
the His64 residue (HOH…Nε(His) = 2.6 Å).75   
 The distance between the two distal pocket water molecule positions in 
MnIIIMb(H2O) is 1.70 Å.  This distance is inconsistent with the presence of a 
dioxygen ligand (c.f., the O–O distance of 1.24 Å in oxyMb),69 as are the refined 
occupancies of the O atoms.  Further, this 1.70 Å distance is too short for a 
HOH…OH2 hydrogen-bonding interaction, and rules out the presence of both 
coordinated and unligated H2O in the same molecule (such presence of coordinated 
and uncoordinated H2O has been observed in the 1.9 Å resolution structure of native 
sw aquometMb).71   
 The location of the distal pocket (uncoordinated) water molecule in 
MnIIIMb(H2O) is reminiscent of the distal docking site for photodissociated CO from 
MbCO as determined by X-ray crystallography.76-78  For example, the crystal structure 
of photolyzed hh MbCO shows the CO ligand in a position that is 3.6 Å from the Fe 
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atom and atop a carbon pyrrole.76  This site is in the general area as, but not the same 
as, the distal pocket Xe binding site (i.e., the Xe4 site).79   
 Importantly, the displacement of the distal pocket water in deoxyMb has been 
linked to the kinetic barriers for CO binding to ferrous Mb.71,80  It is thus likely that 
the presence of two types of distal H2O in MnIIIMb(H2O) (i.e., coordinated and 
uncoordinated) helps explain the presence of two MnIII/MnII redox couples for the 
electrochemical reduction of MnIIIMb68 and the two kinetically separable steps for the 
reaction of azide with MnIIIMb.26  Finally, we note that Moffat and coworkers have 
utilized X-ray difference Fourier techniques to determine that the Mn center in the α-
heme of MnIIIHb binds H2O as a sixth ligand, whereas the β-heme does not and is 
five-coordinate.24   
4.8.2 The Structure of the Reduced MnIIMb Complex.  The reduction of 
MnIIIMb to MnIIMb in solution is a well-studied reaction, and the reduction can be 
effected using dithionite,11,46,81 radiolysis,46 electrochemical methods employing 
surfactant films,68 or employing the mediator oxazine-170 perchlorate.82  Hori et al. 
employed powder and single-crystal multifrequency EPR spectroscopy to determine 
that the metal center in MnIIMb is high-spin 3d5 (S = 5/2)65 and this is consistent with 
a singly-occupied strongly antibonding dx2-y2 orbital.6 
 Arnone and coworkers reported the 3.0 Å resolution crystal structure of the 
metallohybrid hemoglobin Hb(α-FeIICO)(β-MnII) that crystallizes in the deoxyHb T-
state.83  They determined that the β-MnII subunit is structurally isomorphous with the 
normal deoxy β-Fe subunit.  
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 The crystal structure of MnIIMb reported here reveals that the distal pocket 
water molecules are displaced upon dithionite reduction of MnIIIMb(H2O).  Thus, 
unlike the case of MnIIIMb(H2O), no water molecules were located in the vicinity of 
the MnII center.  This contrasts with several reported crystal structures of iron-
containing deoxyMb where a non-coordinated water molecule has been located in the 
distal pocket.69-73,84 
 The apical displacement of the Mn atom in MnIIMb (ΔMn = 0.34 Å) from the 
heme 4N plane is larger than that observed for MnIIIMb(H2O) (ΔMn = 0.18 Å).  This 
increase in apical displacement upon reduction of the protein is similar to that seen in 
the high-resolution structures of reduced Mb (ΔFe = 0.363(11) Å) vs. aquometMb 
(ΔFe = 0.106(7) Å).69  The heme environments of MnIIIMb(H2O) and MnIIMb, 
obtained from the overlay of the protein Cα backbones, are shown in Figure 4.6.  
Differences are evident in the water ligation and distal His64 placement in these 
proteins.  The His64 residue in the reduced MnIIMb more closely overlaps the minor 
conformation of the His64 residue in MnIIMb(H2O).  Figure 4.7 shows an overlay of 
the heme sites in the reduced MnIIMb and deoxyMb (FeIIMb, Figure 4.7).  In the 
reduced FeIIMb case, one of the two conformations of the distal His64 residue reveals 
an inward movement that supposedly helps stabilize the distal pocket water molecule 
through hydrogen-bonding, whereas in the reduced MnIIMb case such a hydrogen-
bond stabilization is not present due to the lack of distal pocket water.  A 
superposition of the heme environments of MnIIMb and FeIIMb is shown in Figure 4.7 





Figure 4.6.   A superposition of the heme environments in the crystal structures of hh 
MnIIIMb(H2O) (this work, shown in light grey) and hh MnIIMb (this work, shown in 
dark grey) using a global Cα structural alignment, and shown from two different 
views.  The Nε atoms of His64 and His93 residues of MnIIMb are shifted from their 
major/minor positions in MnIIIMb(H2O) by 0.95/0.21 and 0.37 Å, respectively.  Also, 
the MnII center is shifted 0.25 Å from its MnIII position.  A meso carbon and its 
connecting pyrrole ring A are shifted towards the proximal side in MnIIMb relative to 









Figure 4.7.  A superposition of the heme environments in the crystal structures of hh 
MnIIMb (this work, shown in light grey) and hh FeIIMb (pdb code 1A6N,69 shown in 
dark grey) using a global Cα structural alignment.  The distal pocket water in hh 
FeIIMb is located 3.53 Å from Fe, and is 2.76 Å from the inward conformation of the 
distal His64 residue; the outer conformation overlaps with that of aquometMb  
 
 
 4.8.3 The Structure of the Azide Complex.  The azide anion is a known 
inhibitor of cellular respiration, and it also inhibits the catalytic activities of catalase, 
cytochrome oxidase, and peroxidases.42  The azide adduct of Mn-substituted Mb has 
been reported,11,81 and has been characterized by optical and resonance Raman 
spectroscopy.22  Hoffman and Gibson reported anomalous binding of azide to 
MnIIIMb, and determined that the reaction of azide with MnIIIMb proceeded in two 
kinetically separable steps to eventually generate MnIIIMb(N3–).26  In contrast, azide 
binding to iron-containing metMb is consistent with a single binding equilibrium.85  
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The 2.8 Å resolution crystal structure of the azide complex of the iron-containing 
horse metHb is known.86,87  The related crystal structure of the azide adduct of metMb 
was first reported by Stryer et al. in 1964.88  A comparison of the crystal structures of 
hh MbIII(N3–) (at 2.0 Å resolution) and its His64Thr mutant (at 1.8 Å resolution) was 
reported by Maurus et al. in 1998.89  In the wild type adduct, the Fe–N–N(N) bond 
was 119°, and the Fe–N(azide) bond was 2.11 Å.  In the His64Thr mutant structure, 
two conformations of the azide ligand were present; the major (~90%) conformation 
oriented the azide ligand towards the interior of the protein (as seen in the wild type 
structure), and the minor conformation oriented the azide ligand towards to exterior 
of the protein towards the solvent.  The latter minor conformation is reminiscent of 
the 1.9 Å resolution crystal structure of the azide adduct of ferric myoglobin isolated 
from the buccal muscles of the Mediterranean mollusc Aplysia limacine, where the 
azide ligand is oriented towards the solvent 90; this protein lacks a distal His64(E11) 
residue. 
The crystal structure of hh MnIIIMb(N3–) reported here, and shown in Figure 
4.1d, is similar to that of wild type MbIII(N3–),89 in which only one conformation of 
the azide ligand was observed.  In both compounds, the azide ligand is oriented 
towards the interior of the protein.  As is the case of the iron-containing MbIII(N3–), 
the azide ligand is oriented towards the distal Ile107 residue and in Van der Waal’s 
contact with Leu29.  The Mn atom in MnIIIMb(N3–) is almost in the heme 4N plane, 
with an apical displacement of only 0.08 Å.  The near in-plane position of Mn is 
consistent with the six-coordination of the metal center and near-complete (94%) 
occupancy of the azide ligand.  The proximal Mn–N(His93) bond length in 
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MnIIIMb(N3–) of 2.50 Å is, however, longer than that observed in the iron-containing 
MbIII(N3–) (2.06 Å), demonstrating the effect that the MnIII d4 center has on this axial 
bond length when compared with the ferric d5 center.  Ferric MbIII(N3–) has been 
shown to exhibit a ground-state low-spin electronic configuration and an observable 
low-spin/high-spin equilibrium at room temperature.85  In contrast, the d4 complex 
MnIIIMb(N3–) is known to be high-spin,26 and this likely accounts for its longer 
proximal metal–N(His93) bond length.   
4.8.4 The Nitric Oxide Complex.  For convenience, the nitrosyl adduct of 
MnIIMb is represented as MnIIMb(NO), although it is perhaps better represented as 
{MnNO}6 (see later).  In order to place the NO ligand conformation observed in 
MnIIMb(NO) in proper context, some discussion of formalism is warranted.91,92  For 
example, the oxidation state formalism has often been used to describe metal nitrosyl 
linkages.  In this formalism, NO binding to a metal center (M) to generate a linear M-
NO unit results in a complex formulated as M–(NO+), where a formal electron 
transfer to the metal has occurred.  Conversely, when a bent M-NO moiety is 
generated, the complex is formulated as M+(NO–).  Clearly, this formalism is overly 
simplistic.  Although it does take into account that NO is a redox active ligand, it does 
not account for cases where the unpaired electron density on NO essentially still 
resides on the ligand in its metal complex.  Enemark and Feltham developed a 
notation that treats the metal-NO fragment as a single unit, and the use of the 
resulting formalism avoids the oxidation state simplification of the metal-NO 
group.93-95  In this {MNO}n formalism, n denotes the number of assigned electrons to 
the metal d orbitals (without consideration of the NO ligand(s)) plus an electron for 
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each of the attached NO ligands.  Thus, the (por)Mn(NO) complex belongs to the 
{MnNO}6 class, and the (por)Fe(NO) belongs to the {MNO}7 class.  According to 
this formalism as applied to nitrosyl metallopophyrins, {MNO}6 compounds have 
preferred linear NO geometries, and {MNO}7 compounds have bent (~145°) NO 
geometries.  In synthetic six-coordinate iron nitrosyl porphyrins of the {MNO}7 class, 
the FeNO angles are in the tight 137–140° range (avg. ~138.5°).96,97  A much wider 
range of FeNO bond angles (112°–160°) is observed in nitrosyl heme proteins, 
however.50  The reported 1.3 Å resolution crystal structures of hh MbNO showed that 
two reproducible FeNO angles (~144° and 120°) are obtained depending on the 
method of preparation of the complex.50  The variability of FeNO angle in the heme 
pocket of MbNO had been demonstrated previously by Hori et al. using single crystal 
EPR spectroscopy; the FeNO angle was 153 ± 5 at 293K, but was 109 ± 5 at 77 K.98  
Chien and Dickenson showed, using single crystal EPR spectroscopy, that the FeNO 
angles in HbKNO were 167° in the α-subunits and 105° in the β-subunits.15  It is thus 
likely that subtle distal pocket effects influence the metal-NO bond geometry in 
nitrosyl adducts of heme proteins.  We now consider the case of MnIIMb(NO) and 
compare the observed geometry to that expected from synthetic manganese nitrosyl 
porphyrins. 
 To date, all synthetic (por)Mn(NO)-containing compounds of the {MnNO}6 
class (i.e., MnIINO) that have been characterized by X-ray crystallography display 
linear Mn-NO groups.39,40,99,100  The expected and observed linearity of the MnNO 
bonds is supported by the spectroscopic characterization of several low-spin 
(por)Mn(NO)-containing compounds.35,37,92,101  Yu et al. employed resonance Raman 
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spectroscopy to demonstrate that steric constraints within the distal face of a synthetic 
“strapped” (por)Mn(NO) complex enhances the Mn–N–O bending mode, and they 
attributed this observation to a tilting of the trans Mn–N(N-base) bond.101 
 As stated in the Introduction, NO adducts of Mn-substituted heme proteins 
have been prepared and characterized by spectroscopy.  MnIIIMb does not bind NO, 
however MnIIMb does.32  Interestingly, Gersonde and coworkers demonstrated, using 
resonance Raman spectroscopy, that the monomeric MnIIIHb compound from the 
insect Chironomus thummi thummi binds NO to give the MnIIINO adduct, but this 
undergoes autoreduction to the MnIINO derivative.33   
 To the best of our knowledge, the crystal structure of MnIIMb(NO) reported in 
this work (Figure 4.3a) represents the first distinctly bent MnNO moiety in a natural 
or synthetic manganese heme complex.  The NO ligand refines to 70% occupancy, 
but the MnNO bend is clearly evident in the structure.  The nitrosyl N atom is 2.6 Å 
away from the Nε atom of the major conformation of the distal His64 residue, 
suggesting strong hydrogen-bond stabilization of the NO molecule in the distal 
pocket.  As mentioned in the Results section, the observed long Mn–NO distance of 
2.53 Å is likely an average distance that has contributions from the unligated five-
coordinate MnIIMb complex and the nitrosyl adduct.  Assuming that the Mn atom 
were in the heme 4N plane in MnIIMb(NO), the resulting Mn–NO distance would still 
be rather long.  Thus, we propose that the geometry of the MnNO moiety observed 
here represents that of a loosely bound NO molecule to the metal center that is held in 
place by strong hydrogen-bonding to the distal His64 residue.  This geometry is also 
likely determined by the method of preparation of the complex, namely the 
 
 115 
nitrosylation of the preformed distal pocket in the MnIIMb crystals.  Such a procedure 
may disfavor linear (strong) binding of the NO ligand without significant movement 
of the distal His64 residue away from its position in MnIIMb.  We are continuing 
attempts to crystallize pre-formed MnIIMb(NO) to test this hypothesis. 
 4.8.5 The Nitrite Complex of MnIIIMb and CoIIIMb.  There is renewed 
interest in the nature of binding of the nitrite anion to heme proteins.43,102  It has long 
been appreciated that the heme-nitrite interaction is an essential one insofar as nitrite 
reduction by the heme-containing nitrite reductases (NiRs) is concerned.  Nitrite is 
reduced to NO by the NiRs103-105 and this process is believed to involve initial binding 
of nitrite directly to the iron center in the heme-containing NiRs.  Crystal structures of 
the nitrite adducts of cytochrome cd 1 NiR from P. Pantotrophus reveals the N-
binding (i.e., nitro) mode of nitrite to the iron center.106 
 
Although this nitrite adduct was obtained by soaking crystals of ferrous NiR with 
nitrite, it is reasonable to assume that such an N-binding mode would facilitate 
protonation of a nitrite terminal O-atom to result in eventual release of NO and a 
water molecule.  The crystal structure of the nitrite adduct of ferric cytochrome c NiR 
from Wolinella succinogenes also shows N-binding of the nitrite anion to the iron 
center, and density functional calculations on the related model compound 
(por)FeIII(NH3)(NO2) reveals that the N-binding mode is more stable than the nitrito 
O-binding mode by >10 kcal/mol.107  The crystal structure of the nitrite adduct of the 
 
 116 
sulfite reductase hemoprotein from E. coli similarly reveals an N-binding mode of the 
nitrite anion to the iron center.108   
 Interestingly, DFT calculations on the nitrite adduct of cytochrome cd1 NiR 
provide intriguing possibilities for nitrite coordination to the heme center in this 
enzyme.109  Although the nitrito O-binding mode was determined to be 4.5 kcal/mol 
higher in energy than the corresponding nitro N-binding mode in the ferric form (6 
kcal/mol in the ferrous form), the nitrito form was considered to also be a viable 
intermediate in NiR catalysis.   
 The nitro N-binding mode has been determined for all crystallographically 
characterized synthetic iron porphyrins containing the nitrite ligand, regardless of 
whether the iron center is formally in the ferric or ferrous state.96  The only exception 
to this is that for the nitrite in the anionic complex [(TpivPP)Fe(NO)(NO2)]– which 
displays both N-binding (nitro) and O-binding (nitrito) of the disordered nitrite 
group.110  Results of DFT calculations on a model iron porphyrin with NO and nitrite 
ligands show that the nitrito linkage isomer (porphine)Fe(NO)(ONO) is only 4.3 
kcal/mol higher in energy than the related nitro isomer (porphine)Fe(NO)(NO2).111 
Our group reported the 1.3 Å resolution X-ray crystal structure of the nitrite 
adduct of ferric horse heart Mb and showed that the nitrite anion was bound to the 
ferric center via the nitrito O-binding mode.50  Importantly, this structure was the first 
to demonstrate that a stable O-binding mode of nitrite is possible in heme proteins.  
Given this rather unexpected nitrito binding mode for the nitrite ligand in the iron-
containing d5 compound MbIII(ONO–) and the role of the distal pocket in stabilizing 
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this (to date) unusual binding mode, we sought to investigate the nitrite binding 
preferences within the distal pockets of the d4 MnIII and d6 CoIII analogues. 
To the best of our knowledge, there is only one report of a crystal structure of 
a synthetic manganese porphyrin containing nitrite, namely that of 
(TPP)MnIII(ONO).112  This compound clearly reveals a nitrito O-binding mode of the 
nitrite anion.  Interestingly, although continuous photolysis of this compound shows 
the formation of (TPP)Mn(O) and NO,112,113 flash photolysis studies on this compound 
reveal dissociation of NO2 from the metal center.114  Recombination of NO2 with the 
(TPP)MnII photoproduct then proceeds via a nitro (TPP)Mn(NO2) intermediate that 
isomerizes to the more stable (TPP)Mn(ONO) compound.114  Not surprisingly, 
therefore, the crystal structure of MnIIIMb(ONO–) also shows that the nitrite anion 
binds to the manganese center via the nitrito O-binding mode (Figure 4.3b).   
The situation for cobalt was not expected, however.  To date, all 
crystallographically characterized nitrite adducts of synthetic cobalt porphyrins 
demonstrate that the nitrite anion is bound to the cobalt centers via the nitro N-
binding mode.115-118  To the best of our knowledge, there is no exception to this 
observation for model cobalt porphyrin compounds.  Indeed, it was demonstrated that 
during the recombination of NO2 with (TPP)CoII (generated from flash photolysis of 
(TPP)CoIII(NO2)), an intermediate forms which decays to (TPP)CoIII(NO2); the 
intermediate was assigned as the nitrito linkage isomer (TPP)CoIII(ONO).119 
To the best of our knowledge, no nitrite adducts of cobalt-substituted heme 
proteins or related cobalt biomolecules have been characterized.  Thus, the structure 
of CoIIIMb(ONO–) represents the first report of a cobalt nitrite heme protein, and is 
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the first stable nitrito binding to cobalt porphyrins to be established.  Clearly, it is 
evident that although information from crystal structures of cobalt nitrite compounds 
of model porphyrins have helped in understanding the mechanisms of action of these 
compounds as catalysts for chemical transformation such as O-atom transfers in 
oxidation reactions (generating (por)Co(NO) intermediates),118 the structures may not 
correlate very well with the geometries present in cobalt-substituted heme proteins.  
The ability of the distal pocket in CoIIIMb to effect the nitrito O-binding preference is 
significant, and suggests that the hydrogen-bonding provided by the distal His64 
residue is primary in stabilizing this binding mode.  Since such a moderate to strong 
hydrogen bonding capability is absent in most synthetic cobalt porphyrins with nitrite 
ligands, it is thus not surprising that this O-binding mode has yet to be observed in 
these model compounds.  It is somewhat surprising, however, that even in the picket 
fence porphyrin derivatives such as (TpivPP)Co(NO2)(1-MeIm) which provide 
electrostatic interactions between “distal” NH groups and bound nitrite, that this 
stabilization is not sufficient to induce O-binding of the nitrite group,116 perhaps due 
to the artificial symmetrical nature of the distal pockets. 
In summary, the X-ray crystal structures reported to date of synthetic Mn, Fe, 
and Co porphryins with nitrite ligands reveal a preference for nitrito O-binding for the 
Mn compound, and nitro N-binding for the Fe and Co compounds.  In the Mb 
derivatives, however, all three metal-nitrite derivatives (MnIII, FeIII, and CoIII) reveal 
the nitrito O-binding mode, suggesting that the distal pocket of Mb is the major 





 The recent biological role of nitrite ion in many physiological processes such 
as hypoxic vasodilation, ischemia reperfusion, and mitochondrial respiration has been 
demonstrated to be due to its conversion to NO under enzymatic or nonenzymatic 
reduction. In the enzymatic pathway, deoxy hemoglobin and deoxy myoglobin have 
been reported to mediate this conversion. We are interested in the active site structure 
of the complexes formed from myoglobin–nitrite or myoglobin-NO adducts and how 
the metal-heme center and the peripheral amino acids in the distal pocket will affect 
the binding mode of these biologically important ligands. Our group has previously 
reported the unusual nitrito O-binding mode of coordinated nitrite in the iron-
containing hh MbIII(ONO). In this chapter, we reported the 1.60 Å resolution crystal 
structures of the nitrite adducts of manganese and cobalt-substituted horse heart 
myoglobin (hh MnMb, hh CoMb). Interestingly, both of the structures reveal the O-
binding mode (hh MnIIIMb(ONO), hh CoIIIMb(ONO)) although all known cobalt 
nitrite model compounds are showing N-bound nitrite coordination mode suggesting 
the effective role of the distal histidine amino acid (His 64) in forcing the O-binding 
mode through the H-bonding with the coordinated oxygen atom of nitrite ion. In 
addition we reported the 1.90 Å resolution crystal structure of MnMb-NO adduct. 
The structure suggests a loosely bound NO in the distal pocket; the Mn–N–O moiety 
is surprisingly bent, and represents the first such distinctly bent metal-NO unit for a 
natural or synthetic manganese porphyrin complex. We also reported the high 
resolution crystal structures of the oxidized Mn-substituted horse heart myoglobin 
(hh MnIIIMb), the reduced form (hh MnIIMb), and complexes of hh MnMb with 
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methanol, and azide. The MnIIIMb compound contains distal pocket water in two 
positions, one coordinated and the other uncoordinated. This finding explains the 
controversial spectroscopic, kinetic, and electrochemical properties reported in the 
literature. The reduced form, MnIIMb, lacks a distal pocket water molecule, in 
contrast to that observed previously for the iron-containing deoxyMb. 
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Table 2.4.  Bond Lengths [Å] for [Ru(bpb)(NO)]2(µ-O). 
------------------------------------------------------------------------------------------------------ 
Ru(1)-N(25)                        1.7486(17) 
Ru(1)-O(27)                         1.8829(3) 
Ru(1)-N(9)  1.9890(16) 
Ru(1)-N(16)  1.9935(15) 
Ru(1)-N(1)  2.1277(15) 
Ru(1)-N(24)  2.1507(16) 
N(1)-C(2)  1.335(2) 
N(1)-C(6)  1.359(2) 
C(2)-C(3)  1.383(3) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.382(3) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.386(3) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.382(3) 
C(5)-H(5)  0.9500 
C(6)-C(7)  1.515(3) 
C(7)-O(8)  1.230(2) 
C(7)-N(9)  1.344(2) 
N(9)-C(10)  1.416(2) 
C(10)-C(11)  1.395(3) 
C(10)-C(15)  1.421(3) 
C(11)-C(12)  1.394(3) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.385(3) 
C(12)-H(12)  0.9500 
C(1S')-H(1S2)  0.99 
C(13)-C(14)  1.388(3) 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.398(3) 
C(14)-H(14)  0.9500 
C(15)-N(16)  1.417(2) 
N(16)-C(17)  1.343(2) 
C(17)-O(18)  1.233(2) 
C(17)-C(19)  1.511(3) 
C(19)-N(24)  1.359(2) 
C(19)-C(20)  1.385(3) 
C(20)-C(21)  1.379(3) 
C(20)-H(20)  0.9500 
C(21)-C(22)  1.380(3) 
C(21)-H(21)  0.9500 
C(22)-C(23)  1.383(3) 
 C(22)-H(22)  0.9500 
C(23)-N(24)  1.339(3) 
C(23)-H(23)  0.9500 
N(25)-O(26)  1.174(2) 
O(27)-Ru(1)#1  1.8829(3) 
Cl(1S)-C(1S)  1.764(3) 
Cl(2S)-C(1S)  1.764(2) 
C(1S)-H(1SA)  0.9900 
C(1S)-H(1SB)  0.9900 
Cl(1')-C(1S')  1.764(4) 
Cl(2')-C(1S')  1.763(4) 
C(1S')-H(1S1)  0.9900 
 
Table 2.5.  Bond Angles [°] for [Ru(bpb)(NO)]2(µ-O). 
------------------------------------------------------------------------------------------------------- 

































































































Table 3.6.  Bond Lengths [Å] for (TTP)Mn(NO)(MeOH). 
 ---------------------------------------------------------------------------------------------------- 
Mn(1)-N(5)                    1.6804(17) 
Mn(1)-N(1)  2.0077(17) 
Mn(1)-N(3)  2.0148(17) 
Mn(1)-N(2)  2.0212(16) 
Mn(1)-N(4)  2.0315(17) 
Mn(1)-O(2)  2.0863(15) 
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O(1)-N(5)  1.165(2) 
O(2)-C(49)  1.455(3) 
N(1)-C(1)  1.372(2) 
N(1)-C(4)  1.374(3) 
N(2)-C(9)  1.380(2) 
N(2)-C(6)  1.384(3) 
N(3)-C(14)  1.376(3) 
N(3)-C(11)  1.379(2) 
N(4)-C(16)  1.377(3) 
N(4)-C(19)  1.377(2) 
C(1)-C(20)  1.403(3) 
C(1)-C(2)  1.442(3) 
C(2)-C(3)  1.345(3) 
C(3)-C(4)  1.437(3) 
C(4)-C(5)  1.403(3) 
C(5)-C(6)  1.405(3) 
C(5)-C(21)  1.497(3) 
C(6)-C(7)  1.437(3) 
C(7)-C(8)  1.352(3) 
C(8)-C(9)  1.441(3) 
C(9)-C(10)  1.402(3) 
C(10)-C(11)  1.389(3) 
C(10)-C(28)  1.504(3) 
C(11)-C(12)  1.446(3) 
C(12)-C(13)  1.347(3) 
C(13)-C(14)  1.445(3) 
C(14)-C(15)  1.402(3) 
C(15)-C(16)  1.395(3) 
C(15)-C(35)  1.496(3) 
C(16)-C(17)  1.443(3) 
C(17)-C(18)  1.358(3) 
C(18)-C(19)  1.443(3) 
C(19)-C(20)  1.394(3) 
C(20)-C(42)  1.501(3) 
C(21)-C(26)  1.392(3) 
C(21)-C(22)  1.404(3) 
C(22)-C(23)  1.386(3) 
C(23)-C(24)  1.384(4) 
C(24)-C(25)  1.394(3) 
C(24)-C(27)  1.513(3) 
C(25)-C(26)  1.398(3) 
C(28)-C(29)  1.386(3) 
C(28)-C(33)  1.391(3) 
C(29)-C(30)  1.389(3) 
C(30)-C(31)  1.381(3) 
C(31)-C(32)  1.390(3) 
C(31)-C(34)  1.513(3) 
C(32)-C(33)  1.387(3) 
C(35)-C(36)  1.389(3) 
C(35)-C(40)  1.393(3) 
C(36)-C(37)  1.394(3) 
C(37)-C(38)  1.385(4) 
C(38)-C(39)  1.391(4) 
C(38)-C(41)  1.511(3) 
C(39)-C(40)  1.388(3) 
C(42)-C(47)  1.389(3) 
C(42)-C(43)  1.397(3) 
C(43)-C(44)  1.393(3) 
C(44)-C(45)  1.387(3) 
C(45)-C(46)  1.387(3) 
C(45)-C(48)  1.513(3) 
C(46)-C(47)  1.391(3) 
Mn(2)-Mn(2)#1  0.3354(18) 
Mn(2)-N(8)  1.676(3) 
Mn(2)-O(4)#1  1.748(3) 
Mn(2)-N(6)#1  2.0044(19) 
Mn(2)-N(8)#1  2.007(3) 
Mn(2)-N(7)  2.020(2) 
Mn(2)-N(6)  2.037(2) 
Mn(2)-N(7)#1  2.038(2) 
Mn(2)-O(4)  2.081(3) 
O(4)-C(74)  1.478(4) 
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O(4)-Mn(2)#1  1.748(3) 
N(8)-O(3)  1.169(3) 
N(8)-Mn(2)#1  2.007(3) 
N(6)-C(50)  1.375(3) 
N(6)-C(53)  1.378(3) 
N(6)-Mn(2)#1  2.0044(19) 
N(7)-C(58)  1.376(2) 
N(7)-C(55)  1.379(3) 
N(7)-Mn(2)#1  2.038(2) 
C(50)-C(59)#1  1.397(3) 
C(50)-C(51)  1.438(3) 
C(51)-C(52)  1.346(3) 
C(52)-C(53)  1.445(3) 
C(53)-C(54)  1.398(3) 
C(54)-C(55)  1.400(3) 
C(54)-C(60)  1.499(3) 
C(55)-C(56)  1.442(3) 
C(56)-C(57)  1.358(3) 
C(57)-C(58)  1.445(3) 
C(58)-C(59)  1.396(3) 
C(59)-C(50)#1  1.397(3) 
C(59)-C(67)  1.502(3) 
C(60)-C(61)  1.396(3) 
C(60)-C(65)  1.398(3) 
C(61)-C(62)  1.390(3) 
C(62)-C(63)  1.383(4) 
C(63)-C(64)  1.387(4) 
C(63)-C(66)  1.517(4) 
C(64)-C(65)  1.396(4) 
C(67)-C(72)  1.389(3) 
C(67)-C(68)  1.394(3) 
C(68)-C(69)  1.390(3) 
C(69)-C(70)  1.389(3) 
C(70)-C(71)  1.380(3) 
C(70)-C(73)  1.513(3) 
C(71)-C(72)  1.390(3) 
C(75)-Cl(2)  1.717(4) 
C(75)-Cl(1)  1.719(3) 
C(76)-O(5)  1.465(4) 
C(77)-O(6)  1.479(5) 
C(78)-O(7)  1.476(5) 
C(79)-O(8)  1.479(5) 
C(80)-O(9)  1.472(5) 
 





























































































































































































































 Table 3.8.  Bond Lengths [Å] for (TTP)Mn(NO)(1-MeIm). 
-------------------------------------------------------------------------------------------------------
Mn(1)-N(5)  1.650(2) 
Mn(1)-N(3)  2.023(2) 
Mn(1)-N(1)  2.024(2) 
Mn(1)-N(2)  2.027(2) 
Mn(1)-N(4)  2.029(2) 
Mn(1)-N(6)  2.096(2) 
O(1)-N(5)  1.174(3) 
N(1)-C(4)  1.374(4) 
N(1)-C(1)  1.381(3) 
N(2)-C(6)  1.376(4) 
N(2)-C(9)  1.379(3) 
N(3)-C(14)  1.370(4) 
N(3)-C(11)  1.377(3) 
N(4)-C(19)  1.374(4) 
N(4)-C(16)  1.384(4) 
N(6)-C(51)  1.324(4) 
N(6)-C(49)  1.374(4) 
N(7)-C(51)  1.341(4) 
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N(7)-C(50)  1.374(4) 
N(7)-C(52)  1.463(4) 
C(1)-C(20)  1.397(4) 
C(1)-C(2)  1.442(4) 
C(2)-C(3)  1.350(4) 
C(2)-H(2A)  0.9500 
C(3)-C(4)  1.449(4) 
C(3)-H(3A)  0.9500 
C(4)-C(5)  1.403(4) 
C(5)-C(6)  1.411(4) 
C(5)-C(21)  1.496(4) 
C(6)-C(7)  1.444(4) 
C(7)-C(8)  1.355(4) 
C(7)-H(7A)  0.9500 
C(8)-C(9)  1.437(4) 
C(8)-H(8A)  0.9500 
C(9)-C(10)  1.402(4) 
C(10)-C(11)  1.388(4) 
C(10)-C(28)  1.498(4) 
C(11)-C(12)  1.446(4) 
C(12)-C(13)  1.339(4) 
C(12)-H(12A)  0.9500 
C(13)-C(14)  1.447(4) 
C(13)-H(13A)  0.9500 
C(14)-C(15)  1.392(4) 
C(15)-C(16)  1.395(4) 
C(15)-C(35)  1.494(4) 
C(16)-C(17)  1.433(4) 
C(17)-C(18)  1.361(4) 
C(17)-H(17A)  0.9500 
C(18)-C(19)  1.439(5) 
C(18)-H(18A)  0.9500 
C(19)-C(20)  1.402(4) 
C(20)-C(42)  1.497(4) 
C(21)-C(22)  1.390(4) 
C(21)-C(26)  1.398(4) 
C(22)-C(23)  1.399(5) 
C(22)-H(22A)  0.9500 
C(23)-C(24)  1.387(5) 
C(23)-H(23A)  0.9500 
C(24)-C(25)  1.389(5) 
C(24)-C(27)  1.512(5) 
C(25)-C(26)  1.388(5) 
C(25)-H(25A)  0.9500 
C(26)-H(26A)  0.9500 
C(27)-H(27A)  0.9800 
C(27)-H(27B)  0.9800 
C(27)-H(27C)  0.9800 
C(28)-C(29)  1.389(4) 
C(28)-C(33)  1.390(4) 
C(29)-C(30)  1.390(4) 
C(29)-H(29A)  0.9500 
C(30)-C(31)  1.381(5) 
C(30)-H(30A)  0.9500 
C(31)-C(32)  1.381(6) 
C(31)-C(34)  1.516(5) 
C(32)-C(33)  1.390(5) 
C(32)-H(32A)  0.9500 
C(33)-H(33A)  0.9500 
C(34)-H(34A)  0.9800 
C(34)-H(34B)  0.9800 
C(34)-H(34C)  0.9800 
C(35)-C(36)  1.397(5) 
C(35)-C(40)  1.397(4) 
C(36)-C(37)  1.392(5) 
C(36)-H(36A)  0.9500 
C(37)-C(38)  1.382(5) 
C(37)-H(37A)  0.9500 
C(38)-C(39)  1.379(5) 
C(38)-C(41)  1.511(5) 
C(39)-C(40)  1.380(5) 
C(39)-H(39A)  0.9500 
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C(40)-H(40A)  0.9500 
C(41)-H(41A)  0.9800 
C(41)-H(41B)  0.9800 
C(41)-H(41C)  0.9800 
C(42)-C(47)  1.397(4) 
C(42)-C(43)  1.400(4) 
C(43)-C(44)  1.398(4) 
C(43)-H(43A)  0.9500 
C(44)-C(45)  1.380(5) 
C(44)-H(44A)  0.9500 
C(45)-C(46)  1.390(5) 
C(45)-C(48)  1.509(5) 
C(46)-C(47)  1.387(4) 
C(46)-H(46A)  0.9500 
C(47)-H(47A)  0.9500 
C(48)-H(48A)  0.9800 
C(48)-H(48B)  0.9800 
C(48)-H(48C)  0.9800 
C(49)-C(50)  1.359(4) 
C(49)-H(49A)  0.9500 
C(50)-H(50A)  0.9500 
C(51)-H(51A)  0.9500 
C(52)-H(52A)  0.9800 
C(52)-H(52B)  0.9800 
C(52)-H(52C)  0.9800 
Mn(2)-N(10)  1.755(9) 
Mn(2)-N(9)#1  1.981(3) 
Mn(2)-N(8)  1.992(3) 
Mn(2)-N(9)  2.068(3) 
Mn(2)-N(8)#1  2.072(3) 
Mn(2)-N(11)  2.047(7) 
N(11)-C(79)  1.332(9) 
N(11)-C(77)  1.482(8) 
N(12)-C(77)  1.349(8) 
N(12)-C(78)  1.375(8) 
N(12)-C(80)  1.486(8) 
C(77)-H(77A)  0.9500 
C(78)-C(79)  1.376(10) 
C(78)-H(78A)  0.9500 
C(79)-H(79A)  0.9500 
C(80)-H(80A)  0.9800 
C(80)-H(80B)  0.9800 
C(80)-H(80C)  0.9800 
N(10)-O(2)  1.127(10) 
C(81)-Cl(2)  1.719(4) 
C(81)-Cl(1)  1.720(4) 
C(81)-H(81A)  0.9900 
C(81)-H(81B)  0.9900 
N(8)-C(53)  1.365(3) 
N(8)-C(56)  1.375(4) 
N(8)-Mn(2)#1  2.072(3) 
N(9)-C(61)  1.369(3) 
N(9)-C(58)  1.378(3) 
N(9)-Mn(2)#1  1.981(3) 
C(53)-C(62)#1  1.396(4) 
C(53)-C(54)  1.439(4) 
C(54)-C(55)  1.345(4) 
C(54)-H(54A)  0.9500 
C(55)-C(56)  1.441(4) 
C(55)-H(55A)  0.9500 
C(56)-C(57)  1.403(4) 
C(57)-C(58)  1.405(4) 
C(57)-C(63)  1.495(4) 
C(58)-C(59)  1.439(4) 
C(59)-C(60)  1.345(4) 
C(59)-H(59A)  0.9500 
C(60)-C(61)  1.436(4) 
C(60)-H(60A)  0.9500 
C(61)-C(62)  1.397(4) 
C(62)-C(53)#1  1.396(4) 
C(62)-C(70)  1.498(4) 
C(63)-C(68)  1.394(4) 
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C(63)-C(64)  1.405(4) 
C(64)-C(65)  1.393(4) 
C(64)-H(64A)  0.9500 
C(65)-C(66)  1.391(5) 
C(65)-H(65A)  0.9500 
C(66)-C(67)  1.379(5) 
C(66)-C(69)  1.513(5) 
C(67)-C(68)  1.387(4) 
C(67)-H(67A)  0.9500 
C(68)-H(68A)  0.9500 
C(69)-H(69A)  0.9800 
C(69)-H(69B)  0.9800 
C(69)-H(69C)  0.9800 
C(70)-C(75)  1.392(4) 
C(70)-C(71)  1.396(4) 
C(71)-C(72)  1.380(4) 
C(71)-H(71A)  0.9500 
C(72)-C(73)  1.396(5) 
C(72)-H(72A)  0.9500 
C(73)-C(74)  1.389(5) 
C(73)-C(76)  1.506(4) 
C(74)-C(75)  1.389(4) 
C(74)-H(74A)  0.9500 
C(75)-H(75A)  0.9500 
C(76)-H(76A)  0.9800 
C(76)-H(76B)  0.9800 
C(76)-H(76C)  0.9800 
C(82)-Cl(4)  1.722(3) 
C(82)-Cl(3)  1.723(4) 
C(82)-H(82A)  0.9900 
C(82)-H(82B)  0.9900 
C(82')-Cl(3')  1.722(4) 
C(82')-Cl(4')  1.722(4) 
C(82')-H(82C)  0.9900 
C(82')-H(82D)  0.9900
 





































































































































































































































































































































































Table 3.10.  Bond Lengths [Å] for (TPP)Mn(NO)(1-MeIm).  
------------------------------------------------------------------------------------------------------- 
Mn(1)-N(5)            1.6411(13) 
Mn(1)-N(4)  2.0189(12) 
Mn(1)-N(2)  2.0200(12) 
Mn(1)-N(1)  2.0248(12) 
Mn(1)-N(3)  2.0280(12) 
Mn(1)-N(6)  2.0882(13) 
O(1)-N(5)  1.1718(17) 
N(1)-C(4)  1.3712(18) 
N(1)-C(1)  1.3738(19) 
N(2)-C(9)  1.3721(19) 
N(2)-C(6)  1.3731(18) 
N(3)-C(11)  1.3735(19) 
N(3)-C(14)  1.3736(17) 
N(4)-C(19)  1.3712(19) 
N(4)-C(16)  1.3728(18) 
N(6)-C(47)  1.321(2) 
N(6)-C(45)  1.3827(19) 
N(7)-C(47)  1.3478(19) 
N(7)-C(46)  1.374(2) 
N(7)-C(48)  1.456(2) 
C(1)-C(20)  1.391(2) 
C(1)-C(2)  1.445(2) 
C(2)-C(3)  1.349(2) 
C(2)-H(2A)  0.9500 
C(3)-C(4)  1.443(2) 
C(3)-H(3A)  0.9500 
C(4)-C(5)  1.398(2) 
C(5)-C(6)  1.397(2) 
C(5)-C(21)  1.4977(19) 
C(6)-C(7)  1.445(2) 
C(7)-C(8)  1.350(2) 
C(7)-H(7A)  0.9500 
C(8)-C(9)  1.442(2) 
C(8)-H(8A)  
C(9)-C(10)  1.401(2) 
C(10)-C(11)  1.398(2) 
C(10)-C(27)  1.499(2) 
C(11)-C(12)  1.4458(19) 
C(12)-C(13)  1.352(2) 
C(12)-H(12A)  0.9500 
 
 140 
C(13)-C(14)  1.443(2) 
C(13)-H(13A)  0.9500 
C(14)-C(15)  1.397(2) 
C(15)-C(16)  1.395(2) 
C(15)-C(33)  1.4982(19) 
C(16)-C(17)  1.446(2) 
C(17)-C(18)  1.348(2) 
C(17)-H(17A)  0.9500 
C(18)-C(19)  1.4409(19) 
C(18)-H(18A)  0.9500 
C(19)-C(20)  1.4038(19) 
C(20)-C(39)  1.498(2) 
C(21)-C(22)  1.387(2) 
C(21)-C(26)  1.390(2) 
C(22)-C(23)  1.393(2) 
C(22)-H(22A)  0.9500 
C(23)-C(24)  1.378(3) 
C(23)-H(23A)  0.9500 
C(24)-C(25)  1.372(3) 
C(24)-H(24A)  0.9500 
C(25)-C(26)  1.392(2) 
C(25)-H(25A)  0.9500 
C(26)-H(26A)  0.9500 
C(27)-C(28)  1.392(2) 
C(27)-C(32)  1.397(2) 
C(28)-C(29)  1.395(2) 
C(28)-H(28A)  0.9500 
C(29)-C(30)  1.383(3) 
C(29)-H(29A)  0.9500 
C(30)-C(31)  1.379(3) 
C(30)-H(30A)  0.9500 
C(31)-C(32)  1.393(2) 
C(31)-H(31A)  0.9500 
C(32)-H(32A)  0.9500 
C(33)-C(34)  1.390(2) 
C(33)-C(38)  1.393(2) 
C(34)-C(35)  1.391(2) 
C(34)-H(34A)  0.9500 
C(35)-C(36)  1.386(2) 
C(35)-H(35A)  0.9500 
C(36)-C(37)  1.387(2) 
C(36)-H(36A)  0.9500 
C(37)-C(38)  1.392(2) 
C(37)-H(37A)  0.9500 
C(38)-H(38A)  0.9500 
C(39)-C(40)  1.388(2) 
C(39)-C(44)  1.397(2) 
C(40)-C(41)  1.392(2) 
C(40)-H(40A)  0.9500 
C(41)-C(42)  1.386(2) 
C(41)-H(41A)  0.9500 
C(42)-C(43)  1.381(2) 
C(42)-H(42A)  0.9500 
C(43)-C(44)  1.390(2) 
C(43)-H(43A)  0.9500 
C(44)-H(44A)  0.9500 
C(45)-C(46)  1.346(2) 
C(45)-H(45A)  0.9500 
C(46)-H(46A)  0.9500 
C(47)-H(47A)  0.9500 
C(48)-H(48A)  0.9800 
C(48)-H(48B)  0.9800 
C(48)-H(48C)  0.9800 
C(49)-C(50)  1.377(3) 
C(49)-C(54)  1.393(3) 
C(49)-H(49A)  0.9500 
C(50)-C(51)  1.381(3) 
C(50)-H(50A)  0.9500 
C(51)-C(52)  1.347(4) 
C(51)-H(51A)  0.9500 
C(52)-C(53)  1.367(4) 
C(52)-H(52A)  0.9500 
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C(53)-C(54)  1.390(3) 
C(53)-H(53A)  0.9500 
C(54)-C(55)  1.500(4) 
C(55)-H(55A)  0.9800 
C(55)-H(55B)  0.9800 
C(55)-H(55C)  0.9800 
C(56)-C(61)  1.373(4) 
C(56)-C(57)  1.377(5) 
C(56)-H(56A)  0.9500 
C(57)-C(58)  1.400(4) 
C(57)-H(57A)  0.9500 
C(58)-C(59)  1.349(4) 
C(58)-H(58A)  0.9500 
C(59)-C(60)  1.359(4) 
C(59)-H(59A)  0.9500 
C(60)-C(61)  1.413(4) 
C(60)-H(60A)  0.9500 
C(61)-C(62)  1.435(4) 
C(62)-H(62A)  0.9800 
C(62)-H(62B)  0.9800 
C(62)-H(62C)  0.9800 
C(63)-C(65)#1  1.388(4) 
C(63)-C(64)  1.392(4) 
C(63)-H(63A)  0.9500 
C(64)-C(65)  1.384(4) 
C(64)-C(66)  1.538(7) 
C(65)-C(63)#1  1.388(4) 
C(65)-H(65A)  0.9500 
C(66)-H(66A)  0.9800 
C(66)-H(66B)  0.9800 
C(66)-H(66C)  0.9800 
 
Table 3.11.  Bond Angles [º] for (TPP)Mn(NO)(1-MeIm).  
------------------------------------------------------------------------------------------------------- 































































































































































































































































Table 3.12.  Bond Lengths [Å] for (T(p-OCH3)PP)Mn(NO)(1-MeIm).  
------------------------------------------------------------------------------------------------------- 
Mn(1)-N(5)                   1.645(3) 
Mn(1)-N(1)  2.015(3) 
Mn(1)-N(3)  2.028(3) 
Mn(1)-N(2)  2.032(3) 
Mn(1)-N(4)  2.034(3) 
Mn(1)-N(6)  2.097(3) 
O(1)-N(5)  1.176(4) 
O(2)-C(24)  1.388(4) 
O(2)-C(27)  1.438(5) 
O(3)-C(31)  1.378(4) 
O(3)-C(34)  1.424(5) 
O(4)-C(38)  1.372(4) 
O(4)-C(41)  1.434(5) 
O(5)-C(45)  1.380(4) 
O(5)-C(48)  1.407(5) 
N(1)-C(1)  1.365(4) 
N(1)-C(4)  1.404(4) 
N(2)-C(9)  1.375(4) 
N(2)-C(6)  1.382(4) 
N(3)-C(11)  1.365(4) 
N(3)-C(14)  1.398(4) 
N(4)-C(19)  1.370(4) 
N(4)-C(16)  1.377(4) 
N(6)-C(51)  1.307(5) 
N(6)-C(49)  1.382(5) 
N(7)-C(50)  1.331(5) 
N(7)-C(51)  1.368(5) 
N(7)-C(52)  1.446(6) 
C(1)-C(20)  1.427(5) 
C(1)-C(2)  1.429(5) 
C(2)-C(3)  1.360(5) 
C(3)-C(4)  1.434(5) 
C(4)-C(5)  1.410(4) 
C(5)-C(6)  1.398(5) 
C(5)-C(21)  1.501(5) 
C(6)-C(7)  1.420(5) 
C(7)-C(8)  1.341(5) 
C(8)-C(9)  1.434(5) 
C(9)-C(10)  1.396(5) 
C(10)-C(11)  1.413(5) 
C(10)-C(28)  1.514(5) 
C(11)-C(12)  1.439(5) 
C(12)-C(13)  1.360(5) 
C(13)-C(14)  1.420(5) 
C(14)-C(15)  1.402(5) 
C(15)-C(16)  1.400(5) 
C(15)-C(35)  1.501(5) 
C(16)-C(17)  1.445(5) 
C(17)-C(18)  1.352(5) 
C(18)-C(19)  1.455(4) 
C(19)-C(20)  1.380(5) 
C(20)-C(42)  1.500(5) 
C(21)-C(26)  1.377(5) 
C(21)-C(22)  1.385(5) 
C(22)-C(23)  1.391(5) 
C(23)-C(24)  1.385(5) 
C(24)-C(25)  1.378(5) 
C(25)-C(26)  1.397(5) 
C(28)-C(29)  1.378(5) 
C(28)-C(33)  1.393(5) 
C(29)-C(30)  1.387(5) 
C(30)-C(31)  1.366(5) 
C(31)-C(32)  1.372(5) 
C(32)-C(33)  1.377(5) 
C(35)-C(36)  1.387(5) 
C(35)-C(40)  1.389(5) 
C(36)-C(37)  1.377(5) 
C(37)-C(38)  1.387(5) 
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C(38)-C(39)  1.383(5) 
C(39)-C(40)  1.399(5) 
C(42)-C(47)  1.377(5) 
C(42)-C(43)  1.389(5) 
C(43)-C(44)  1.378(5) 
C(44)-C(45)  1.387(5) 
C(45)-C(46)  1.357(5) 
C(46)-C(47)  1.393(5) 
C(49)-C(50)  1.352(6) 
C(53)-Cl(1)  1.717(4) 
C(53)-Cl(2)  1.720(4) 
C(53')-Cl(1')  1.719(4) 
C(53')-Cl(2')  1.720(4) 
C(53")-Cl(1")  1.715(4) 
C(53")-Cl(2")  1.720(4) 
Table 3.13  Bond Angles [º] for (T(p-OCH3)PP)Mn(NO)(1-MeIm).  
------------------------------------------------------------------------------------------------------- 



































































































































Cl(1")-C(53")-Cl(2")        114.5(3)
 
 
 
 
 
 
